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Abstract
Poxviruses are large dsDNA viruses unique in their cytoplasmic replication. This autonomy
from the host nucleus poses novel challenges to genome replication, recombination, and
repair. Biochemical and genetic studies have confirmed that the viral genome encodes a
repertoire of replication components (polymerase, processivity factor, single-strand DNA
binding protein, primase/helicase, DNA ligase, scaffold protein). However, our knowledge
of the mechanism of viral DNA replication remains incomplete, as is our understanding of
which, if any, cellular proteins participate.

We have shown that infection does not induce or dampen the cellular DNA damage
response but that a key component of this response, the ATR protein kinase, plays a role
in viral genome replication. Inhibition of ATR destabilizes the small subunit (RRM2) of the
cellular ribonucleotide reductase, delays the accumulation of nascent viral genomes, and
results in the accumulation of subgenomic viral DNA fragments.

To understand how vaccinia virus responds to exogenous DNA damage, we subjected
cells to UV irradiation prior to (-1 hpi) or during (4 hpi) infection. Pre-irradiation of cells
decreased protein synthesis and led to an ~12-fold reduction in viral yield. In addition to
these cell-specific insults, irradiation at 4hpi introduced both cyclobutene pyrimidine
dimers (CPDs) and 6-4 photoproducts (6-4-PPs) lesions into the viral genome, halted
further DNA synthesis, and led to a more significant, ~35-fold reduction in viral yield. DNA
lesions persisted throughout infection and were indeed present in the genomes
encapsidated into nascent virions. Depleting several components of the cellular nucleotide
excision repair (XP-A, -F, -G) did not render infections hypersensitive to UV. However,
infections performed with viruses lacking the cellular DNA ligase (A50) or structure-
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specific nuclease (G5) were hypersensitive to UV irradiation (~3-fold and ~100-fold,
respectively). When the DNA polymerase inhibitor araC was added to WT infections at the
time of UV irradiation (4 hpi), hypersensitivity to UV irradiation was also seen (~10-fold).
Virions produced under the latter condition contained elevated levels of CPD adducts,
strongly suggesting that the viral polymerase can remove or repair UV lesions introduced
into the viral genome.
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Chapter 1-Introduction
Poxviruses: What are they, and why are they important?
Poxviruses, of which vaccinia virus is the prototypic member, are large dsDNA viruses
belonging to the family Poxviridae. These viruses infect various hosts including mammals,
insects, and birds [1]. Furthermore, the entire infectious lifecycle occurs in the host cell’s
cytoplasm. These viruses are now encompassed within a larger group known as
nucleocytoplasmic large DNA viruses (NCLDVs) [2]. Historically, poxviruses include one
of the deadliest viruses in human history, variola virus, the causative agent of smallpox.
Its eradication in 1977 using vaccinations of vaccinia virus or cowpox marks one of the
pinnacle achievements within the biomedical field. Another obligate human pathogen,
Molluscum contagiosum virus (MOCV), is still prevalent today, with over 3 million new
cases a year in the US alone. Furthermore, monkeypox virus (MPXV) remains of concern
as it is endemic in parts of Africa, and a recent case was even identified in Texas [3].
Beyond the impact on humans, poxviruses are of serious zoonotic threat.

The study of the poxvirus life cycle has elucidated numerous aspects of mammalian cell
biology. A prime example is the analysis of the B1 kinase and its similarity to a family of
cellular kinases known as vaccinia-related kinases (VRKs). These studies revealed that
VRK1 is important in regulating the function of Baf via phosphorylation during cell cycle
progression [4, 5]. These studies were followed up, and it was uncovered that
overexpression of VRK1 results in cancer progression as VRK1 facilitates a mesenchymal
to epithelial transition [6]. These findings support a role of VRK1 as a cancer promoter.
Furthermore, extensive characterization and genetic manipulation of poxviruses have led
to their use as both vaccine and oncolytic vectors. With the recent outbreak of SARS-
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CoV2, there has been an increased awareness in the need for ever-ready vectors for
vaccine development. Indeed, a vaccine for SARS-CoV2 utilizing modified vaccinia virus
Ankara (MVA) is in phase 3 clinical trials (recruiting on 2/14/22) [7]. As for oncovirotherapy,
two main species of poxviruses have been used, vaccinia and myxoma virus. There is
growing interest in combinatorial therapies using oncolytic viruses and standard of care
therapies (reviewed in [8]).

Finally, the exclusion of the poxviral lifecycle to the cytoplasm is unique among all other
mammalian DNA viruses. Therein lies the possibility that poxviruses have evolved creative
and innovative mechanisms to replicate and metabolize their genome. Beyond the ability
to identify novel targets for poxviral antivirals, an exploration into the process of poxviral
DNA metabolism may uncover yet unknown mechanisms in DNA metabolism.

Physical characteristics of poxviral virions and genomes
Vaccinia infections produce two forms of virions: enveloped virions (EV) or mature virions
(MV). Over 95% of the infectious particles produced from an infected cell are kept as MVs.
Still, a subset of ~5% undergoes a secondary wrapping event using membranes derived
from the Golgi apparatus and then undergo exocytosis to be released into the extracellular
environment [1, 9, 10]. The physical structure of the virions resembles a brick with a core
shaped like a dumbbell. These large virions have a size of ~330 x 260 x 125 nm [11].
Besides the dumbbell-shaped core, the virion contains proteinaceous lateral bodies which
which are thought to release viral immunomodulatory proteins into the cell after virion entry
[9]. The viral genome is maintained within the core.
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The vaccinia genome is 194 kb and contains more than 200 genes. It is organized as a
double-stranded linear duplex with covalently closed hairpin termini. The genome as a
whole is very AT-rich (>66%), and the hairpins even more so (~92%). These hairpins also
include extrahelical bases in complementary inverted isoforms known as flip and flop [1214]. Proper maintenance of flip and flop on the monomeric genome is due to the formation
of concatemeric junctions which require processing before finally forming the two
monomeric genomes (see Fig 1-2). The terminal regions of the viral genome are
necessary and sufficient for the initiation of viral DNA replication, supporting the possibility
of a replication origin [12, 15]. The telomeric regions of the viral genome are also
necessary for proper encapsidation into virions using the viral protein I6 [16, 17]. Recent
studies have demonstrated that viral DNA that accumulates as subgenomic fragments
does not get encapsidated into virions, suggesting that both hairpins are required for
proper packaging [18].

The genome contains no introns and does not undergo splicing. Genes encoding
immunomodulatory proteins or other accessory proteins that mediate virus/host
interactions cluster towards the termini. Essential genes encoding proteins required for
the basic lifecycle are found within the central portion of the genome. The protein-coding
genes were named by the fragment (from largest to smallest: A to P) resultant from HindIII
restriction digest, followed by numeric order from left to right within the fragment, and
finally L or R for the directionality in which transcription of the gene occurs [19].

Vaccinia virus lifecycle
The vaccinia virus lifecycle is outlined in Fig 1-1. The lifecycle is highly regulated, with
each step dependent on the prior one. In short, virions enter the cell via direct fusion with
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Figure 1- 1- Overview of the Vaccinia Virus Life Cycle
The Vaccinia virus life cycle is highly organized and regulated as each stage relies on the
previous. Viral entry is facilitated either by direct fusion of the viral membrane with the
plasma membrane or macropinocytosis followed by release from an endosomal
compartmtent. Upon entry into the cytoplasm, the lateral bodies (yellow ovals) are
released, and the core becomes activated and changes shape. Early viral genes are then
transcribed within the core using encapsidated viral machinery. The viral mRNAs are
extruded and translated using the host translational machinery, whereby these proteins
facilitate removal of the core wall (uncoating). The genomic DNA is then exposed to the
replication machinery and replication factories form. The initiation of DNA replication
allows for the expression of intermediate and late viral genes, which facilitate the formation
of virions by manipulating endoplasmic reticulum membranes in a process known as
morphogenesis. Genomes are then packaged into virions before undergoing a maturation
process to become infectious particles, MVs. A small subset of MVs undergoes a
secondary wrapping event (EVs) then exits via exocytosis.
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the plasma membrane or macropinocytosis. Early gene transcription occurs within the
virion cores upon introduction into the cytoplasm. The newly synthesized transcripts are
extruded through the core wall and are translated using the host translational machinery.
These early viral proteins are essential for the process of uncoating: the removal and
degradation of the proteinaceous core wall. This process provides the nascent, early viral
proteins access to the viral genome. Initiation of viral DNA replication is sufficient for the
expression of intermediate and late genes, which are essential for the process of virion
morphogenesis. Membranes are diverted from the endoplasmic reticulum (ER) and form
crescent membranes, which are either elongated or fuse with other crescents to form the
complete membrane of immature virions (IV). IV are filled with viroplasm, electron-dense
cytoplasmic material containing the viral proteins destined for inclusion in virions. Prior to
membrane closure, the newly synthesized viral genomes are encapsidated to form
immature virions with nucleoids (IVN). Further maturation results in the formation of MVs
discussed previously, and a small subset undergoes the secondary wrapping event to
become EVs. In the following sections, we will briefly discuss the process of viral entry,
uncoating, gene expression, and morphogenesis. However, the primary focus of the
studies herein is on the process of viral DNA replication, recombination and repair, also
known as DNA metabolism. We will discuss these processes and the factors responsible
in-depth.

Virus Entry
Four viral proteins facilitate MV attachment to the plasma membrane: D8, A27, H3, and
A26, binding heparin sulfate, chondroitin sulfate, or laminin [20]. These proteins are
redundant as deletion of one does not result in defects in viral attachment. The entry fusion
complex or EFC comprises 11 viral proteins: A16, A21, A28, F9, G3, G9, H2, J5, L1, L5,
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and O3 [20]. This complex facilitates hemifusion and pore formation, whereby the
interaction with the cell surface then facilitates enveloping of the virion dependent on actin
filaments. Interestingly, vaccinia encodes mechanisms to prevent superinfection utilizing
the proteins A56 and K2, which will express on the cell surface of infected cells [1].
Inclusion into the cytoplasm results in the dissolution of the lateral bodies, and the core
expands. This expansion allows for permeability of the viral core to rNTPs, thereby
initiating transcription of early viral genes in the core using the encapsidated viral
transcription machinery [21, 22].

Uncoating
Removal of the proteinaceous core wall is essential to allow the viral DNA replication
machinery access to the viral genome. The early class of viral proteins is critical to this
process as inhibitors of protein synthesis block uncoating. D5, a AAA+ ATPase, is
essential for this process, and, more recently, B18, C5, and M2 were found to have roles,
albeit redundant, in uncoating [23, 24]. This process is also dependent on proteasomal
activity but not ubiquitination, suggesting viral coat proteins are prepared for degradation
in the previous round of replication [25]. Upon removing the viral protein coat, the genome
is exposed and ready to be replicated.

Gene expression
Viral gene expression is a highly regulated process utilizing a cascade mechanism,
whereby early genes encode transcription factors for intermediate genes, intermediate
genes encode transcription factors for late genes, and late genes encode transcription
factors for early genes. Late proteins acting as transcription factors for early genes are
encapsidated, allowing for transcription of the early genes within the cores during the next
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round of infection [26]. Analysis of viral transcript levels within infected cells supports these
findings[1].

The temporal regulation of viral gene expression also helps orchestrate the following
stages of the viral lifecycle: DNA replication, morphogenesis, and virion maturation. Early
genes are responsible for replicating the viral genome, while intermediate and late genes
are responsible for morphogenesis and virion maturation. More recent studies have found
that post replicative genes (intermediate and late), while not crucial for genome replication,
are essential for genome processing [27].

Viral transcription is almost entirely facilitated by viral factors including a multi-subunit RNA
polymerase, RNA helicase, capping enzyme, termination enzyme, polyA polymerase and
stage-specific transcription factors [1]. YY1 is the only known cellular transcription factor
important for viral transcription, and it facilitates intermediate/late gene transcription [28].
Following translation of newly synthesized early proteins and removal of the proteinaceous
viral coat, genomes are ready to be replicated by the viral DNA metabolizing enzymes.

DNA metabolism: viral DNA replication, recombination, and repair
Viral DNA replication begins as early as 2 hpi and continues until ~10-12 hpi, after which
it plateaus. Vaccinia encodes many DNA metabolizing enzymes (table 1-1), as might be
expected since DNA replication occurs outside of the host cell nucleus. The following
sections will outline the factors responsible for different processes of viral DNA
metabolism, the proposed model of poxvirus DNA replication, and the little known about
poxviral DNA recombination and repair.
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Table 1 - 1 Vaccinia Virus Proteins with DNA Metabolizing
Activities
Vaccinia encodes a suite of proteins essential for various aspects of DNA metabolism,
including dNTP biosynthesis, DNA replication, and DNA processing. Broken into three
groups, Vaccinia encodes multiple proteins to regulate the pools of dNTPs (A), replicate
its genome (B), and correctly process and package the viral genome (C). The proteins
responsible for A and B will be discussed in-depth.
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Poxvirus precursor nucleoside metabolism
Some poxviruses, including vaccinia, encode enzymes for producing dNTPs during
infection. These enzymes are important for productive infection of resting or quiescent
cells, but not actively proliferating cells [29]. The full suite of enzymes includes a thymidine
kinase (TK), a thymidylate kinase, ribonucleotide reductase (large and small subunit), a
dUTPase, and a uracil DNA glycosylase (UDG) [30-34].

The viral TK is similar to the human TK and is complemented by the human TK in actively
proliferating cells [35]. Interestingly, the viral TK is sensitive to negative feedback by dTTP
or dTDP [36], a discovery that shifted the field from using 3H-thymidine labeling to visualize
DNA synthesis to assessing viral DNA accumulation by Southern blots. dUTPase is an
enzyme important in regulating levels of dUTP. The essential nature of the viral dUTPase
during in vivo infections lacking D4, the UDG, might shed some light on the importance of
dUTP regulation during poxvirus infection [29].

The virally encoded ribonucleotide reductase small (F4) and large (I4) subunits form a
heterotetrameric complex that is an enzymatically active ribonucleotide reductase (RR)
[37, 38]. These proteins are very similar to their cellular counterparts (>70% similarity),
with one noticeable exception: F4 lacks the first 81 amino acids present in the cellular
RRM2 [32, 39, 40]. The similarity of these proteins extends beyond sequence identity, as
the viral subunits can interact with their cellular counterparts (I4:RRM2 and F4:RRM1)
[40]. I4 and F4 are expressed early during infection, suggesting they could be essential in
providing or supplementing cellular dNTP pools for viral DNA replication. F4 is more
important for viral replication in actively proliferating cells than I4 [40], an exciting finding
given other orthopoxviruses do not encode a ribonucleotide reductase small subunit.
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The expression of these proteins early during infection help prepare the cytoplasmic
replication factories to synthesize viral genomes.

Poxvirus DNA replication
As a dsDNA virus that replicates exclusively in the cytoplasm, there are a slew of
challenges that must be faced to replicate the viral genome properly. The first problem is
the physical autonomy from cellular DNA metabolizing enzymes which could be co-opted
to replicate the viral genome. Early studies revealed that vaccinia virus was capable of
replicating its genome even in enucleated cells, suggesting VV must encode all the
essential factors [41]. The second challenge is orchestrating DNA replication absent of the
nucleus or a membrane-bound compartment. However, studies demonstrated that ER
membranes surrounded cytoplasmic viral replication factories by as early as 3 hpi [42].
The mechanism behind how ER membranes are utilized to wrap cytoplasmic replication
factories is yet unknown. The third issue is how VV replicates its genome faithfully and
quickly. By the end of the replication cycle, there are 10,000 nascent viral genomes. How
do poxviruses facilitate such a high rate of DNA replication? Is this an error-prone
process? These questions will be discussed, and our studies will further our understanding
of these processes.

The proposed mechanism
There are two proposed models for poxvirus DNA replication (Fig 1-2, A i vs ii): a selfpriming model and a semi-discontinuous model not unlike the eukaryotic mechanism.
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The self-priming model (i) involves an as yet unknown nuclease introducing a nick in the
terminal region of the viral genome. The newly exposed 3’ hydroxyl recruits the replicative
viral holoenzyme, and synthesis occurs towards the hairpin. The self-complementarity of
the newly synthesized DNA results in isomerization and formation of a hairpin loop, and
replication then occurs towards the distal hairpin. Replication of the extrahelical bases
located in the hairpin termini result in the formation of a concatemeric junction. The
genomes remain as concatemeric species until resolution by the virally encoded Holliday
junction resolvase, A22 [27]. There is now increasing interest in the involvement of
recombination in facilitating proper and productive DNA replication. In short, replication
would form dsDNA intermediates with blunt ends that could be processed by a 5’-3’
exonuclease to introduce 3’ ssDNA overhangs. These overhangs would be bound by a
single-stranded binding protein with strand annealing or strand invasion activity. Invasion
of a complementary template strand would then allow for the recruitment of the
holoenzyme. This process would allow for the simultaneous replication of one template
genome by multiple holoenzymes, thereby increasing the rate of viral DNA replication.

The semi-discontinuous model of VV replication is similar to the eukaryotic system of DNA
replication. More recent studies have found that the telomeric viral DNA is necessary and
sufficient for the initiation of viral DNA replication [12, 15]. The possibility of an origin of
replication, D5 having primase/helicase activity in vitro, and that a ligase (viral or cellular)
is essential for DNA replication support the semi-discontinuous model of DNA replication.
Therefore, leading and lagging strand synthesis would occur around replication forks
formed at the potential origin (as modeled in Fig 1-2).
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Figure 1-2. Models of Vaccinia Virus DNA Replication, and a
Glimpse at the Viral Replication Fork.
Two different mechanisms for VV DNA replication: a self-priming model (i) and a
discontinuous model (ii). The self-priming model requires a nick in the telomeric hairpin
region of the viral genome (2) which allows for the recruitment of the viral holoenzyme (3).
The complementarity of the highly AT-rich telomeric DNA results in isomerization,
positioning DNA replication to proceed towards and around the distal hairpin (4). Copying
of the hairpin leads to the formation of a concatemeric junction whose resolution is
required for the formation of progeny genomes (5). More recently, growing evidence
suggests recombination may be linked to viral DNA replication. Recombinational priming
would allow for the reproduction of one template by multiple holoenzymes, thereby
increasing the rate of DNA synthesis (6). Finally, resolution of the concatemeric junction
by A22 generates the progeny monomeric genome (7). As for the discontinuous model,
the need for an enzymatically active ligase and the primase activity of D5 suggested that
lagging strand synthesis might occur. Fragments of divergent, RNA-linked DNA fragments
provide preliminary support for a bidirectional origin that maps to the telomeric region.
Thus, VV DNA replication may include both leading and lagging strand synthesis. (ii). With
extensive biochemical and genetic analyses, nine viral proteins were identified as
essential (E9, D4, A20, I3, D5, B1, and H5) or accessory (A50 and G5) for viral DNA
replication (B).
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While the mechanism of viral DNA replication remains partially understood, the
identification and characterization of viral proteins essential to this process have been
extensively studied. Each viral protein will be discussed in the following subcategories: the
viral holoenzyme, essential viral proteins, and accessory viral proteins.

The viral holoenzyme
E9L
The E9L gene, expressed in the early class of VV genes, encodes a 116kDa protein that
has both 5’ to 3’ DNA polymerase and 3’ to 5’ proofreading exonuclease activities [43-45].
There are two distinct enzymatic states of the E9 polymerase: distributive and processive.
Each is dependent on conditions such as the concentration of divalent cations, salt, or
interaction with other viral factors [46]. The polymerase adds up to 30 nucleotides per
second in its processive state in vitro, with upwards of 2000 nucleotides added per binding
event. However, the in vitro conditions required for processivity suggest that a processivity
factor is required for processive viral DNA synthesis.

The Vaccinia genome is AT-rich (68%) [47]. The affinity of the E9 polymerase for each of
the dNTPs does not account for the vast difference in AT content from GC: 2.9, 4.0, 2.7,
and 0.9 µM for dATP, TTP, dCTP, and dGTP, respectively [48]. Interestingly, E9 has an
affinity of 3.1 uM for UTP, suggesting E9 is capable of misincorporating dUTP. As
previously mentioned, the E9 polymerase must require a processivity factor in vivo for
rapid viral DNA synthesis. Indeed, E9 copurifies with D4 and A20. Further study
demonstrated that overexpression of A20 and E9 leads to a marked increase in
polymerase processivity [49].
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D4R
A uracil DNA glycosylase enzyme of approximately 25kDa is encoded by the D4R gene
and is expressed in the early class of VV genes [50, 51]. D4R is homologous to the Shope
fibroma virus (SFV) D6R gene, a known uracil DNA glycosylase. The McFadden lab
confirmed D4R as an enzymatically active uracil DNA glycosylase via an ethidium bromide
fluorescence assay detecting the presence of abasic sites following uracil excision.
Furthermore, isolation of a D4R mutant virus was unsuccessful implicating D4R as an
essential gene for VV replication [51]. Uracil DNA glycosylases are essential enzymes in
the base excision repair pathway that remove uracil moieties wrongfully incorporated into
the viral genome or derived from deaminated cytosines [52]. Thus, further study of D4’s
enzymatic role in VV DNA replication was required.

A20 was shown to interact with D4 via a yeast two hybrid screen, pointing towards a
possible role for a D4 and A20 complex [53]. Indeed, following further characterization,
the Traktman lab identified that A20, D4, and E9 copurify and that D4 provides processivity
to the E9 polymerase in a manner dependent on A20 interaction [54]. Interestingly, the
enzymatic activity of D4 is dispensable to its role in providing processivity to the DNA
polymerase, implying that the reparative function of D4 is separate from its replicative role.
However, D4 is enzymatically active in vitro as abasic sites form when the holoenzyme
(D4:A20:E9) encounters uracil moieties [48]. Combined with the fact that the E9
polymerase has similar affinities for UTP as TTP, the data suggests that the reparative
function of D4 is intrinsically connected to its replicative role.

A20R
A20 is expressed early during viral infection and acts as the flexible linker between D4,
the viral uracil DNA glycosylase, and E9, the viral DNA polymerase, providing processivity
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to the DNA polymerase [49, 53, 55]. Besides D4 and E9, A20 interacts with D5, the
Vaccinia putative primase and helicase, and H5, a viral scaffolding protein [53]. All of these
proteins are essential for the replication of viral genomes. Through coimmunoprecipitation
analysis, A20 interacts with D4, D5, and H5 at nonoverlapping regions suggesting A20
might function as a scaffold [56]. A20 cannot be purified and isolated on its own from
bacterial expression systems, but the Traktman lab found that A20 copurified with D4 [54].
The inability of A20 to be purified without its interacting partner D4 suggests that A20 is
unstable as a monomer. In sum, A20 acts as the flexible linker that forms the heterodimeric
VV processivity factor with D4, thus shifting the E9 polymerase to become processive.

Essential viral proteins
D5R
D5 is an AAA+ ATPase with putative primase and helicase function and is expressed early
during VV infection [57-60]. Multiple temperature-sensitive (ts) mutants created by the
Condit lab had genetic lesions mapped to the D5R gene [61]. At nonpermissive
temperatures, these mutants resulted in a dramatic decrease in VV DNA synthesis [58,
60]. Characterization of the D5 protein revealed similarities to the AAA+ ATPase family,
and the Traktman lab determined D5 to be a nucleic acid-independent NTPase [59].
Putative primase activity was determined by the Moss lab, and it was found that D5 forms
multimers which would allow D5 to form a ring around the viral DNA [62]. This data
supports a model that D5 acts as a primase for the holoenzyme (E9:A20:D4) to allow for
DNA replication. Interestingly, a siRNA screen found that D5 is not only essential in DNA
replication but also uncoating [63]. The concept of viral proteins playing multiple roles in
the lifecycle is commonplace in poxvirology.
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H5R
H5 is first expressed early during VV infection [64]. H5 binds both DNA and RNA at similar
affinities and is readily phosphorylated by the VV encoded B1 kinase [64, 65]. H5 also
interacts with several other viral proteins involved in DNA replication and transcription [53,
66]. A temperature-sensitive mutant virus (Dts57), which had genetic lesions mapped to
the H5R gene, resulted in a complete loss of viral DNA replication at nonpermissive
temperatures suggesting that H5 is essential for viral DNA replication [67]. Furthermore,
H5 plays an importantrole in VV transcription, in particular, late transcription termination
[68]. β-thiosemicarbazone is an inhibitor of VV gene elongation. A resistant viral mutant
was created that had mutations mapped to the H5R gene, thereby genetically solidifying
H5’s role in viral transcription [69]. H5’s interactions with multiple proteins in DNA
replication and late transcription suggest H5 could be a scaffolding protein providing a hub
off which other proteins function [70]. Recently, the creation of a recombinant virus lacking
the H5R gene along with a complementing cell line was created by the Traktman lab [71].
The removal of H5 led to a profound defect in VV DNA replication but no defect in stages
of the VV lifecycle before DNA replication [71]. Thus, confirming H5 is essential for VV
DNA replication.

I3
I3 is expressed early during viral infection [72]. I3 functions as a DNA binding protein with
a significantly higher affinity for single-stranded DNA than double-stranded DNA, even
though I3 does not contain an OB domain [73]. An OB domain has a variety of functions
but is typically the domain involved in preferentially binding single-stranded DNA over
double-stranded DNA (Reviewed by [74]). Additionally, I3 forms higher order multimers in
vitro and in vivo and is readily phosphorylated on serine residues [72, 73]. I3 is also
involved in homologous recombination (HR) during VV infection as measured by
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recombination between plasmids during viral infection [75]. These data suggest that I3
could function similarly to the cellular single-stranded DNA binding proteins. Indeed,
mutational analyses of charged residues in I3’s C-terminus showed that loss in DNA
binding capabilities and/or multimerization resulted in a marked decrease in viral DNA
accumulation in vivo [73].

Deletion of I3 (v∆I3) results in almost complete loss of viral DNA accumulation in all cell
lines tested [76]. However, when vΔI3 infected a cell line inducible for I3, viral DNA
accumulation could be rescued in the presence of doxycycline, supporting that I3 is
essential for viral DNA replication [77]. Development of cell lines expressing mutant forms
of I3 defective in DNA binding or multimerization allowed for transient complementation
with v∆I3. Interestingly, I3 mutants defective in DNA binding and multimerization resulted
in the accumulation of subgenomic fragments of viral DNA, while mutants defective in only
multimerization led to a decrease in viral DNA accumulation but little to no accumulation
of subgenomic fragments [77]. This data suggests that the ssDNA binding capabilities of
I3 are essential in the formation of full-length viral genomes, further implicating the role I3
might have beyond its essentiality in viral DNA replication.

B1R
Ts mutants with lesions in the B1R gene led to a significant reduction in viral DNA
accumulation at non-permissive temperatures [78]. B1 is a serine/threonine kinase and
attempts to isolate a B1 null mutant were unsuccessful, suggesting that the function of B1
is essential for viral replication [79]. B1 was identified to be paralogous to three mammalian
kinases, vaccinia-related kinases or VRK 1-3 [80]. VRK1 could complement a ts B1 mutant
when it was expressed from the viral genome, but the other two isoforms could not [81].
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Furthermore, rescue of H5 phosphorylation, the only viral substrate of B1, did not rescue
viral DNA replication and yield, suggesting that B1 phosphorylation of H5 is not important
for viral DNA replication [81]. Barrier to autointegration factor or Baf binds dsDNA with
high affinity and no sequence specificity. Pools of Baf are found within the cytoplasm of
infected cells where Baf can bind viral DNA. B1, VRK1 and VRK2 can all phosphorylate
Baf which blocks Baf’s ability to bind DNA [80]. Without B1, Baf is found to associate with
viral factories in the cytoplasm of VV infected cells, but shRNA lentiviral depletion of Baf
rescued a ts B1 mutant VV [82]. Therefore, phosphorylation of Baf by B1 blocks Baf’s
ability to bind viral DNA allowing for replication.

Accessory viral proteins
G5R
Site directed mutagenesis of charge-to-alanine residues in the G5R gene found that G5
alanine mutants had increased temperature sensitivity compared to the wtG5 virus [83].
Sequence analysis of G5 identified high homology to the human flap endonuclease-1
(hFEN-1) and EXO1 families of nucleases [84]. hFEN-1 has high specificity for DNA flaps
and its activity is controlled via post-translational modifications and interacting partners
[85]. Biochemical analyses of G5 demonstrated that G5 is a 5’ flap endonuclease which
cleaves the hinge of 5’ flaps, and 5’ to 3’ exonuclease (Czarnecki and Traktman,
unpublished). Furthermore, creation of a knockout G5R recombinant virus (vΔG5) resulted
in the accumulation of mostly subgenomic viral DNA fragments indicating that G5 is
essential for the formation of full-length genomes (Czarnecki and Traktman, unpublished;
[86]). Along with transient complementation of vDI3 infections with I3 mutants lacking DNA
binding activity, the loss of G5 results in accumulation of seemingly stable subgenomic
vDNA fragments. The fragments are not due to nicks in the viral genome as the fragments
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resolve under native conditions. Could these subgenomic fragments be replication
intermediates or are they degradation products caused by cytoplasmic cellular nucleases?
G5 is also important for VV recombinatorial frequency (rf) as vΔG5 infections have a
significantly reduced rate of recombination between plasmids [86]. Depletion of I3 also
results in reduced rf. These findings support a model that replication of the viral genome
is coupled to recombination.

A50R
A50 is the viral DNA ligase and is expressed early in the viral life cycle [87]. A50 has
reparative capabilities in that it can ligate duplexed DNA [88]. Furthermore, the VV DNA
ligase has similarity to the human DNA ligases (around 30%) with a particularly high
similarity with the active site of hLig3 [89, 90]. Genetic analysis of A50 indicated that
although A50 is an enzymatically active DNA ligases, it is important but not essential for
viral DNA replication [91, 92]. The discovery of a VV primase (D5) sparked further interest
in the A50 ligase due to the requirement for DNA ligases to join Okazaki fragments created
during lagging strand synthesis [93]. However, since A50 is dispensable for productive
infections in tissue culture, there would need to be an additional ligase involved to process
Okazaki fragments. Indeed, siRNA knockdown of the cellular DNA ligase 1 during an A50
deficient VV infection resulted in a more severe reduction in viral DNA accumulation than
when A50 alone is removed [94]. Furthermore, hLig1 is found in the viral cytoplasmic
factories during VV infection [94]. VV is sensitive to etoposide treatment, and resistant
viruses mapped to genetic lesions in the A50R gene [95]. Although VV encodes a type 1
topoisomerase, it does not encode type 2 topoisomerases which would be important for
the resolution of complex DNA structures to allow for DNA replication. A yeast two-hybrid
screen of A50 indicated that it interacts with Top2B. Infections lacking the A50 protein
were insensitive to etoposide treatment [96]. Immunofluorescence of Topo2B indicated
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that it is recruited to viral replication factories during infection as well [96]. Mutation of
A50’s essential residues for Top2B interaction alleviates VV’s etoposide sensitivity as
Top2B is no longer localized to the cytoplasmic factories during infection [96].

Although this is the current suite of proteins known to be responsible for metabolism of the
viral genome, there is growing interest in accessory proteins which may shed some light
on the mechanisms of VV DNA replication. Later, we will discuss the growing body of
evidence that cellular proteins may play some accessory roles.

Poxvirus DNA recombination
Vaccinia infected cells are known to undergo high rates of recombination [97]. The
importance of recombination remains unclear. Recently, plasmids containing either the N
or C terminal region of the luciferase gene with ~100bp of overlapping sequence were
utilized to test recombinatorial frequency (rf) during VV infection. Using this technique, I3,
G5, and E9 were all found to be important for maintaining optimal rf during infection [18,
98, 99]. The mechanism remains unknown, but one proposed model of VV recombination
is through a single strand annealing or invasion mechanism. This model is further
supported by recent findings that I3 has single strand annealing activity in vitro similar to
that of Rad51 (Seahorn et al, unpublished).

Poxvirus DNA repair
As large dsDNA viruses with a multitude of enzymes essential for the production of
infectious yield, proper and faithful maintenance of the viral genome may be quite
important for poxviruses. Indeed, poxviruses encode enzymes with known DNA repair
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activities like E9 (3’-5’ proofreading activity), D4 (uracil DNA glycosylase), G5 (Fen1/Exo1
like nuclease), and many viruses within the Chordopoxviridae family also encode a CPDlyase gene [100, 101]. However, the capabilities of poxviruses to repair their genomes
remain unknown. A recent study examined the capability of VV to repair double stranded
breaks (DSB) introduced via Crispr/Cas9 targeting [102]. This group determined that DNA
ligase IV translocates to cytoplasmic viral replication factories to facilitate nonhomologous
end joining reactions to repair DSB.

However, there are multiple forms of DNA damage which VV might encounter during
infection, both endogenous and exogenous. Early studies examined how VV replication
was affected when UV irradiating viral particles prior to infection [103-106]. These studies
found that early gene expression was blocked due to transcriptional defects in the core of
irradiated particles. Infection of patient derived XP deficient cell lines did not increase VV
sensitivity to UV irradiation prior to infection. However, sites of UV lesions, sensitive to T4
endonuclease, within the viral genome decreased over time following infection of Vero
cells [106]. These findings were complicated by the inability to differentiate between
whether there were nascent genomes lacking lesions, or if there was repair of the parental
genomes. Importantly, this was the first finding that VV might be capable of undergoing
genomic repair.

As for the endogenous forms of DNA damage, wrongful incorporation of uracil moieties or
deamination of cytosine can result in improper base pairing requiring base excision repair
(BER). Elegant studies found that the VV polymerase has similar affinity for dUTP as TTP
[107]. These results are counterintuitive and suggest that the virus may employ other
means to regulate dUTP pools. Furthermore, wrongfully incorporated dUTP can be
excised by the VV UDG (D4), resulting in the formation of an abasic site. These abasic
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sites act as roadblocks for viral DNA replication as the holoenzyme is incapable of
translesion synthesis in vitro [107]. Therefore, either a viral protein is required to process
abasic sites, or the cellular apurinic lyase (APE1) is recruited to process abasic sites prior
to viral DNA replication.

There still exist a multitude of questions regarding the capabilities for poxviruses to
undergo DNA repair, whether these processes would be facilitated by viral or cellular
proteins, and how important this process might be for the production of infectious virus.
Addressing some of these questions was one of our primary aims.

Viral morphogenesis and virion maturation
As mentioned, assembly of virions is facilitated by intermediate and late proteins. The
master regulator of this process is the viral kinase, F10 [108-110]. The importance of
phosphorylation during various stages of the viral lifecycle remains unknown, but it is clear
that deletion or mutation of F10 blocks the formation of crescent membranes, the first
visual intermediate in the formation of virions. Crescents are membranes derived from the
ER and are made up of a single lipid bilayer (Fig 4-4) [111]. They are then enlarged to
form “toenail” like structures where they translocate to the viroplasm, an area of highly
concentrated viral protein within the cytoplasm. Formation of the immature virion (IV) from
these crescents requires a host of proteins including A14, A17, A6, A11, A30.5, H7, and
L2 [112-126].The immature virions envelops the viroplasm, which contains of all the
necessary factors for the next round of infection, including the viral RNA polymerase and
early gene transcription factors. The shape of the immature virion and the clear outer
defined shell is determined by the D13 protein, which has a double jelly-roll structure and
forms a capsid-like exoskeleton. It adheres to the IV membrane by interacting with the
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viral membrane protein A17. Encapsidation of the viral genome requires the FtsK-family
AAA+-ATPase A32 and the telomere binding-protein I6; the membrane protein A13 is also
needed for this process. Mutation, suppression, or deletion of these proteins result in a
complete block in genome encapsidation, such that the virions are noninfectious although
they still mature (Fig 4-4, B) [16, 17, 127-129]. When genomes are properly encapsidated,
IVs become immature virions with nucleoids (IVNs). Interestingly, when genome
encapsidation is blocked, viral DNA accumulates in cytoplasmic crystalloids. Whether
these crystalloids are normal intermediates for the encapsidation of viral genomes or only
form when encapsidation is blocked remains unknown. The transition from IVNs to mature
virions (MV) is marked by three key processes: release of the D13 outer shell, a shift in
the morphology of the virion from circular to brick shaped and proteolytic cleavage of
numerous components of the virion. Proteolytic cleavage of A17 by I7 is necessary for the
removal of the exterior D13 shell, shifting the structure of the IVNs to the brick shaped MV
structure [130-134]. Furthermore, the core proteins p4a, p4b, A12, G7, and L4 all undergo
proteolytic cleavage during virion maturation [133, 135, 136]. The culmination of these
processes results in the proper production of the MV and the first form of infectious
particle. Beyond the scope of this work, there are a small subset of MVs which undergo
additional processing and wrapping which become enveloped virions (EVs). At the end of
this entire process, there are around 2,000 to 10,000 infectious particles produced from
one infected cell.

Involvement of host factors in vaccinia virus DNA metabolism
Intersection between the cellular DNA Damage Response Pathway and poxvirus
replication
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As mentioned, there is a growing body of work suggesting cellular DNA metabolizing
proteins may be important for viral replication. As infections of enucleated cells have no
defect in viral DNA accumulation, these proteins must play some accessory role or be
present in the cytoplasm.

An unbiased approach coined isolation of proteins on nascent DNA (iPOND) identified
TopoII A and B, SMC4, and PCNA as being enriched on nascent viral DNA [137]. As
mentioned earlier, recruitment of topoisomerase IIA/B is facilitated by direct interactions
with the viral DNA ligase (A50). The importance of an enzymatically active topoisomerase
was examined in the context of a topoisomerase inhibitor, etoposide. Interestingly,
resolution of branched, concatemeric viral genomes was blocked when etoposide is
present [138]. These data are intriguing, but no follow up work has been conducted to
examine whether Top2B plays a role in vDNA replication.

Proliferating cell nuclear antigen (PCNA) was also enriched on viral genomes, and studies
found that silencing of PCNA resulted in about a 4-fold reduction in total vDNA levels [139].
Could PCNA be acting as a sliding clamp during vDNA replication, increasing the rates of
vDNA synthesis? Further analysis would be required to fully understand what, if any, role
PCNA plays in vDNA replication.

Other studies have examined the role Ataxia telangiectasia mutated and Rad3 related
(ATR) plays during viral DNA replication. ATR is an essential protein involved in cellular
DNA checkpoint regulation following stalled replication forks or ssDNA damage like abasic
sites and bulky adducts ([140]; reviewed in [141]). A master regulator of DNA damage
effectors, ATR phosphorylates numerous DDR proteins like Exo1, RPA2, Rad51, and XPA
[142, 143]. Typically, ATR phosphorylation either stabilizes, allows for translocation to
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sites of DNA damage, or activates the enzymatic activity of its substrates. Using small
molecule inhibitors of ATR’s kinase activity, one group found that viral DNA accumulation
was reduced [139]. However, it was unclear what role ATR played in facilitating viral DNA
replication. Our studies herein greatly expand and identify an ATR substrate important for
viral DNA metabolism.

DNA damage: mechanisms of DNA repair following UV irradiation
As our studies delve into the importance of cellular and viral factors in the process of viral
DNA repair, it is important to outline how these processes are facilitated on cellular DNA
in eukaryotic cells. Below we describe the mechanism by which DNA lesions introduced
by UV irradiation are repaired.

UV irradiation is divided into three categories depending on the wavelength: UV-A, UV-B,
and UV-C. UV-C from the sun’s rays is completely blocked by the atmosphere,, but UV-B
is not and can introduce two main forms of UV lesions: 6,4-photoproducts (6,4-PPs) and
cyclobutene pyrimidine dimers (CPDs) (Reviewed in [144]). Both result in distortions of
the DNA double helix and cause steric hindrance of processive DNA polymerases such
as those within the Β-family. CPDs form through covalent bonding between adjacent
thymidines, specifically between the fifth and sixth carbon of the pyrimidine ring, whereas
6,4-PPs form through covalent bonding between the fourth and sixth carbon and resulting
in greater helical distortion (Reviewed in [145]). In eukaryotic cells, the lesion recognition
complex consisting of XPC and Rad23b detects 6,4-PPs more readily than CPDs,
resulting in preferential repair of such lesions [146].
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Nucleotide excision repair (NER) is the primary mechanism responsible for repair of UV
lesions within cellular genomes. Many of the essential proteins in this process are part of
the xeroderma pigmentosa (XP) family of complementation groups. Deficiencies in these
proteins result in xeroderma pigmentosum, a disease characterized by a greater sensitivity
to UV irradiation that culminates with elevated cancer risk [147]. There are six necessary
and sufficient proteins that mediate NER: XPB, XPD, XPF, XPG, XPA, and RPA [148150]. Interestingly, NER is preferentially directed to transcriptionally active genes.

During global genome repair (reviewed in [144], and shown in Fig 1-3), XPC-Rad23b
recognizes a UV lesion and recruits the transcription factor IIH (TFIIH) (B to C). The TFIIH
complex includes the helicases of opposite polarity: XPB (3’-5’ translocation) and XPD (5’3’ translocation). These helicases unwind approximately 20 nucleotides on each side of
the UV lesion ~20 nts (C). The newly ssDNA is then bound by XPA and RPA (replication
protein A, an SSB) (D). ATR phosphorylates XPA, greatly increasing its stability.
Phosphorylated XPA also has a greater affinity for RPA, which is also phosphorylated by
ATR. These single stranded binding proteins recruit the nucleases XPF and XPG (D and
E), either through direct transient interactions or due to conformational changes of the
DNA facilitated by SSB loading on DNA. The XPF and XPG endonucleases recognize and
cut DNA flaps of opposite polariy, with acting at 3’ flaps and XP at 5’ flaps. Together, their
activities lead to the excision of 32 nt fragment encompassing the damaged region (E and
F). The newly exposed 3’ overhangs recruits specialized “repair” polymerases, such as
polymerases within the φ and Σ family, which can synthesize a new patch of ssDNA (F).
Following the activity of a DNA ligase, the DNA is fully repaired (G).
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Figure 1-3. The Core Process of Nucleotide Excision Repair.
The nucleotide excision repair process only requires six cellular proteins: XPA, RPA, XPB,
XPD, XPF, and XPG. Following the introduction of UV lesions (A), the Rad23b-XPC
complex recognizes the lesion (B) and recruits TFIIH, which includes the opposite polarity
helicases (XPB and XPD) (C). These helicases unwind around the lesion allowing XPA
and RPA to bind opposite the damaged DNA template (D). These SSBs recruit the
nucleases, XPF and XPG, which excise a strand of about 32 cents around the UV lesion
(E and F). The newly ssDNA is then replicated by the translesion family of polymerases
and requires the sliding and loading clamps (RFC and PCNA) as well as a ligase (Lig1 or
LigIII) (G). The result is a repaired DNA template.
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Goals of this thesis
The data generated in the following chapters has been gathered with two goals in mind:
characterizing the importance of cellular accessory proteins in viral DNA metabolism and
expanding our knowledge of the capabilities of vaccinia virus to maintain and repair its
genome. These goals were developed from the perspective that poxviral DNA replication,
recombination, and repair may be intimately coupled. Though poxviruses encode a
comprehensive suite of DNA metabolizing enzymes, they lack the full complement present
in eukaryotic cells. While early studies examined total viral DNA accumulation, we
wondered whether cellular proteins might be important for genome processing or
maintenance. Taking these thoughts one step further, we sought to identify whether
vaccinia virus was capable of DNA repair following exogenous DNA damage, and what, if
any, factors would facilitate this process. This work revealed that ATR’s kinase activity is
important for viral DNA replication and genome integrity. The resultant reduction in
infectious viral yield caused by ATR inhibition could be rescued by expression of an RRM2
derivative incapable of interacting with Cyclin F. The rescue in infectious viral yield did not
extend to a rescue in viral genomic integrity or DNA accumulation, implicating that ATR
inhibition might cause more than one defect during viral replication. Additionally, although
inefficient compared to other repair systems, vaccinia virus can repair UV lesions. This
process is facilitated by viral but not cellular proteins. Finally, a brief overture was taken
to study the importance of the structure specific nuclease, G5, in viral DNA metabolism.
These studies require thorough follow-up, but tentatively support a model of
recombination-dependent viral DNA replication.
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Chapter 2 – Materials and Methods
General methods.
Reagents.
Lipofectamine 2000 and Click-iT Plus EdU AlexaFluor 488 were purchased from Life
Technologies (Grand Island, NY). Paraformaldehyde (PFA) was purchased from EM
sciences (Hartfield, PA). Zeta-Probe blotting membranes were purchased from Bio-Rad
(Hercules, CA). Protran nitrocellulose membranes were purchased from GE Healthcare
Life Sciences (Boston, MA). [35S]-methionine and [32P]-dNTP were purchased from
PerkinElmer Life Sciences (Boston, MA). SeaKem LE Agarose was purchased from Lonza
Inc. (Allendale, NJ). Molecular weight standards for pulse-field gel electrophoresis
(Lambda PFGE marker) were purchased from New England BioLabs Inc. (Ipswich, MA).
Proteinase K and cytosine arabinoside were purchased from Sigma Aldrich (St. Louis,
MO). Pancreatic RNase was purchased from Roche Diagnostics (Indianapolis, IN).
SybrGold was purchased from Invitrogen (Waltham, MA).

Antibodies.
AlexaFluor 488 goat anti-rabbit (GAR) IgG and AlexaFluor 594 goat anti-mouse (GAM)
IgG were purchased from Life Technologies (Grand Island, NY).

Table 2-1 – Primary Antibodies
Antibody
I3

Name
or Product
manufacturer Number
Peabody
N/A

Species Block
Rabbit

5%
sanalac

WB
IF
IP
dilution dilution dilution
1:1500 1:400
1:100
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L4

Antionette

N/A

Rabbit

F17

Latifah

N/A

Rabbit

A20

Tether

N/A

Rabbit

I6

XXX

N/A

Rabbit

F10

Terminator

N/A

Rabbit

H5

pATH H5

N/A

Rabbit

A30

XXX

N/A

Rabbit

L2

XXX

N/A

Rabbit

A5

XXX

N/A

Rabbit

E9

Cheesehead

N/A

Rabbit

XPA

Sc-28353

Mouse

Sc-13563

Mouse

Sc-398032

Mouse

Sc- 515174

Mouse

pSQ/TQ

Santa
Cruz
Biotechnology
Santa
Cruz
Biotechnology
Santa
Cruz
Biotechnology
Santa
Cruz
Biotechnology
Abcam

130947

Rabbit

RPA32

Abcam

2175

Mouse

Ku70

Santa
Cruz
Biotechnology
Santa
Cruz
Biotechnology
Cell Signaling
Technologies
Cell Signaling
Technologies
Cell Signaling
Technologies
Santa
Cruz
Biotechnology
Santa
Cruz
Biotechnology
Santa
Cruz
Biotechnology
Cell Signaling
Technologies

Sc-17789

Mouse

Sc-8408

Mouse

12302

Rabbit

133D3

Rabbit

2577S

Rabbit

Sc-126

Mouse

Sc-398294

Mouse

Sc-56

Mouse

9722

Mouse

XPG
XPF
ATR

Chk1
pChk1
S317
pChk1
S345
γH2-AX
S14
P53
RRM2
PCNA
eiF2a

5%
sanalac
5%
sanalac
5%
sanalac
5%
sanalac
5%
sanalac
5%
sanalac
5%
sanalac
5%
sanalac
5%
sanalac
5%
sanalac
5%
sanalac
5%
sanalac
5%
sanalac
5%
sanalac
5%
BSA
5%
sanalac
5%
sanalac
5%
sanalac
5%
BSA
5%
BSA
5%
BSA
5%
sanalac
5%
sanalac
5%
sanalac
5%
sanalac

1:750
1:2000
1:500
1:1000
1:500
1:1500
1:500
1:500
1:200
1:250
1:500

1:100

1:200

1:100

1:100
1:200
1:1000
1:1000
1:1000
1:200
1:1000
1:500
1:1000
1:1000
1:200
1:200
1:1000

1:100
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p-eiF2a
(Ser 51)
HA

Cell Signaling 9721
Technologies
BioLegend
901513

Rabbit

V5

ThermoFisher

Mouse

His

Rabbit

Flag

Santa
Cruz Sc-803
Biotechnology
Sigma
F3165

TetR

Clontech

Mouse

Calnexin
Β-tubulin

Enzo
Life ADI-SPASciences
860-F
abcam
6046

CPD

Cosmo Bio

NMDND001 Mouse

6,4-PP

Cosmo Bio

NMDND002 Mouse

R960-25

631131

Mouse

Mouse

Rabbit
Rabbit

5%
BSA
5%
sanalac
5%
sanalac
5%
sanalac
5%
sanalac
5%
sanalac
5%
sanalac
5%
sanalac
5%
sanalac
5%
sanalac

1:500
1:2000
1:1000

1:200

1:100

1:1000
1:1000
1:1000
1:1000
1:1000
1:4000

1:400

1:1000

1:200

Cells.
African green monkey BSC40 cells were maintained at 37°C in Dulbecco modified Eagle
medium (DMEM) (Life technologies) containing 5% fetal bovine serum (FBS) (Gibco).
HEK-293 T, HeLA, A549, and CV1 cells were maintained at 37°C in DMEM containing
10% FBS. CV1 cells expressing an inducible G5 and I3 allele were previously generated
by members of the lab ([76] and Czarnecki and Traktman, unpublished) and were
maintained at 37° C in DMEM containing 10% FBS with 125µg/ml of Hygromycin.

Depletion of cellular proteins using sh NA lentiviral transductions.
Plasmids (pLKO.1) encoding sh NA sequences targeting our genes of interest (XPA, XPG,
XPF, or hCLK2) were ordered from the MUSC sh NA technology core within the Hollings
Cancer Center. The ‘sense’ strands of the sh NA sequences are listed in Table 2-2. Cell
lines generated are listed in table 2-4. Lentivirus stocks were prepared in HEK-293 T cells
using the pLL3.7 LentiLox system (Addgene) [5]. Confluent HEK-293 T cells were

43
transfected with 12µg plasmid of interest, 0.5µg helper plasmids (pREV-RSV and
pGag/Pol), and 1µg envelope plasmid (pVSVG) using lipofectamine 2000. Transfected
cells were incubated for 24 h at 37 C before changing the media to harvest media (10mM
4-(2-hydroxyethyl)-1- piperazineethanesulfonic acid (HEPES), 2.5mM sodium butyrate,
0.5% BSA, and 1% penicillin-streptomycin in DMEM containing 10% FBS). After 24 h in
harvest media, lentiviral particles were collected from the medium and 10µg/ml polybrene
was added. The collected supernatant was filtered th ough a 0.45µm syringe and stored
at -80° C for use up to one year past collection.

BSC40 cells were transduced with the indicated stock and cells carrying the incorporated
transgene were selected by including puromycin (97.5 µg/ml) in the culture medium. Cells
were used for experimental analysis as long as immunoblot analysis confirmed target
protein depletion, which lasted approximately 3 to 4 weeks in culture under selection.

Table 2-2 – shRNA sequences
Code

(TRC Sequence

Number)
XPA 1
(N0000083194)
XPA 2
(N0000083196)
XPG 78
(N0000050778)
XPG 79
(N0000050779)
XPG 80
(N0000050780)
XPG 81
(N0000050781)
XPG 82
(N0000050782)
XPF 3
(N0000078583)
XPF 7
(N0000078587)
hCLK2 28
(N0000355628)
hCLK2 05
(N0000197205)

5’-CCGGGCATTAGAAGAAGCAAAGGAACTCGAGTTCCTTTGCTTCTTCTAATGCTTTTTG-3’
5’-CCGGCATGAGTATGGACCAGAAGAACTCGAGTTCTTCTGGTCCATACTCATGTTTTTG-3’
5’-CCGGCCAGCGAAATAGAAGCAGTTTCTCGAGAAACTGCTTCTATTTCGCTGGTTTTTG-3’
5’-CCGGCCTCCTTTACAAGAGGAAGAACTCGAGTTCTTCCTCTTGTAAAGGAGGTTTTTG-3’
5’-CCGGGCTTTCAGATTCTAAACGAAACTCGAGTTTCGTTTAGAATCTGAAAGCTTTTTG-3’
5’-CCGGCCTGTATTAAAGCAACTCGATCTCGAGATCGAGTTGCTTTAATACAGGTTTTTG-3’
5’-CCGGCCAATGGAAATTGACTCGGAACTCGAGTTCCGAGTCAATTTCCATTGGTTTTTG-3’
5’-CCGGGCGCAAGAGTATCAGTGATTTCTCGAGAAATCACTGATACTCTTGCGCTTTTTG-3’
5’-CCGGCCAAGATACGTGGTTCTTTATCTCGAGATAAAGAACCACGTATCTTGGTTTTTG-3’
5’ – GTCCGTTCTCGAAGCAGTTAT -3’
5’- GCTCTTCGATCTGATTGAAAG -3’
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Generation of lentiviral particles for stable expression.
pcDNA3-RRM2 was ordered from AddGene (Watertown, MA) and used as a template for
generating inserts encoding the full-length HA-tagged RRM2 or a truncation mutant
lacking the first 50 amino acids (labeled herein as ∆N). PCR reactions were performed
using primers encoding an N- or C-terminal HA epitope tag (Primer 1 and 4),and
containing either N-terminal BamH1 site (Primers 1 and 2) or C-terminal Nde1 site (Primer
3 and 4). Digested inserts were ligated to an appropriate digested pHAGE-Hygror-MCS
backbone (pHM) (Table 2-3). Following ligation, our plasmids were transformed into
HB101 cells. Sequence analysis was performed to ensure the lack of any mutations using
EuroFins Genomic Sequencing (Luxembourg, Luxembourg).

Using our pHM-RRM2 plasmids, we generated lentivirus stocks carrying our gene of
interest (HA-RRM2, HA-∆N RRM2, RRM2-HA, and ∆N RRM2-HA). Briefly, HEK-293 T
cells were transfected with 12µg pHM-RRM2, 0.5µg of each helper plasmid (pREV-RSV,
pGag/pol, and pTAT), and 1µg envelope plasmid (pVSVG) using lipofectamine 2000.
BSC40 cells were transduced with lentivirus carrying each of our desired RRM2 constructs
and cells carrying the transgene were selected th ough inclusion of hygromycin (125µg/ml)
in the culture media. Cells were used for experimental analysis as long as immunoblot
analysis confirmed target protein expression.
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Table 2-3 – Primers used for generation of epitope tagged RRM2
Primer
N-terminal HA tagged WT RRM2
(1)

Sequence
5’ - CGC CTC GAG ATG TAC CCA TAC GAC
GTA CCA GAC TAC GCA ctc tcc ctc cgt gtc c

N-terminal untagged WT RRM2
(2)
N-terminal tagged 50-389 RRM2
(3)

5’ - CGC CTC GAG ATG ctc tcc ctc cgt gtc c-

N-terminal untagged 50-389
RRM2 (4)
C-terminal untagged RRM2 (5)
C-terminal tagged RRM2 (6)

- 3’
3’

5’ - CGC CTC GAG ATG TAC CCA TAC GAC
GTA CCA GAC TAC GCA atc ttc cag gag ccc
acg- 3’
5’ - CGC CTC GAG ATG atc ttc cag gag ccc
acg- 3’
3’ – C CTA CGA CTG AAG ATT CCT AGG CG
– 5’
3’ - GG AAC CTA CGA CTG AAG TGC GTA
GTC TGG TAC GTC GTA TGG GTA ATT CCT
AGG CG – 5’

Table 2-4 - Generated Cell Lines
Cell Line

Expression
Outcome
shXPA1
Silenced
BSC40
XPA
shXPA2
Silenced
BSC40
XPA
shXPG
Silenced
BSC40
XPG
shXPF1
Silenced
BSC40
XPF
shXPF2
Silenced
BSC40
XPF
sh hCLK2-1 Silenced
BSC40
hCLK2
sh hCLK2 -2 Silenced
BSC40
hCLK2
HA-RRM2
N-terminal
BSC40
tagged
RRM2
RRM2-HA
C-terminal
BSC40
tagged
RRM2
N-terminal
HA-∆N
tagged 50RRM2
389 RRM2
BSC40

Expression
System
Lentiviral
Transduction
Lentiviral
Transduction
Lentiviral
Transduction
Lentiviral
Transduction
Lentiviral
Transduction
Lentiviral
Transduction
Lentiviral
Transduction
Lentiviral
Transduction

Genomic
Insertion
Multiple
Random
Multiple
Random
Multiple
Random
Multiple
Random
Multiple
Random
Multiple
Random
Multiple
Random
Multiple
Random

Promoter
Pol II

Antibiotic
Selection
Puromycin

Pol II

Puromycin

Pol II

Puromycin

Pol II

Puromycin

Pol II

Puromycin

Pol II

Puromycin

Pol II

Puromycin

CMV

Hygromycin

Lentiviral
Multiple
Transduction Random

CMV

Hygromycin

Lentiviral
Multiple
Transduction Random

CMV

Hygromycin
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Lentiviral
Multiple
∆N RRM2- C-terminal
tagged
50Transduction
Random
HABSC40
389 RRM2

CMV

Hygromycin

Growth curve assay and doubling time.
2 x 105 cells were plates on 6 well dishes and incubated for 48 h at 37° C. Cells were
harvested and cell pellets were resuspended in 1µl of complete media. 10µl was added to
10µl of 1x Trypan blue and counted using a hematocytometer. Doubling time was then
calculated as 2x = nfinal / ninitial. Growth curve assays were conducted similarly but cells were
collected and counted every 24 h for 96 h and plotted as the average cell number for each
cell line at the respective time point.

Viruses.
WR strain of VV (WT) stocks were prepared by ultracentrifugation of cytoplasmic lysates
of infected BSC40 cells th ough 36% sucrose; titers were assessed by plaque assays
performed on BSC40 cells [151]. Deletion viruses lacking the G5R or I3L allele were
generated by previous members of the lab (Czarnecki and Traktman, unpublished; [76]).
Stocks were prepared as described for the WT virus, but grown and tittered on
complementing CV1 cells expressing the G5 or I3 proteins in trans. A modified virus,
vSK20 (labeled herein as v∆A50), was kindly provided by Dr. Geoffrey Smith [152].

Preparation of digital figures.
Statistical analysis and graph preparation were performed using SigmaPlot software
(Systat Software, Chicago, IL) or GraphPad Prism (San Diego, CA). Final figures were
assembled and labeled with Canvas software (Deneba Systems, Miami, FL).
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Virological methods.
Quantification of infectious virus yield.
BSC40 cells were infected with WT virus [multiplicity of infection (MOI) 5] for 18h;
harvested cells were washed once with PBS and cell pellets were resuspended in 1mM
Tris pH 9.0. Samples were then disrupted by freeze-thawing (3X) and viral yield was
quantified in plaque assays performed on complementing cell lines (typically BSC40 cells).

Quantification of viral DNA accumulation by Southern dot blot hybridization.
Cells from 35-millimeter dishes were harvested at various time points from 3-18hpi, as
described in the text. Pellets were resuspended in 500µl 10x SSC (1.5M NaCl; 0.15M
sodium citrate), 1M NH4Ac and disrupted via freeze-thawing (3X) and sonication (2X, 15
sec each). Using a dot blot apparatus (Bio-Rad) loaded with a Zeta-Probe membrane,
30µl of each sample was spotted in technical triplicate, denatured using denaturing buffer
(1.5M NaCl; 0.5M NaOH) (1X, 10 min) and washed with 10x SSC (2X, 5 min). Membranes
were hybridized to [32P]-labeled fragments of the viral genome as described in the
hybridization methods. Data were obtained using phosphorimager analysis (Typhoon
FLA-9000) and quantified using ImageQuantTL software.

Pulse-field gel electrophoresis (PFGE).
6-centimeter dishes of BSC40 cells were infected and treated as described in the text.
Harvested cell pellets were suspended in 60µl plugs of PBS/0.5% agarose and stored
overnight at 4° C. The following day, samples were digested in 1ml of 1% sarcosyl,
0.05mM EDTA, and Proteinase K (50 µg/ml) for 24h at 50°C. Plugs were loaded into the
wells of a 1% Seakem Gold Agarose Tris Borate EDTA (TBE) gel and resolved using a
CHEF Mapper XA apparatus (Bio-Rad): 6 V/cm for 12h at 14°C with a switching time
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gradient of 1 to 25s, a linear ramping factor, and a 120° angle. Ethidium bromide (EtBr) or
Sybr Gold were used to visualize DNA; images were captured using a FluorChem E
documentation system (ProteinSimple, Santa Clara, CA). Gels were then depurinated
using 2M NaCl for 15 min, denatured using 1.5M NaCl, 0.5M NaOH for 45 min, and
neutralized using 1.5M NaCl, 1M Tris pH 7.4 for 45 min. Afterwards, gels were transferred
to either Zeta probe or nitrocellulose membrane using a standard capillary transfer. These
membranes were either hybridized to [32P]-labeled DNA fragments of the viral genome or
probed with an antibody that recognizes CPD DNA adducts. (When CPD adducts were
being monitored, gels were not stained and imaged prior to transfer, because such
treatment induces DNA adducts).

Nick translation.
Radionucleotides [32P] dATP, TTP, dGTP, and dCTP were ordered from Perkin Elmer
(Waltham, MA). Using a plasmid containing the target DNA sequence, typically the HindIII
“D fragment” of the viral genome, 100ng of DNA was added to 75µCi of each
radionucleotide (for 4-hot probes) or 75µCi of [32P] dATP and TTP (for 2-hot probe), 75µM
cold dCTP and dGTP (for 2-hot probe), 10 U of E. coli DNA polymerase, 2ng DNase1,
and 1µl of reaction buffer L and incubated for 45 min at 15° C. 40ml of TE and 1µl of 0.5M
EDTA pH 8 was added to stop the reaction. 1µl was taken to examine the initial CPM of
these probes. Unincorporated nucleotides were cleared from the solution by using G30
spin columns (Cytiva; Malborough, MA). 1µl was taken from the flow through to examine
the CPM levels following clearance of unincorporated nucleotides. CPM were calculated
using the LS6500 scintillation counter protocol “Cherenkov” specific for

P activity. The

32

comparative CPM would provide a relative ratio of incorporated to unincorporated [32P]
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dNTPs. DNA probes produced from nick translation were used for hybridizations as long
as the % incorporation was >30% (2-hot) or >60% (4-hot).

Hybridization of [32P] DNA for Southern blot analysis.
Following immobilization of DNA on Zeta Probe membrane, samples were incubated in a
hybridization oven at 42° C for 2.5 – 4h with a prehybridization solution (50% formamide,
6xSSC, 0.5% SDS, 5xDenharts, and 0.2mg of denatured salmon sperm DNA). [32P]
radiolabeled probes made by nick translation for either plasmid or vDNA were then added
to fresh prehybridization solution. Hybridization took place overnight at 42° C. The next
morning, membranes were washed 3 times with 2xSSC for 15 min at room temperature
then twice with 0.2xSSC, 0.1% SDS for 30 min at 55° C. Membranes were dried between
sheets of Whatman paper, placed in a plastic sheet protector, and put down in a
phosphorimager cassette. Membranes were developed using either Classic Blue
Autoradiography Film BX (MidSci; Valley Park, MO) or FujiFilm for anywhere between 6
h and 7 days depending on the experiment.

Immunoblot analysis of viral and cellular protein levels.
Cell pellets were lysed on ice using 1xPLB (10mM NaPO4 pH 7.4; 100mM NaCl; 1% Triton
X-100; 0.1% SDS; 0.5% DOC) containing both protease and phosphatase inhibitors
(1µg/ml leupeptin and pepstatin; 1mM phenylmethylsufonyl fluoride; 1mM sodium
orthovanadate, 1mM NaF, and 0.01 U benzonase). If samples were frozen following lysis,
samples were clarified by sedimenting particulates at 1,700 rpm for 7 min at 4 °C. 5x
protein sample buffer (PSB) was added, and samples were resolved electrophoretically
before being transferred to nitrocellulose membranes. Depending on the optimized
antibody blotting conditions, membranes were blocked with milk or bovine serum albumin
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(BSA). The membranes were then probed with antisera specific for viral or cellular proteins
in buffers containing various concentrations of NaCl (500mM NaCl - TBST; 325mM NaCl
– MTBST; 150mM NaCl – FTBST) followed by HRP-conjugated secondary antibodies.
Immunoblots were developed using chemiluminescent SuperSignal West Pico reagents
(Pierce, Rockford IL), visualized by exposure on a FluorChem E documentation system
(ProteinSimple,

Santa

Clara,

CA)

and

quantified

using

AlphaView

software

(ProteinSimple).

Immunofluorescence analysis.
BSC40 monolayers were infected and treated as described in the text. Cultures were then
fixed with 4% PFA, washed and permeabilized with 0.1% of 0.5% Triton-X100 in PBS (15
min, room temperature). 5% BSA was added for 1 h before samples were probed with
various antibodies (see Table 2-1) followed by Alexa Fluor GAR 488nm and GAM 594nm
secondary antibodies. DAPI (4’,6’-diamidino-2-phenylindole) was added for 30 min and
slides were mounted with Vectashield (Vector laboratories, Inc., Burlingame, CA). Images
were captured using a Nikon Eclipse Ti microscope and NIS Elements AR4.4 software
(Tokyo, Japan).

Viral uncoating assay.
BSC40 or HeLA cells were seeded into 4-chamber slides 24 hours prior to infection. A
subset of samples were treated with ATR inhibitor (VE-822) or cycloheximide (25µg/ml) 1
h prior to infection. Cultures were infected with WT virus (MOI 15) and araC (20mM) was
added immediately after adsorption. At 3 hpi, samples were processed for
immunofluorescence as described in the viral specific methods. Briefly, samples were
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probed with an antibody to A5, a viral core protein, and stained with DAPI before being
mounted.

Metabolic labeling of nascent proteins with [35S]-methionine.
BSC40 or HeLa cells were infected, irradiated, or treated with ATR inhibitors as described
in the text. At either 1h post UV (uninfected) or 3, 6, 9 or 12 hpi, 100µCi/ml [35S]-methionine
was added to cultures in modified DMEM containing L-glutamine but not methionine (Cat.
No. 10013CV) for 45 min. Cultures were then harvested, lysed using 1xPLB, and resolved
electrophoretically before being fixed in a 10% acetic acid, 40% methanol solution. The
gel was then dried between sheets of cellophane and visualized by phosphorimaging
analysis (Typhon FLA-9000).

TCA precipitation of [35S]-methionine labeled proteins.
Aliquots from the metabolic labeling described above were spotted onto Whatman paper,
precipitated with 5% TCA (trichloroacetic acid) and washed with 95% ethanol followed by
100% acetone before being loaded in scintillation vials. Scintillation vials were filled with
scintillon (EcoLite, MP BioChemicals) before being counted using a scintillation counter
(Beckman Coulter LS-6500).

Extraction of cytoplasmic vDNA for examination of UV lesions within the viral
genomes.
BSC40 cells were infected with WT virus (MOI 5) for 4.5, 7, 10 or 18 hpi. Infected samples
were either left unirradiated or irradiated with 60 J/m2 UV at 4 hpi. Uninfected samples
were included as a control. Samples were harvested and resuspended in FLAG lysis
buffer (1% Triton-X100, 0.1% Tween 20, 50µM EDTA, 50mM Tris pH 7.4, and 100mM
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NaCl) for 5 min on ice. 5µl of sample was taken to examine via light microscopy to ensure
that nuclei remained intact. Samples were then sedimented at 1700 rpm for 5 min at 4° C
before continuing with the cytoplasmic soluble fraction (supernatant).

Cytoplasmic extracts were then treated with Proteinase K (10µg/ml) for 3 h at 65° C before
performing two phenol-chloroform and two isoamyl chloroform extractions. Samples were
then treated with pancreatic RNase (25µg/ml) for 1h at 37° C. DNA was ethanol
precipitated before concentration was analyzed using a NanoDrop 2000c (Thermofisher;
Waltham, MA). For CPD detection, 40ng of DNA was used while 400ng was required for
6,4-PP detection. Samples were loaded into a 1% agarose, 1xTAE (tris-acetate-EDTA)
gel and resolved at 100 V for ~2 h in 1xTAE. For detection of VV DNA, samples were
stained using EtBr and imaged using a FluorChem E documentation system. For detection
of CPDs or 6,4-PPs, agarose gels were immediately depurinated, denatured, and
neutralized before being capillary transferred as outlined in the PFGE protocol.

Visualization of CPD lesions in PFGE-resolved DNA samples.
After resolution of DNA, samples were transferred to Zeta-Probe membranes using a
standard Southern blot transfer protocol. Membranes were blocked with 5% milk F-TBST
for 1h at room temperature before probing with antibodies recognizing either CPDs or 6,4PPs. Membranes were probed overnight at 4°C at 1:4,000 (CPD) or 1:1,000 (6,4-PP) in
1% milk F-TBST. The following day, membranes were treated as described above in
immunoblot protocol.
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Plasmid replication assay.
6-centimeter dishes of BSC40 cells were either left uninfected or infected with WT virus
(MOI 5). A subset of samples was then transfected with 2µg of either unirradiated pBSIIKS
plasmid DNA or plasmid DNA that had been irradiated with, 60, or 90 J/m2. Cultures were
collected 10, 14, or 18 hpi and DNA was extracted using the QIAamp DNA mini kit
(Qiagen; Venlo, Netherlands). Each sample was digested for 1.5 h at 37° C in duplicate
with 2µg being digested with BamH1 and 5µg being digested with BamH1 and Dpn1.
Digested samples were resolved on a 1% agarose TAE gel (typically resolved at 100V,
>2h) and stained with EtBr before being imaged using the FluorE chem gel dock. The gel
was treated as described previously for capillary transfer and hybridization; the [32P]-DNA
probe was generated using 100ng pBKIIS as the template for nick translation. Following
development on FujiFilm (Minato, Japan), scans were taken using an FLA-7000 Typhoon.

Electron microscopy.
6-centimeter dishes of BSC40 cells were either left unirradiated or irradiated with 60 J/m2
UV at 1h prior to or 4 h post infection with WT virus [MOI]. Samples were harvested at 18
h and processed for transmission electron microscopy as previously described [17]. Cell
pellets were embedded in Embed 810 resin (Electron Microscopy Sciences, Hatfield, PA).
Thin sections were examined on a JEOL JEM-1010 microscope and images were taken
using a Hamamatsu camera.

Analysis and purification of mature virions by sucrose gradient ultracentrifugation.
15-centimeter dishes of BSC40 cells (4 per sample) were left unirradiated or irradiated
with 60 J/m2 UV at -1hpi or 4hpi. All infections were performed with WT virus (MOI 5) for
18h. Cells were harvested, washed with PBS, and resuspended in 10mM Tris pH 9.0.
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Cells were broken using a Dounce homogenizer and nuclei were removed by
sedimentation. The cytoplasmic fraction was sonicated and layered on top of a 36%
sucrose cushion (10mM Tris pH 9.0); ultracentrifugation was performed at 25,000xg for
90 min at room temperature. Pellets were then resuspended in 200μl 1mM Tris pH 9.0,
sonicated twice for 15 sec each, and layered on top of 25-40% sucrose gradients prepared
in 1mM Tris pH 9.0. Virions were resolved th ough the gradient by ultracentrifugation at
6000xg for 50 min at 4° C.

In some cases, light scattering bands were pulled using an 18g needle, removing ~200ul
per sample. In other cases, the bottom of the tube was pierced, and equal-sized fractions
were collected. In both cases, a final sedimentation at 9200xg for 45 min at 4°C was used
to collect the virions. Titers were determined by plaque assay on BSC40 cells and total
protein concentration was quantified using a BCA protein assay kit (Thermo Fisher). In
some cases, DNA analysis was performed by spotting samples on Zeta-Probe
membranes which were then probed with [32P]-labeled fragments or anti-CPD antibodies;
in other cases, samples were subjected to PFGE prior to further analysis.

Transient complementation of UV irradiated v∆G5 infections with mutant G5 alleles.
CV1 cells expressing WT G5 or G5 alleles containing a mutation in the predicted catalytic
sites (D33A, A171V, and D198A) were generated by Dr. Maciej Czarnecki (unpublished).
Each cell line, including a CV1 cell line expressing a chloramphenicol transferase (CV1CAT) allele (known to not impact viral replication), were plated on 35-mm dishes. Cells
were induced with doxycycline (10µg/ml) 24 h prior to infection. The following day, cells
were treated as described in the UV irradiation specific methods. Plaque assays were all
performed on pre-induced CV1-G5 cells.
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Co-immunoprecipitation assays.
6-centimeter dishes of BSC40 cells were infected with WT virus, vG5-V5, or v∆G5 for 7 to
10 h before being collected. Cell pellets were lysed in 1.2ml of FLAG lysis buffer for 30
min on ice before either continuing with the immunoprecipitation protocol or clarifying the
lysates via sedimentation at 1700 rpm for 7 min to remove the nuclei. An antibody to the
desired target protein was added for at least 4 h on ice with intermittent mixing. Protein-G
Sepharose beads (10mg/sample) or magnetic DynaBeads (2mg/sample) were then added
for at least 1.5 h with constant end-over-end mixing. Samples were then vortexed at full
strength for 1 min, collected by sedimentation at 14k rpm for 2 min and resuspended in
900µl of FLAG lysis buffer [3 times]. Samples were then resuspended in 50ml of 1xPSB
and boiled for at least 5 min. Samples were sedimented at max speed and the supernatant
was used as the elution for SDS-PAGE.

Visualization of proteins by silver staining of SDS-PAGE.
Following SDS-PAGE, gels were washed with 50% methanol twice for 15 min before
shifting to 5% methanol for one additional wash of 10 min. The gel was rinsed with diH20
th ee times before washing with 10µM DTT (dithiothreitol) for 20 min. After reducing with
DTT, the gel was washed in a 0.1% silver nitrate (AgNO3) solution for 20 min. The gel was
then rinsed with diH20 and developed in a solution of 6% sodium carbonate (w/v) and
1.85% formaldehyde until staining was complete.

Qualitative assessment of viral DNA replication.
BSC40 cells were seeded into 4 or 8-well chamber slides 24h prior to infection. Cells were
then infected with either WT virus or v∆G5 at an MOI of 5 for 2.5, 3.5, or 4.5 hpi. At each
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time point, the medium was removed and replaced with 5% FBS DMEM containing EdU
(20mM) for 20 min. Afterwards, samples were placed on ice, washed 2x with cold PBS,
and fixed in 4% paraformaldehyde for 15 min. Following fixation, samples were washed
twice more with cold PBS before storing at 4° C overnight.

The following day, samples were permeabilized in 0.1% Triton-X100 for 15 min at room
temperature. Then, using the Click-iT EdU Alexa Fluor 488 Flow Cytometry Assay Kit (Life
Technologies; Waltham, MA), click chemistry was performed to attach the Alexa Fluor 488
to EdU within each sample. Afterwards, samples were probed with an antibody
recognizing I3 for 1 h at room temperature before washing twice more with cold PBS.
Samples were incubated with goat anti-rabbit Alexa Fluor 594 for 1 h at room temperature.
Finally, following 2 more washes in PBS, samples were stained with DAPI for 30 min at
room temperature before slides mounting media and cover slips were added and slides
were sealed.

Generation of a recombinant virus (vIND G5-V5) expressing V5-tagged G5 under an
inducible promoter.
The plasmid, pJS4, with a bicistronic viral promoter was previously generated [153] and
has been used in the generation of numerous inducible viruses [108, 127, 154]. pJS4
contains TetR under the regulation of a bicistronic early/late viral promoter. G418r was
cloned into the pJS4 plasmid by Dr. Maciej Czarnecki to allow for selection of recombinant
viruses. Finally, a cassette containing an epitope tagged (V5) G5 allele under the
regulation of the viral I2 promoter and a triple TET operator was synthesized and added
into pJS4 by GeneArt (Regensburg, Germany). The inducible G5R and TeTr allele are
flanked by the left and right halves of the TK gene, which enables their insertion into the
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TK locus via homologous recombination. Using the virus lacking the endogenous G5R
allele (v∆G5) generated by Dr. Maciej Czarnecki, confluent 60-mm dishes of BSC40 cells
were infected at either low (0.03) or high (3) MOI. Following adsorption, 3.5µg Sca1linearized pIND G5-V5 was transfected into each of these cultures.

For high (3) MOI cultures, cells were collected at 24 hpi, freeze-thawed (3x) and sonicated
(2x, 15”); 1, 5, or 10 µl were then used to infect fresh monolayers of BSC40. After
adsorption, doxycycline (10µg/ml) and G418 (2mg/ml) were added, and infections were
allowed to proceed for 48 h. At 48 hpi, infected cells were collected for iterative plaque
purification (IPP).

For low (0.03) MOI cultures, doxycycline and G418 were added at 16 hpi and infections
were allowed to proceed until 48 hpi. These cells were harvested and iterative plaque
purification was then performed.

Iterative plaque purification of vIND G5-V5.
Infected cells (from both high and low MOI conditions) were subjected to freeze thaw (3x)
and sonication (2x, 15”) and then used to infect fresh monolayers of BSC40 cells 10cm
dishes. Doxycycline and G418 were added at adsorption and infections were allowed to
proceed for 48 h. Dishes were then stained with neutral red (33µl/ml) for 30 min at 37° C.
Individual plaques were picked and resuspended in 100µl of 1mM Tris pH 9. PCR analysis
was performed on the collected plaques for the NEO cassette (proof of plasmid
integration) and viral A30 gene (proof of viral infection). After the first round of IPP, the
next few rounds were performed on 12-well plates. IPP continued until all progeny virus
contained NEO as detected by PCR (four rounds of IPP). vIND G5-V5 isolates were then
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expanded on increasingly larger dishes and then purified using sucrose sedimentation as
outlined in the viruses protocol. Proper integration and lack of mutation in the inducible
G5-V5 allele was assessed by sequence analysis using Eurofins Genomic DNA
sequencing services. Primers for PCR amplification of A30, NEO, and G5R, as well as
primers for sequence analysis of 3xTetOp G5-V5, are listed in table 2-5.

Table 2-5 – Primers used in the generation of vIND G5-V5
Primer

Purpose

Sequence

Neo P

IPP validation

Neo Q

IPP validation

A30-31 forward
A30-31 reverse
TK-L For
CO-G5 For 1
CO-G5 For 2
CO-G5 For 3
CO-G5 Rev 1
CO-G5 Rev 2

IPP validation
IPP validation
Sequencing
Sequencing
Sequencing
Sequencing
Sequencing
Sequencing

5’- CAA GAT GGA TTG CAC GCA GGT
TC -3’
5’- GCC ATG ATG GAT ACT TTC TCG
GCA CGG TAC -3’
5’- GTA GAC GCG TAT TGC GC -3’
5’- CGG TAG AAT GCT TTG GC -3’
5’- GGA ACG GGA CTA TGG -3’
5’ – CGT GAC CCT GTT CAT CG – 3’
5’ – CCT GGC CAA ACT GAC C – 3’
5’ – CCT GTC CTC CTA CAT CG – 3’
5’ – CTC CCG ATT CGC AGC – 3’
5’ – GCT ATC AGG ACA TAG C – 3’

Tissue Culture Treatment

Use of small molecule inhibitors targeting ATR or ATM kinase.
Inhibitors targeting either ATR (AZ-20, VE-821, and VE-822) or ATM (KU60019 and
KU55933) were ordered from Selleckchem (Houston, TX). Concentrations of each drug
were selected based on cytotoxicity assessed by mitochondrial viability (MTT assay),
efficacy (ability to block phosphorylation of Chk1 in the presence of etoposide), and
previous literature [139, 155, 156]. Working concentrations were determined to be 15µM
AZ-20, 20µM VE-821, 10µM VE-822, 5µM KU60019, and 40µM KU55933, each of which
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was dissolved in DMSO. Unless otherwise stated, each drug was added 1 h prior to
infection and maintained th oughout infection.

MTT Assay.
BSC40, A549, or HeLA cells were seeded on 96-well plates. Confluent monolayers were
treated with ATR or ATM inhibitors ranging in concentration from 3 to 100µM. After 24 h
of treatment, 10µl of 3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide (MTT)
was added to each sample and incubated for 3 h at 37° C. 100µl of an MTT stop solution
(50% DMF, 20% SDS) was added and samples were rocked for 1 h at room temperature.
Plates were loaded on a Synergy HTX Multi-Mode plate reader (Agilent; Santa Clara, CA)
and 570nm absorbance was quantified. Cell viability was calculated as a percentage
compared to a paired vehicle control.

UV irradiation of BSC40 cells.
Confluent dishes of BSC40 cells were irradiated using a UV crosslinker (VWR – B116536);
the medium was aspirated immediately prior to irradiation and replaced immediately after
irradiation. Doses of 0, 15, 30, 60 and 180 J/m2 were used. As indicated in the text, cells
were either irradiated at 1 h prior to infection (-1 hpi) or at 4h after infection (4 hpi) (or left
untreated).
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Chapter 3 - Intersection between Vaccinia Virus and the DNA
Damage Response: Perturbation of the Cellular Environment
Disrupts VV replication.
Rationale:
Poxviruses are large dsDNA viruses that replicate exclusively in the cytoplasm of
mammalian cells. Vaccinia virus, the prototypic poxvirus, encodes ~200 genes and has a
genome of 194kb. The plethora of encoded genes essential for viral replication and its
physical separation from the host nucleus support a paradigm that poxviruses are
remarkably autonomous. This paradigm is no more apparent than in studies examining
how poxviruses metabolize their genomes. Vaccinia virus has no defect accumulating viral
DNA when infecting enucleated cells compared to nucleated cells [157]. However, recent
studies have demonstrated that cellular factors are recruited to viral cytoplasmic
replication factories and may play a role in viral replication [28, 137, 158]. Indeed, inhibition
of ATR or depletion of PCNA reduced viral DNA accumulation [139]. How inhibition of ATR
or depletion of PCNA reduces viral DNA accumulation remains unknown. Could these
impacts be due to ATR or PCNA acting directly as part of the viral DNA replication
machinery, or could depletion or inhibition disrupt the cellular milieu, thereby generating a
suboptimal cellular environment for viral infection? These findings make it abundantly
clear that the intersection between the host cell and poxviruses is more complex than
previously understood.

Nuclear replicating DNA viruses like human papillomaviruses (HPV) and herpes simplex
virus (HSV) manipulate many aspects of the cellular DNA damage response either to
evade detection or promote replication (Reviewed in [159]). Meanwhile, the involvement
of the cellular DNA damage response pathway in poxvirus infections is relatively
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unstudied. In attempting to identify cellular DNA metabolizing proteins important in VV
DNA replication, activation of the DDR might shed light on which cellular factors VV
utilizes. VV encodes a kinase, B1, that phosphorylates the barrier to autointegration factor
(Baf) [160]. Baf is important for detecting and sequestering dsDNA present in the
cytoplasm, either foreign pathogen DNA or cellular DNA leaked into the cytoplasm due to
nuclear rupture [161-163]. Furthermore, cellular DNA ligase 1 is recruited to cytoplasmic
viral replication factories where it can complement VV infections lacking A50, the viral
DNA ligase [158]. PCNA, TOP2A, TOP2B, and SMC4 are tightly bound on nascent viral
DNA as identified following isolation of proteins on nascent DNA (iPOND), although the
importance of these proteins in vDNA metabolism remains unknown [137]. Beyond these
studies, little is known whether cellular DNA metabolizing proteins play a role in VV
replication or if VV antagonizes the DDR pathway to evade host detection. We initiated
these studies to examine the interplay between VV infection and the host DNA
metabolizing enzymes.

While VV encodes numerous factors responsible for the metabolism of its genome, there
are still deficiencies in the full suite of DNA metabolizing enzymes compared to eukaryotes
or prokaryotes. Either specific DNA metabolizing activities are unnecessary for the
replication and processing of the viral genome, or VV infection translocates cellular DNA
metabolizing factors to cytoplasmic replication factories. We hypothesize that VV infection
could manipulate the DDR to evade detection, co-opt cellular DNA metabolizing factors,
or generate an optimal cellular environment for viral replication.
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Results:
How does VV infection alter the DNA damage response pathway?
Does VV infection activate a cellular stress response?
Cytoplasmic DNA viruses must avoid detection from host cells to allow for replication
without activation of cellular immune signaling. VV encodes a kinase, B1, which
phosphorylates barrier to autointegration factor (Baf), thereby inhibiting its ability to bind
dsDNA [160]. In ts mutant viruses encoding a defective B1 allele, Baf binds viral DNA and
blocks DNA replication. Baf is but one of the cytoplasmic DNA sensors encoded by the
cell, and many of these sensors intersect with the DNA damage response pathway. To
address whether VV infection activates the DNA damage response pathway, we
performed immunoblot analysis on either infected BSC40 cells or HeLa cells throughout
infection (0-24 hpi) (Fig 3-1, A). There is no increase in γH2-AX or pChk1 S345 up to 14
hpi. However, we see increased γH2-AX and pChk1 S345 from 14-24 hpi. At this point in
the viral lifecycle, viral DNA accumulation has peaked, and most of the infectious virus
has been produced. Therefore, we believe the activation is due to the increased stress on
the cell caused by ongoing and prolific viral replication. A recent publication revealed that
the viral kinase, F10, is essential for activating the DDR marked by pChk1 S345 [164].
The induction of γH2-AX and pChk1 S345 are identical in both cell lines tested, supporting
that this is not a cell type-specific phenotype. Inducing a DDR is but one side of the coin.
If DDR effectors were restriction factors for VV infection, infections might dampen the
DDR.

Does VV infection alter a cellular stress response?
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As mentioned, activation of the DDR could lead to upregulation of antiviral genes or cause
changes to the cellular environment that would detrimentally impact viral replication.
Therefore, while VV infection doesn’t activate a DDR until late in infection, VV could block
such activation. Using etoposide, a topoisomerase poison, as an inducer of cellular stress,
we infected BSC40 or HeLa cells with either WT or ∆A50 virus (MOI 5) for 5 h before either
leaving untreated or treating with etoposide from 5 to 6 hpi. As a control for DDR activation,
we treated uninfected BSC40 or HeLa cells with etoposide for 1h. We then collected the
samples and performed immunoblots examining the relative levels of γH2-AX and pChk1
S345 (Fig 3-1, B). VV infection is sensitive to etoposide treatment as the viral DNA ligase,
A50, recruits topoisomerase 2a and 2b to the viral DNA [165]. Deletion of A50 alleviates
this effect. Furthermore, there is no significant replication defect of the ∆A50 virus
compared to the WT virus in tissue cultured cells. Therefore ∆A50 was included to control
the possible disruption etoposide might have on WT infected cells. Using I3 and L4 as
early (I3) and late (L4) viral gene expression markers, their levels remain unchanged
across each of the conditions, as do γH2-AX and pChk1 S345. There is less than a 20%
reduction in the levels of pChk1 S345 between the WT infected and uninfected samples,
suggesting that VV infection does not dampen the DDR. Etoposide addition is but one
mechanism to introduce DNA damage. Using a complementing system, we examined
whether VV infection dampens sustained DDR signaling.

How does VV infection impact the longevity of the DDR/cellular stress response?
Although VV infection does not dampen the DDR activated through treatment with
etoposide for 1h, we wanted to address whether VV infection would reduce the sustained
activation of the DDR following the introduction of cellular stress. We also wanted to test
whether the virus would differentially affect the DDR if activated prior to or during infection.
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Figure 3-1. VV infection does not induce nor dampen a DNA damage response
(DDR).
VV infection does not induce a DDR until after 14 hpi (A). HeLa (Top) or BSC40 (bottom)
cells were infected with WT virus (MOI 5). Infected cells were harvested at 2, 4, 6, 10, 14,
18, and 24 hpi and processed for immunoblot analysis. Controls included cells treated with
etoposide (50µM) for 1 hr or untreated. Immunoblots were probed for Calnexin (loading
control), pChk1 S345, tChk1, L4 (viral protein), and γH2AX (n=2; a representative
immunoblot is shown). VV infection does not dampen a DDR induced by etoposide
treatment (B). BSC40 (left) or HeLa (right) cells were left uninfected or infected with WT
or ∆A50 virus (MOI 5) for 5 hr. Infected cultures were then either left untreated or treated
with etoposide (50mM) for 1 hr and all samples were harvested at 6 hpi. Harvested
samples were processed for immunoblot analysis and probed for calnexin, pChk1 S345,
tChk1, I3 (viral protein), L4 (viral protein), and gH2AX (n=4; a representative immunoblot
is shown). VV infections do not dampen a sustained DDR (C). BSC40 cells were
untreated, irradiated prior to infection (-1 hpi), or irradiated during infection (4 hpi). A
subset of treated cells were infected with WT virus (MOI 5). Cells were harvested at 3, 6,
and 9 hpi before being processed for immunoblot analysis. Immunoblots were probed for
ATR, calnexin, Ku70, pChk1 S345, total Chk1, F17 (viral protein), and L2 (viral protein)
(n=3; a representative immunoblot is shown).
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Using UV irradiation as a tool to introduce cellular stress (both the DDR and unfolded
protein response (UPR) [166]), we irradiated one set of BSC40 cells 1h prior to infecting
with WT virus. We then UV irradiated another set of infected cells at 4 hpi. We collected
samples for immunoblot analysis at 3, 6, and 9 hpi; as a control, we had uninfected
samples matched to each condition (Fig 3-1, C). Under each UV irradiated condition, we
can see the induction of γH2-AX and pChk1 S345 as expected. Additionally, whether we
introduce UV irradiation prior to or post infection, we see similar levels of both markers in
the infected and uninfected samples, suggesting that VV infection does not affect
sustained activation of the cellular stress response either.

Is ATR’s kinase activity active during VV infection?
Does VV infection activate ATR/ATM effectors?
Up to this point, we have assessed activation of the DDR using two specific markers,
pChk1 S345 and γH2-AX. While these are both common substrates of numerous DDR
signaling pathways, they do not represent the whole swath of DDR signaling. To better
analyze the change in phosphorylated DDR effectors during infection, we utilized an
antibody recognizing substrates of Ataxia telangiectasia mutated (ATM) and Ataxia
telangiectasia mutated and Rad3-related (ATR).

DDR signaling is controlled by three central kinases: ATM, ATR, and DNA-PK (Reviewed
in [141]). Each is activated in response to a variety of DNA damages. ATM typically
mediates the response to double-stranded breaks (DSB), while ATR is activated in
response to UV irradiation and endogenous DNA stress. The substrates phosphorylated
by each kinase are highly regulated with little crossover. The full spectrum of ATR and
ATM substrates are numerous, and these substrates are important for regulating gene
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expression, DNA repair, and cell cycle progression. ATR’s kinase activity is activated by
the 9-1-1 (Rad9-Hus1-Rad1) complex and interaction with ATR interacting protein
(ATRIP) and TopBP1. ATM’s kinase activity is activated by association of the MRN (Mre11-Rad50-Nbs1) complex at sites of DSB. Interaction of both the 9-1-1 and MRN complex
with sites of DNA damage results in a positive feedback loop in activation of ATR and
ATM, respectively. There is some crossover in these effectors like RPA, the singlestranded binding protein of the cell; however, two primary substrates differ in that ATM
phosphorylates Chk2 while ATR phosphorylates Chk1. These kinases remain active until
the repair of damaged DNA templates is complete. Once DNA damage repair is complete,
phosphatases deactivate ATR and ATM (Reviewed in [167], [168]). With these data in
mind, we set out to examine the change in ATR and ATM phosphorylated substrates
during VV infection in an unbiased method.

ATR and ATM readily phosphorylate motifs of either serine or threonine followed
immediately by glutamine, known as pSQ/TQ sites [143]. Using a commercially available
antibody recognizing such motifs, we asked whether VV infection causes a change in the
pSQ/TQ profile either by increasing the levels or causing the phosphorylation of substrates
only seen following DNA damage. To validate the detection of pSQ/TQ motifs in
immunoblot assays, we collected BSC40 cells left unirradiated or UV irradiated with 60
J/m2. DNA damage caused by UV irradiation is known to activate ATR primarily.
Unsurprisingly, there are several phosphorylated proteins containing the pSQ/TQ motif in
uninfected, untreated cells (Fig 3-2, A). ATR is an essential gene activated upon
endogenous replication stress and cell cycle progression, so detecting phosphorylated
SQ/TQ sites absent of DNA damage is not surprising. Importantly, we can see a clear
increase in the levels of a few pSQ/TQ proteins when comparing our unirradiated sample
to our UV irradiated samples (Fig 3-2 A, red stars).
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Figure 3-2. VV infection does not cause an increase in the steady-state levels of
ATR or ATM substrates until after 7 hpi.
UV irradiation of uninfected cells induces ATR and ATM effectors as detected by
immunoblot using the pSQ/TQ antibody (A). BSC40 cells were either unirradiated or
irradiated at t=0 and harvested at 2, 4.5, 7, 10, and 18 hours post treatment. Samples
were harvested and processed for immunoblot. The entire membrane was probed for
pSQ/TQ (n=4; a representative immunoblot is shown). VV infection does not induce ATR
effectors until after 7 hpi (B). BSC40 cells were infected with WT virus (MOI 5) and either
treated with a vehicle control or ATR inhibitor (10µM VE-822). Cultures were harvested at
2, 4.5, 7, 10 and 18 hpi and processed for immunoblot analysis. The entire membrane
was probed for pSQ/TQ (n=2; a representative immunoblot is shown).
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Having validated the specificity of the pSQ/TQ antibody, we infected BSC40 cells in the
presence or absence of an ATR inhibitor (10 µM VE-822) and collected samples at 2, 4.5,
7, 10, or 18 hpi. Consistent with our previous analysis that VV infection did not activate
cellular stress until late in infection, we do not detect a significant increase in the levels of
pSQ/TQ proteins until 18 hpi (Fig 3-2, B, red stars). Interestingly, a few proteins detected
during infection are not present in any of the other conditions (Fig 3-2, B, green stars).
When an ATR inhibitor is present during infection, there is a decrease in the steady-state
levels of certain substrates. Still, these effects are typically seen later in infection from
between 7-18 hpi (Fig 3-2, B, yellow stars). These data suggest that any induction of the
DDR pathway following infection does not occur until late time points of infection (after
~10 hpi) when vDNA replication has been completed.

Does VV infection intersect at all with the cellular stress response pathway?
Does impairing the cellular stress response hamper viral infection?
Having seen that VV infection does not dampen sustained activation of the DDR pathway
or cause activation of DDR markers until late in infection, we wondered whether the
DDR/cellular stress impacted VV infection. Ataxia-telangiectasia and Rad3 related (ATR)
is a master regulator of the cellular stress response (reviewed in [141]). Typically, ATR is
activated following endogenous or exogenous DNA damage like those caused by stalled
replication forks or UV irradiation. ATR is also an essential gene whereby deletion or
mutations causing loss of ATR’s catalytic activity result in embryonic lethality [140].
Therefore, using small molecule inhibitors (VE-821, VE-822, and AZ-20), we wanted to
study how inhibition of ATR might impact VV replication.
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Having validated each ATR inhibitor’s ability to block pChk1 S345 activation and lack of
cytotoxic effect at the working concentration, we assessed the impact of ATR inhibition on
infectious viral yield (Fig 3-3). ATR inhibitors were added 1h prior to infection and
maintained throughout infection. BSC40 and HeLa cells were infected with WT virus (MOI
5) and collected at 18 hpi for assessment via plaque assay and immunoblot. Treatment
with various ATR inhibitors reduced viral yield approximately 10 to 15-fold in BSC40 cells
(Fig 3-3, A) and 15 to 30-fold in HeLa cells (Fig 3-3, B). Interestingly, infected HeLa cells
treated with the ATR inhibitor, VE-822, resulted in a decreased accumulation of late viral
proteins marked by L4 and F17 (Fig 3-3, C). The reduction in steady-state levels was
specific to the intermediate/late temporal class of viral genes, as I3 levels were unaffected.

We performed plaque assays to examine cell-to-cell spread to expand our understanding
of how ATR inhibition reduces infectious viral yield. BSC40 cells were left untreated or
treated with VE-822 and infected with 100 PFU of WT virus for 48 h. Cell monolayers were
stained with crystal violet, and relative plaque sizes were compared between treated and
untreated conditions. As expected, there’s a decrease in plaque size consistent with a
reduction in infectious yield in the ATRi treated infections (Fig 3-3, D).

Does inhibiting ATR impact viral DNA replication, genome processing, or integrity?
Many ATR substrates are DNA metabolizing enzymes, whether they be DNA binding
proteins like RPA, nucleases like Exo1, or polymerases like DNA polymerase η (Reviewed
in [141]; [142]). Therefore, we asked whether inhibition of ATR would impact viral DNA
replication. First, we performed Southern dot blots of WT infected BSC40 or HeLa cells in
the presence or absence of each ATR inhibitor (Fig 3-4, A and B). In BSC40 cells, there
was approximately a 40-60% reduction in viral DNA levels at 10 hpi following ATR
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Figure 3-3. ATR inhibition reduces VV infectious yield.
Inhibition of ATR’s kinase activity using three small molecule inhibitors reduces viral
infectious yield in both cell lines tested (A and B). HeLa (A) or BSC40 (B) cells were treated
with each small molecule (VE-821, VE-822, and AZ-20) 1 h prior to infection and their
presence maintained throughout infection. All samples were harvested at 18 hpi and either
processed for immunoblot (A and B) or titrated via plaque assay to assess viral yield (C,
left and right). Immunoblots were probed for calnexin, I3 (early viral protein), L4 (late viral
protein), and F17 (late viral protein) (n=8; a representative immunoblot is shown). Viral
yield is plotted as the average of three biological replicates with the error bars representing
the SEM (*, p<0.05; **, p<0.01; ***, p<0.001). Inhibition of ATR’s kinase activity reduces
plaque size (D). BSC40 cells were either left untreated or treated with ATRi (10µM VE822). Cells were infected with 100 PFU WT virus. At 48 hpi, cells were stained with crystal
violet and imaged (n=3; plaques shown).
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inhibition. The effect was marginally more significant in HeLa cells, with VE-822 causing
the greatest impact: 2.5-fold (Fig 3-4, B). VV replicates its genome in excess of that
required, so the ~2-fold decrease in viral DNA levels could not be responsible for the ~1log decrease in infectious viral yield (Fig 3-3). Therefore, we wanted to perform timecourse assays to provide a more comprehensive view of how VV replicates its genome
following ATR inhibition. BSC40 or HeLa cells were treated with each of the ATR inhibitors
1h prior to infection and then infected with WT virus. Samples were collected at 3, 4.5, 6,
8, and 10 hpi before being processed for Southern dot blot analysis (Fig 3-4, C and D).
Interestingly, ATR inhibition caused a delay in viral DNA accumulation in both cell lines
tested, where at 4.5 hpi, there is a 100-fold decrease in viral DNA levels, while at 10 hpi,
there is only ~2-fold decrease. We also see a difference in the profile of viral DNA
accumulation in infected ATR inhibited BSC40 cells versus HeLa cells (Fig 3-4, C vs. D).
While the line of best fit for viral DNA accumulation from infected BSC40 cells suggests
an exponential rate, the infected HeLa cells form a linear rate.

To assess the impact of ATR inhibition on genome quality and processing, we performed
pulsed-field gel electrophoresis (PFGE) of infected HeLa cells treated with each of the
ATR inhibitors. There are four distinct species of viral DNA seen from infected cultures:
branched concatemeric DNA, dimeric genomes, monomeric genomes, and subgenomic
fragments. Branched concatemeric DNA does not resolve under native conditions and
exists within the well. These DNA species are intermediates that can be resolved via the
Holliday junction resolvase activity of A22 [27]. Dimeric genomes are similar but resolve
at ~2x the size of the monomeric genomes. The monomeric genomes are those which
have been properly processed and are encapsidated into virions. These genomes resolve
at ~194kb. Finally, subgenomic fragments accumulate as a smear at sizes below the
monomeric genome. These fragments have typically been seen to resolve around 48 kb
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Figure 3-4. ATR inhibition delays the accumulation of viral DNA.
Inhibition of ATR’s kinase activity reduces vDNA levels at 10 hpi (A and B). BSC40 (A) or
HeLa (B) cells were treated with various ATRi or a vehicle control before being infected
with WT virus (MOI 5). At 10 hpi, cells were collected and levels of viral DNA were
assessed by Southern dot blot analysis. Samples from infected BSC40 and HeLa
cellswere spotted in technical triplicate, and data are plotted as the average of 6 and 10
biological experiments, respectively. The error bars represent the SEM (***, p<0.001).
ATR inhibition delays the accumulation of viral DNA (C and D). BSC40 (C) or HeLa (D)
cells were treated with various ATRi or a vehicle control before being infected with WT
virus (MOI 5). Samples were harvested at 3, 4.5, 6, 8 or 10 hpi and the levels of viral DNA
were assessed by Southern dot blot analysis. Data are plotted as the average of three
biological experiments with the error bars representing the SEM.
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[18, 76]. PFGE Southern allows us to analyze each of these viral DNA species using a
combination of changing the direction of the electrical current and increasing the frequency
in which that current is changed.

Samples were allowed to proceed until 10 hpi before being collected (Fig 3-5). Viral
monomeric genomes resolve at 194kb (red arrow). ATR inhibition with each inhibitor
reduced the amount of viral genomes produced comparable to the decrease seen in bulk
viral DNA levels (Fig 3-4 to 3-5). There is also a significant smear of DNA following ATR
inhibition in our infected samples (black brackets) as observed after EtBr staining.
Surprisingly, we detected subgenomic viral DNA fragments in the VE-822 treated, WT
infected HeLa cells (Fig 3-5, black brackets). Furthermore, we see a reduction in the levels
of viral monomeric genomes. We also note that there is no increase in the levels of
unresolved viral DNA following ATR inhibition (blue arrows). Therefore, ATR inhibition
reduces viral DNA levels and causes a portion of viral DNA to accumulate as subgenomic
fragments.

Genetic confirmation of small molecule inhibitors targeting ATR
When using small molecule inhibitors or drugs, we risk the possibility of off-target and
nonspecific effects. These drugs were screened across the human proteome but certainly
not against the VV proteome. We wanted to validate that the effect seen on VV infections
was due to inhibition of ATR and not due to the off-target impacts before continuing our
study. ATR is an essential gene, so small interfering RNA (siRNA) and short hairpin RNA
(shRNA) directly targeting ATR were not valid approaches. Upon further study, hCLK2
was identified as a protein important but not essential for ATR’s kinase activity [169, 170].
hCLK2 is an accessory protein of ATR like ATRIP and TopBP1 and binds ATR. When
silencing hCLK2 using siRNA, UV irradiation-induced phosphorylation of Chk1 at S317 is
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Figure 3-5. ATR inhibition with VE-822 causes VV infection to accumulate DNA as
subgenomic fragments.
Fewer monomeric genomes accumulate following ATR inhibition of infected cultures, and
inhibition via VE-822 results in the accumulation of viral subgenomic fragments. HeLa cells
were treated with each ATR inhibitor or a vehicle control and infected with WT virus (MOI
5). At 10 hpi, samples were processed for PFGE analysis. A representative image of the
EtBr staining is shown (left) as well as the corresponding Southern blot (right); the red
arrow marks the monomeric viral genome, the blue arrow the branched, concatemeric viral
DNA, and black brackets the subgenomic viral DNA fragments (n=10; a representative
EtBr and Southern blot is shown).
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reduced ~3-fold compared to the WT control. Furthermore, stable cells lines depleted of
hCLK2 (40% of endogenous levels) caused a >2-log decrease in HSV infectious yield
[171]. With this knowledge, we used a lentiviral delivery system to stably transduce BSC40
cells with either a scrambled sequence of RNA (shScrm) or two shRNA targeting hCLK2
(sh hCLK2- 05 and hCLK2-28).

Both shRNA constructs reduced the levels of endogenous hCLK2, but sh hCLK2-28
reduced endogenous hCLK2 to ~23.7%, which, based on previous publications, is
sufficient to see impaired ATR signaling (Fig 3-6, A). Each of these cell lines was infected
with WT virus (MOI 5) for 10 or 18 h before being collected for Southern dot blot (10 hpi)
or immunoblot and viral yield (18 hpi) analyses. Compared to the scramble control, the
viral yield was reduced ~10-fold in both cells lines depleted of hCLK2, consistent with the
reduction we see when using small molecule inhibitors of ATR (Fig 3-6, B).

We next assessed vDNA levels by Southern dot blot at 10 hpi in each cell line (Fig 3-6,
C). Infection of both hCLK2 depleted cell lines led to a ~4-fold decrease in vDNA levels at
10 hpi compared to our scramble control cell line. This fold change is comparable to that
seen in our ATR inhibited infections (~2-fold). It is important to note that these cells did
not survive more than six sequential passages (n=2) before either undergoing cell death
or losing shRNA-mediated repression of hCLK2. Therefore, we continued our studies
using the ATR inhibitor, VE-822.

Does the delay in viral DNA accumulation impact other stages of the viral lifecycle?
The viral lifecycle is segmented into stages where each relies on the success of the
previous stage for productive replication. The delay in viral DNA accumulation is not
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Figure 3-6. The ATR accessory protein, hCLK2, is important for viral replication and
DNA accumulation.
Depletion of hCLK2 phenocopies the impact of ATR inhibition on viral replication, but has
an even more severe impact on viral DNA accumulation (A, B, and C). BSC40 cells were
stably depleted of hCLK2 by lentiviral delivery of two different shRNA constructs and
selection with Puro; immunoblot analysis confirmed knockdowns of 60-70% normalized to
Β-tubulin (loading control) (n=3, a representative image is shown). Depletion hCLK2
reduces infectious yield and vDNA levels (B and C). shRNA-expressing BSC40 cells were
infected with WT virus (MOI 5). At 10 hpi, samples were collected and processed for
Southern dot blot analysis (B). At 18 hpi, samples were collected and titrated on BSC40
cells to quantify viral infectious yield (C) (n=3)
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guaranteed to impact the expression of intermediate and late viral genes. By 18 hpi, ATR
inhibited infections have similar intermediate and late viral proteins levels as marked by
F17 and L4. However, we asked whether there was a delay in the synthesis of viral
proteins similar to the effect seen on viral DNA accumulation.

WT infected BSC40 or HeLa cells were left untreated or treated with AZ-20, VE-821, or
VE-822. At 0, 2, 4, 6.5, and 9 hpi, cells were pulsed with [35S]-methionine for 45 min before
being collected, processed for SDS-PAGE, and imaged using a phosphorimager (Fig 3-7,
A and B). The untreated infections provide a standard profile of viral protein synthesis
where early proteins are seen by 2 hpi (green arrows), and intermediate/late proteins are
first detectable by 4 hpi (blue arrows). In all ATR inhibited infections, there is a clear delay
in the levels of synthesized late proteins at each respective time point such that the
synthesized late viral protein profile of 4 hpi untreated infections resembles the 6.5 hpi
ATRi treated infections. There is also a reduction in the levels of synthesized late viral
proteins in the VE-822 treated samples (Lane 14 and 15, A and B). Levels of synthesized
early viral proteins (green arrows) are not significantly changed between untreated and
treated infections. These data support the conclusion that ATR inhibition causes a delay
in the progression of the viral lifecycle.

Does ATR inhibition impact the early stages of the viral lifecycle, namely early gene
expression and viral uncoating?
As mentioned, the viral lifecycle is regulated such that a block in one stage causes a block
in all proceeding stages (no uncoating = no DNA replication, etc.). Assuming entry into the
mammalian cell, viral DNA replication is dependent on both expression of the ‘early’
temporal class of viral genes and uncoating, thereby providing the newly synthesized viral
proteins access to the genome. So, we next asked whether the delay caused by ATR
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Figure 3-7. ATR inhibition delays the expression of intermediate and late viral
proteins.
The synthesis of intermediate and late viral proteins is delayed following ATR inhibition (A
and B). HeLa (A) or BSC40 (B) cells were treated with either a vehicle control or
corresponding ATR inhibitor. Cells were then infected with WT virus (MOI 5). At each time
point (uninfected (t=0) or 2, 4, 6.5, and 9 hpi), cells were labeled with [35S]-methionine for
45 min; cell lysates were resolved by SDS-PAGE to visualize the profile of nascent
proteins (n=2; a representative image is shown).
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inhibition was due to deficiencies in early gene expression or uncoating. Using a suite of
antibodies recognizing early viral proteins, we performed immunoblots of infected BSC40
cells in the presence or absence of the ATR inhibitor, VE-822 (Fig 3-8, A). Early gene
expression begins as soon as 30 min past infection, so we collected samples at 2, 3.5, 5,
and 7 hpi to provide a temporal expression profile. We detected no difference in the
expression of D5, I3, L2, or A20 across each time point between the ATR inhibited and
untreated infections (Fig 3-8, A).

Numerous factors facilitate viral uncoating and involves the breakdown and degradation
of proteins making up the viral core wall [24]. Using a viral uncoating assay as previously
described, we examined whether ATR inhibition caused similar defects in uncoating as
cycloheximide, which is known to block this process (Fig 3-8, B). Using A5 as a marker of
the viral core, we can see that untreated and AraC treated infections readily uncoat and
form prereplication foci. Cycloheximide treated infections do not, and we can see the
pinpoint foci of A5. ATR-inhibited infections profile more similar to the AraC treated
infections as the A5 foci are much more diffuse than the cycloheximide conditions.
Therefore, ATR inhibition does not cause a defect in viral uncoating either.

Eliminating the possibility that the delay phenotype seen with ATR inhibition was due to
issues in early gene expression or uncoating, we have pinpointed the phenotypic effect of
ATR inhibition to be a delay in DNA replication and an accumulation of subgenomic viral
DNA fragments. However, we do not know how ATR inhibition could cause such an effect.
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Figure 3-8. ATR inhibition does not cause defects in early viral gene expression or
uncoating.
Steady state levels of early viral proteins remain unchanged following ATR inhibition with
VE-822 (A). BSC40 cells were left uninfected or infected with WT virus (MOI 5). Cells were
treated with either a vehicle or 10mM VE-822. Samples were collected at 2, 3.5, 5, and 7
hpi and processed for immunoblot analysis. Immunoblots were probed for calnexin, D5
(early viral protein), A20 (early viral protein), I3 (early viral protein), L4 (late viral protein),
and L2 (early viral protein) (n=2; a representative immunoblot is shown). Uncoating is
unaffected by inhibition of ATR (B). BSC40 cells were infected with WT virus (MOI 15).
Cells were either left untreated or treated with araC (20µM, top right), cycloheximide
(50µM, bottom left), or VE-822 (10µM, bottom right). At 3 hpi, cells were fixed with 4%
paraformaldehyde and stained with A5 (green, component of the core wall) or DAPI (blue)
(n=2; a representative image is shown).
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How does ATR inhibition disrupt the cellular environment such that viral DNA
replication is delayed and subgenomic viral DNA fragments accumulate?
At what stage must ATR be inhibited to impact infectious viral yield?
We identified that the two prevailing phenotypes following ATR inhibition are a delay in
viral DNA accumulation and accumulation of subgenomic viral DNA fragments. Execution
point experiments allow us to examine when the drug or treatment needs to be present.
First, we treated BSC40 cells with ATR inhibitor VE-822 4 h prior to infection, 1 h prior to
infection or 4 hpi. These cells were infected with WT virus (MOI 5) for 18 hpi before
assessing infectious viral yield and protein accumulation (Fig 3-9). Interestingly, there is a
time-dependent decrease in infectious viral yield where at – 4 h, there is a 72-fold
reduction in viral yield, and at 4 hpi, there is only a 2-fold reduction (Fig 3-9, A). This data
is striking at 4 hpi when there’s only been 1 h of vDNA replication, yet there’s little to no
impact on infectious viral yield. Furthermore, we have shown that 1 h of ATR inhibition is
sufficient to block the phosphorylation of Chk1, so why would adding ATR inhibitor 3 h
earlier (from -1 hpi to -4 hpi) cause an even more significant impact?

Execution point experiments can also be refined to synchronize infections to a specific
stage. For example, infecting cells in the presence of araC causes a block at DNA
replication. Subsequent washing out of araC allows infection to proceed through the
lifecycle. To assess whether ATR inhibition disrupted synchronized viral infections at
either early gene protein synthesis or viral DNA accumulation, we treated infected BSC40
cells with either CHX or araC. Each was washed out of cultures at either 3 or 4 hpi,
respectively. ATR inhibitor, VE-822, was added to a subset of infections 1h prior to
washing out CHX or araC to ensure that ATR was inhibited before washout. Finally,
infections were washed out of araC or CHX and either left untreated or treated with ATR
inhibitor until 18 hpi (Fig 3-9, B). The viral yield was assessed under each condition.
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Figure 3-9. ATR needs to be inhibited long before infection to have a maximal
impact.
Inhibition of ATR 4 hr prior to infection causes an almost 2-log decrease in infectious yield,
whereas inhibition at 4 hpi has no significant impact (A). BSC40 cells were infected with
WT virus (MOI 5). Cells were treated with either a vehicle or ATR inhibitor (VE-822) at 4
hr prior to infection, 1 hr prior to infection, or 4 hpi. At 18 hpi, samples were collected and
viral yield was assessed (n=3). Inhibition of ATR immediately prior to early gene
expression or DNA replication has no impact on viral infectious yield (B). BSC40 cells were
infected with WT virus (MOI 5). Cells were either untreated (grey), treated with ATR
inhibitor (red), treated with araC (until 4 hpi) and washed out into a vehicle control or ATR
inhibitor (horizontal hashes), or treated with cycloheximide (until 3 hpi) and washed out
into a vehicle control or ATR inhibitor (vertical hases). At 18 hpi, samples were collected,
and viral yield was assessed (n=3).
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Washout of CHX or araC into ATR inhibitor did not reduce infectious viral yield (Fig 3-9,
B). These data suggest that ATR inhibition needs to happen prior to infection before early
protein synthesis and DNA replication to impact infectious viral yield. We also know that
the longer cells are treated with ATR inhibitor, the more significant the impact on infectious
viral yield. We still do not understand how ATR inhibition impacts viral replication, but we
can eliminate some possibilities. It’s not that ATR is phosphorylating a critical effector,
viral or cellular, as the steady-state levels of phosphorylated SQ/TQ proteins do not
change until late time points of infection, and ATR inhibition does not change the pSQ/TQ
profile at early time points. Therefore, we believe ATR plays an indirect role in the viral
lifecycle. Could ATR’s kinase activity regulate a cellular substrate that plays a more direct
role in the viral lifecycle?

How does ATR inhibition impact steady-state levels of ribonucleotide reductase small
subunit 2 (RRM2)?
RRM2 is one of two subunits making up the enzymatically active heterotetrameric RR
(ribonucleotide reductase) complex (Reviewed in [172]). Two molecules of RRM2 interact
with two molecules of RRM1 to form the RNR complex (Reviewed in [173]). RRM2
expression is regulated in a cell cycle-dependent manner, in that protein levels increase
in S-phase and rapidly decrease in G2. RRM1 expression is constant throughout the cell
cycle, and the RRM1 protein has a significantly longer half-life than RRM2, so RRM2 is
the rate-limiting protein in nucleotide biosynthesis.

The regulation of RRM2 expression is multifaceted both at the transcription and protein
levels. A recent study demonstrated that Cyclin F binds RRM2, thus translocating
phosphorylated RRM2 from the nucleus to the cytoplasm for proteasomal degradation
[174]. This interaction requires the threonine on which RRM2 is phosphorylated (Thr33)
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and the Cyclin F binding domain (CXL). Furthermore, ATR signaling was shown to be
important for this process. Although ATR did not phosphorylate RRM2 or Cyclin F,
inhibiting ATR’s kinase activity resulted in greater steady-state levels of cyclin F and a
subsequent decrease in RRM2 levels. These data used HCT116 ATR Flox/− cells to
examine how RRM2 levels change in the presence and absence of 4-OHT (4hydroxytamoxifen), which ablates ATR. Therefore, we asked whether our small molecule
inhibitor, VE-822, would recapitulate these results. BSC40 cells were either untreated or
treated with VE-822 and collected at 3, 5, or 7 h post treatment. Surprisingly, we observed
a significant decrease in RRM2 levels as early as 3 h post treatment, with very little
subsequent change seen from 3 to 7 h post treatment (Fig 3-10).

Does VV infection modulate RRM2 steady-state levels?
E7, an human papillomavirus (HPV) oncoprotein, is necessary and sufficient for
upregulation of RRM2 during HPV infection [155]. In unpublished data from the lab of Dr.
David Evans, siRNA depletion of RRM2 reduces VV yield ~1-log (like the decrease seen
of our ATR inhibited infections). VV also encodes homologs to the cellular RRM1 and
RRM2; I4 and F4, respectively [37-39]. I4 and F4 interact with the cellular RRM proteins
forming mixed heterotetrameric RR complexes and are expressed early during viral
infection [40]. Deletion or mutation of F4 causes a more severe decrease in viral yield and
DNA levels than deletion or mutation of I4 [40]. Interestingly, cell lines expressing high
levels of RRM2 (PANC1) result in higher viral yields across all viruses tested than cells
expressing low levels of RRM2 (CAPAN1). With these data in mind, we asked whether
WT VV infection modulated RRM2 expression and if VV infected cells were still sensitive
to RRM2 depletion following ATR inhibition. BSC40 cells were left untreated or treated
with VE-822 1 h prior to infection. Cells were then infected with WT virus (MOI 5) for 2, 4,
and 6 h before being collected and processed for immunoblot analysis (Fig 3-10, A). There
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Figure 3-10. ATR inhibition reduces the steady state levels of RRM2 in the absence
or presence of viral infection.
ATR inhibition causes a greater than 10-fold decrease in steady state levels of RRM2 by
2hr post treatment. BSC40 cells were treated with a vehicle control or ATR inhibitor (VE822). A subset of treated cells were infected with WT virus (MOI 5). Cells were harvested
at 2, 4, and 6 hours post treatment before being processed for immunoblot analysis.
Immunoblots were probed for ATR, calnexin, A20, RRM2, RPA2, and γH2AX (n=3; a
representative immunoblot is shown).

95

96
was no change in the levels of RRM2 during infection compared to uninfected cells.
However, we see a very similar magnitude of decrease (~20-fold) in the levels of RRM2
in our infected, ATR inhibited cells compared to our uninfected, ATR inhibited cells.
Clearly, VV infection is neither inducing RRM2 expression nor disrupting RRM2’s ATRCyclin F regulatory pathway. γH2AX levels are also upregulated following ATR inhibition
as might be expected given the importance of ATR in responding to endogenous DNA
damage. While VV does not induce an ATR-specific DDR, the significant decrease in
RRM2 levels following ATR inhibition of VV infected cells is the first detected disruption of
the cell. These data suggest that ATR might be indirectly important for VV replication.
Could the depletion of RRM2 levels be responsible for reducing viral yield seen when
inhibiting ATR?

Are there cell type-specific differences in the phenotype observed when ATR is inhibited
during VV infection?
The profile of VV infection is distinct across cell lines. For example, VV infected BSC40
cells accumulate ~40% more DNA and accumulate detectable levels of intermediate and
late proteins sooner than similarly treated HeLa cells (Fig 3-11, A-C). Our lab has
previously published that there are also cell line-specific differences in the phenotype of
cells infected with a virus lacking the I3 allele [76]. Keeping in mind that varying RRM2
levels have a distinct impact on viral replication, we wanted to ask whether there was a
correlation between the steady-state levels of RRM2 within a cell line and viral sensitivity
to ATR inhibition.

Using a combination of oncogenic (HeLa and A549 cells) and non-transformed (BSC40
and CV1 cells) cells, steady-state levels of RRM2 were examined in the absence of
infection. A subset of cells was treated with ATR inhibitor for 4 h to examine the decrease
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Figure 3-11. Slight variations in the kinetics of vDNA synthesis between infections
of BSC40 and HeLa cells.
BSC40 cells accumulate more viral DNA and L4 than HeLa cells early during infection, but
do not have a significant change on viral infectious yield. BSC40 (squares) or HeLa
(circles) cells were infected with WT virus (MOI 5). Samples were harvested at 4, 6, 8, 10,
and 18 hpi and the levels of viral DNA were assessed by Southern dot blot (A) or titrated
via plaque assay to assess viral yield (B) (for the 18 hpi sample). Data are plotted as the
average of three biological experiments with the error bars representing the SEM. Levels
of L4 at 6 hpi are greater in BSC40 cells than HeLa cells (C). BSC40 (left) or HeLa (right)
cells were infected with WT virus (MOI 5). Samples were harvested at 2, 6, 8, 10, 14, 18,
and 24 hpi and processed for immunoblot analysis. Immunoblots were probed for calnexin,
L4 (intermediate viral protein), and F17 (late viral protein) (n=2; a representative
immunoblot is shown).
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in RRM2 levels across each cell line. BSC40, CV1, and HeLa cells all have relatively
similar levels of RRM2, while A549 cells have almost 5-fold less (Fig 3-12, A). All cells
exhibit similar sensitivity to ATR inhibitor in that there was a significant decrease (~3 to
10-fold) in RRM2 levels. Based on these data, we hypothesize that VV infected A549 cells
would be more sensitive to ATR inhibition if RRM2 were the key effector.

The infectious viral yield was measured in each cell line at 18 hpi either in the presence
or absence of an ATR inhibitor (3-12, B). Oncogenic cell lines exhibited a minor increase
in sensitivity to ATR inhibition than non-transformed cells, in that ATR inhibition caused a
> 30-fold decrease in viral yield in HeLa cells but only a 10-fold decrease in BSC40 cells.
Infected A549 cells had a decrease in infectious viral yield greater than the BSC40 or CV1
cells but like HeLa cells, even though endogenous RRM2 levels were much lower than
HeLa cells (Fig 3-12, A). Viral protein levels remain relatively unchanged across each
condition and cell line, as were consistent with our previous data.

Are there cell type-specific differences in the viral genome integrity when ATR is inhibited?
The two phenotypic effects seen on VV infections when ATR is inhibited are a delay in
vDNA accumulation and an accumulation of subgenomic vDNA fragments. Therefore, we
hypothesized that there would be a more severe impact on vDNA integrity and
accumulation in ATR inhibited HeLa and A549 cells. Each cell line was infected and
treated with ATR inhibitor as outlined in Fig 3-12 before performing PFGE Southern on
these samples at 10 hpi (Fig 3-13). Consistent with previous results, there is little to no
change in the accumulation of vDNA in BSC40 cells at 10 hpi with or without the ATR
inhibitor; however, there is a clear increase in the accumulation of subgenomic fragments
such that over half of the total vDNA is subgenomic (~54%, black brackets) (Fig 3-13).
Infection and treatment of CV1 cells profile similarly to BSC40 cells, but even a more
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Figure 3-12. ATR inhibition reduces RRM2 steady-state levels and infectious viral
yield across multiple cell lines.
Endogenous RRM2 levels differ among cell lines, and ATR inhibition significantly reduces
levels of RRM2 across each cell line tested (A). BSC40, HeLa, CV1, and A549 cells were
either treated with a vehicle control or ATR inhibitor (VE-822). Samples were harvested at
4 hr post treatment and processed for immunoblot analysis. Immunoblots were probed for
ATR, calnexin, RRM2, and γH2AX. A longer exposure is shown on the right (n=3; a
representative immunoblot is shown). ATR inhibition reduces viral yield at least 10-fold in
each infected cell line with the greatest defect seen in A549 cells (B). BSC40, CV1, A549,
and HeLa cells were treated with either a vehicle control or ATR inhibitor (VE-822) 1 hr
prior to infection. Cells were then infected with WT virus (MOI 5). At 18 hpi, samples were
harvested and titrated via plaque assay to assess viral yield. Viral yield is plotted as the
average of three biological replicates with the error bars representing the SEM.
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significant percentage of the vDNA accumulates as subgenomic fragments (~73%). Both
correspond to a 1-log decrease in viral yield (Fig 3-12). For HeLa cells, vDNA
accumulation is reduced 2.5-fold following ATR inhibition (Fig 3-4, A), a more significant
effect than that seen in BSC40 cells (Fig 3-4, B). Our PFGE Southern analysis
recapitulates the difference in vDNA accumulation between cell lines with the addition that
almost all of the detectable vDNA accumulates as either subgenomic fragments or
branched intermediates unable to resolve under native conditions in HeLa cells (3-13,
black brackets and blue arrow). This effect is exacerbated in A549 cells as there is no
detectable vDNA at 10 hpi following ATR inhibition under these conditions and exposure.
These data provide insights into why infection of the oncogenic cell lines, HeLa and A549,
causes a greater defect in infectious viral yield when ATR is inhibited than CV1 or BSC40
cells. It is important to note that at 18 hpi, infectious viral yield is only reduced ~40-fold
when ATR is inhibited during infection of A549 or HeLa cells. If no viral monomeric
genomes accumulated, we would expect to see a severe impact on infectious viral yield.

Does the expression of RRM2 mutants resistant to Cyclin F degradation rescue ATR
inhibited viral infections?
There is certainly a correlation between the amount of vDNA accumulated following ATR
inhibition and endogenous cellular RRM2 levels (Fig 3-12 compared to fig 3-13). Cyclin F
is responsible for facilitating RRM2 degradation when ATR is inhibited [174]. Careful
biochemical analysis identified that Thr33 and a CY motif (AA 49-51) are necessary and
sufficient for this interaction. F4, the virally encoded RRM2, lacks the first 81 amino acids
of the cellular homolog [40]. This truncation includes Thr33 and the CY motif; therefore,
we believe that the viral F4 is insensitive to cyclin F degradation. If the cellular RRM2 is
responsible for the phenotypic effects seen when inhibiting ATR during VV infection, then
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Figure 3-13. ATR inhibition during VV infection of various cell lines has similar
impacts on viral genome integrity.
ATR inhibition results in the accumulation of subgenomic fragments during VV infection,
while in A549 cells, little to no viral DNA is accumulated. BSC40, HeLa, CV1, and A549
cells were treated with either a vehicle control or ATR inhibitor (VE-822) 1 hr prior to
infection. Cells were then infected with WT virus (MOI 5). At 10 hpi, samples were
collected and processed for PFGE analysis. A representative image of the EtBr staining
is shown (left) as well as the corresponding Southern blot (right); the red arrow marks the
monomeric viral genome, the black brackets viral subgenomic fragments, and blue arrows
the branched, concatemerized viral DNA (n=2; a representative EtBr and Southern blot is
shown).
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would expressing RRM2 constructs lacking Thr33 and the CY motif rescue these
infections?

We next generated lentiviral particles for transduction of BSC40 cells to stably express
four epitope-tagged RRM2 constructs (N-terminal HA-tagged WT RRM2, N-terminal HAtagged ∆N RRM2, C-terminal HA-tagged WT RRM2, or C-terminal HA-tagged ∆N RRM2).
RRM2 steady-state levels were then examined in each of the cell lines. N-terminal HAtagged WT and ∆N RRM2 were expressed ~ 20-fold more than endogenous RRM2 (Fig
3-14, A). A monoclonal antibody recognizing the N-terminal region of RRM2 did not detect
either the N- or C-terminal HA-tagged ∆N RRM2 constructs. Furthermore, C-terminal HAtagged ∆N RRM2 was undetectable by an antibody recognizing the HA epitope.

These newly generated cell lines were then tested by examining viral yield at 18 hpi in the
presence or absence of an ATR inhibitor (Fig 3-14, B). The pHM control and WT RRM2
constructs do not rescue ATR inhibited infections, as there is still a 10- and 5-fold
reduction, respectively. However, the ∆N RRM2 constructs rescue viral yield. Immunoblot
analysis of these cells found that the WT RRM2 levels decrease following ATR inhibition,
but ∆N RRM2 (only N-terminal detectable) do not (Fig 3-14, B). These data support our
hypothesis that ATR inhibition disrupts viral replication by depleting cellular RRM2 levels.
Our next steps were to assess vDNA levels and integrity in each of these cell lines in the
presence or absence of an ATR inhibitor.

We performed these assays in the N-terminal HA-tagged RRM2 constructs as both N- and
C-terminal HA-tagged constructs were rescued, and the N-terminal HA-tagged constructs
were detectable by immunoblot. Each cell line was infected with WT virus (MOI 5) in the
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Figure 3-14. Cell lines expressing RRM2 resistant to cyclin F degradation rescue
ATR inhibited VV infections.
Overexpression of epitope-tagged RRM2 constructs results in a greater than 20-fold
increase in steady-state levels as compared to endogenous levels (A). BSC40 cells stably
overexpress HA-RRM2 or HA-∆N RRM2 via lentiviral delivery of the transgene;
immunoblot analysis confirmed overexpression of RRM2 to ~20-fold more than
endogenous levels (n=2, a representative image is shown). ∆N-RMM2 rescues viral
infectious yield in the presence of ATR inhibitor, and is insensitive to degradation following
ATR inhibition (B and C). Transduced BSC40 cells were treated with either a vehicle
control or ATR inhibitor (VE-822) 1 hr prior to infection. Samples were then infected with
WT virus (MOI 5). All samples were harvested at 18 hpi and either processed for
immunoblot (C) or titrated via plaque assay to assess viral yield (B). Immunoblots were
probed for calnexin, HA (RRM2), and L4, (n=4; a representative immunoblot is shown).
Viral yield is plotted as the average of three biological replicates with the error bars
representing the SEM.

107

108
presence or absence of ATR inhibitor for 3, 4.5, and 6 hpi for Southern dot blot analysis
or 10 hpi for Southern PFGE analysis. While the expression of ∆N RRM2 rescues viral
yield, the accumulation profile of vDNA is not (Fig 3-15, A). There is ~2-fold more vDNA
in the WT RRM2 and ∆N RRM2 expressing cells at each time point tested than the pHM
control cells. The relative fold changes in the vDNA levels at each time following ATR
inhibition do not change. As for the Southern PFGE, there are no striking changes in the
profile of vDNA in each cell line when ATR inhibitor is present (Fig 3-15, B). Consistent
with our previous results, there is little to no change in total vDNA levels at 10 hpi when
ATR inhibitor is present. However, there is a clear accumulation of subgenomic vDNA
fragments (black brackets) and a reduction in the amount of monomeric viral genomes
(red arrow). In the WT RRM2 expressing cells, there’s a similar profile of vDNA species to
that seen in the pHM cells, except there is ~2-fold more vDNA in each condition. Finally,
the ∆N RRM2 expressing cells profile similarly to the WT RRM2 expressing cells,
suggesting that the RRM2-mediatated rescue in yield is not correlated to vDNA
accumulation or genomic integrity following ATR inhibition.
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Figure 3-15. Expression of RRM2 resistant to cyclin F degradation does not rescue
vDNA accumulation or genomic integrity following ATR inhibition.
Expression of RRM2 (full-length and truncation) does not rescue the decrease in viral DNA
accumulation seen early during viral infection when ATR is inhibited (A). Transduced
BSC40 cells were treated with either a vehicle control (black lines) or ATR inhibitor (red
lines). Cells were then infected with WT virus (MOI 5). Samples were harvested at 3, 4.5,
6 hpi and the levels of viral DNA were assessed by Southern dot blot analysis. Data are
plotted as the average of three biological experiments with the error bars representing the
SEM. Expression of ∆N-RRM2 does not rescue viral genomic integrity following ATR
inhibition (B). Transduced BSC40 cells were treated with either vehicle control or an ATR
inhibitor. Samples were then either left uninfected or infected with WT virus (MOI 5). At 10
hpi, samples were collected and processed for PFGE analysis. A representative image of
the EtBr staining is shown (left) as well as the corresponding Southern blot (right); the red
arrow marks the monomeric viral genome, the black brackets viral subgenomic fragments,
and blue arrows the branched, concatemerized viral DNA (n=2; a representative EtBr and
Southern blot is shown).
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Summary:
Here we have identified that VV infection neither induces nor dampens the DDR. Effectors
of both ATR and ATM are phosphorylated during infection, as seen in infected cultures
with no noticeable changes until after 7 hpi. A subset of ATR/ATM phosphorylated
substrates are increased and activated late during infection, consistent with the activation
seen of pChk1 S317 and γH2-AX. At these time points of infection, processed, monomeric
viral genomes are packaged into virions, so it is doubtful that these newly phosphorylated
DDR proteins are involved in viral DNA metabolism. Compared to nuclear replicating DNA
viruses like HSV or HPV, this is unique as both HPV and HSV activate certain pathways
within the DDR to facilitate viral replication and vDNA metabolism.

While VV infection does not induce or dampen a DDR, this did not eliminate the possibility
that VV might utilize some aspect of this signaling pathway. Using a combination of small
molecule inhibitors and depleted cell lines, we found that disruption of ATR’s kinase
activity causes a delay in viral DNA accumulation culminating in a delay of each sequential
stage of the viral lifecycle. Furthermore, ATR inhibition results in a partial accumulation of
viral subgenomic fragments. The accumulation of viral subgenomic fragments has only
been observed when infecting cells with a virus lacking the G5 or I3 allele. There are two
possibilities: ATR phosphorylates viral or cellular proteins important for facilitating viral
genome maintenance, and initiation of vDNA replication or ATR’s kinase activity is
important in preparing the cellular milieu for VV infection. We hypothesized that the latter
was more likely for multiple reasons, which will be discussed later.

ATR’s kinase activity is important in regulating the stability of RRM2 at the protein level by
decreasing steady-state levels of cyclin F. How ATR regulates cyclin F levels is still
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unknown, but RRM2 levels are significantly reduced when ATR is inhibited during
infection. The role of cellular ribonucleotide reductase in VV replication is only partially
understood. Preliminary data suggests the cellular RRM2 is the more important of the RR
subunits (Evans et al., unpublished). Expression of RRM2 mutants capable of interacting
with RRM1 but not cyclin F rescue the impact ATR inhibition has on VV replication.
However, these resistant RRM2 mutants do not rescue the impact of ATR inhibition on
vDNA accumulation of genomic integrity. These data implicate multiple stages of viral
replication impacted by ATR inhibition. We still do not yet understand how ATR inhibition
is affecting VV replication.
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Chapter 4-Examination of how exogenous DNA damage impacts
vaccinia virus replication and DNA metabolism.
Rationale:
Vaccinia virus DNA metabolism (replication, recombination, and repair) is complex. While
numerous viral factors have been identified as important for vDNA replication, the
mechanism of how VV replicates its genome remains elusive (Reviewed in [175]). All the
canonical DNA replication machinery is encoded by VV: a proofreading polymerase and
processivity factor, putative helicase/primase, replicative single stranded binding protein,
DNA ligase, etc. However, important questions remain, such as whether replication entails
both leading and lagging strand synthesis, recombinatorial priming, or a specific origin of
replication. As for DNA recombination, plasmid recombination assays have revealed that
the viral DNA machinery can perform homologous recombination (HR). Depletion of the
I3 SSB, mutation of the E9 polymerase’s proofreading exonuclease activity, or deletion of
the G5 endonuclease/exonuclease result in reduced rates of plasmid recombination,
suggesting that these proteins are involved in some mechanism of HR [18, 98, 99].

The most understudied element of VV DNA metabolism is DNA repair. UV irradiation has
long been used as a tool to inactivate virions prior to infection [105]. UV irradiation of VV
virions inactivates them by disrupting transcription in the viral core, thereby blocking early
gene expression and vDNA replication [105]. Studies dating back to 1960 characterized
the possible contribution of Xeroderma Pigmentosum (XP) complementation groups in the
reactivation of UV irradiated VV virions. These studies utilized patient-derived cell lines
with mutations in several XP proteins. The results differed, with two groups finding that XP
proteins were not important for reactivation of UV irradiated VV virions, and one group
supporting the opposite [103, 104]. A 1994 study showed that UV-induced lesions
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susceptible to cleavage by the T4 endonuclease decreased within the viral genomes over
time. However, there were significant limitations to these findings [106]. As mentioned, UV
irradiation of VV virions reduces transcription within the viral core, thereby causing
significant defects in early viral gene expression. Depleted early viral proteins would hinder
viral uncoating, blocking any access DNA metabolizing enzymes might have to the
damaged viral genomes. These studies also did not consider how vDNA levels changed
following UV irradiation. Using this prior knowledge, we designed our experiments to
examine how exogenous DNA damage might impact VV replication. Instead of irradiating
virions, we irradiated during ongoing viral DNA replication (4 hpi), using irradiated cells (1 hpi) as a control for disruption of cellular processes. We hypothesized that VV would
undergo DNA repair by utilizing a yet unknown mechanism made up of viral proteins
and co-opted cellular proteins.

Results:
What DNA damaging agents should we use?
Introducing exogenous DNA damage can be accomplished in a multitude of ways, such
as introducing small molecules cisplatin, doxyrubicin, bleomycin and etoposide or by
directly damaging DNA with UV or γ irradiation. Each insult causes a unique form of DNA
damage whose repair requires distinct response pathways (Reviewed in [176]).

The pathobiology of poxviruses results in the formation of lesions or ‘pocks’ in the skin,
where the virus and infected cells are exposed to harmful UV light; therefore, UV irradiation
is a physiologically relevant source of DNA damage to VV. Furthermore, our
understanding of how UV irradiation damages DNA, the mechanisms responsible for
repair of UV lesions, and our tools for studying this process have grown tremendously
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since studies on the impact of UV lesions on VV replication last took place in 1994 [106].
Our basic approach was to leave BSC40 cells unirradiated, irradiate them prior to infection
(-1 h), or irradiate during infection (4 h), and then assess multiple aspects of the infectious
cycle, including genome replication and production of infectious virus.

How does UV irradiation impact viral DNA replication?
Impact on viral genome accumulation and integrity. After virion entry, early gene
expression occurs within the sub-viral core. After early proteins are expressed, the core
undergoes an uncoating event that releases the viral genome and allows DNA replication
to initiate. The linear phase of replication is thought to take place between ~2-10 hpi.
Therefore, when we UV irradiate our infected cells at 4 hpi, we are introducing UV lesions
(6,4-PPs and CPDs) during ongoing viral DNA replication. These bulky adducts are known
to cause helix distortions and have been shown to stall the movement of processive
cellular polymerases [144, 177, 178]. We therefore assessed the profile of viral DNA
accumulation in unirradiated cells and cells exposed to 30 or 60 J/m2 UV (4 hpi). The time
course of viral DNA accumulation (3, 4, 4.5, 7 and 10 hpi) was quantified using Southern
dot blot analyses (Fig 4-1, A left and quantified on the right). The characteristic profile of
DNA accumulation was seen in unirradiated cells; however, in cells exposed to 30 or 60
J/m2 UV at 4hpi, no further accumulation of viral DNA was seen between 4 and 10 hpi.

Southern dot blots provide a quantitative assessment of bulk viral DNA levels, but do not
reveal the integrity of the viral genomes. Subgenomic fragments might accumulate if the
viral replicative holoenzyme synthesized DNA before stalling and collapsing across the
bulky adducts caused by pyrimidine dimer formation. Furthermore, if degradation of viral
genomes was occurring, we hypothesized that full length genomes containing UV lesions
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Figure 4-1: UV irradiation during VV infection introduces UV lesions into the VV
genomes and halts further VV DNA accumulation.
UV irradiation (30 or 60 J/m2) at 4 hpi halts further viral DNA accumulation (A and B) and
introduces UV lesions, both 6,4-Photoproducts (6,4-PP) and cyclobutane pyrimidine
dimers (CPD), into the viral genome (C and D). (A) BSC40 cells were either left uninfected
or infected with WT virus (MOI 5) and left unirradiated (blue) or irradiated at 4 hpi (30 or
60 J/m2, pink or purple, respectively). Samples were harvested at 3, 4, 4.5, 7 or 10 hpi and
the levels of viral DNA were assessed by Southern dot blot analysis. Each sample was
spotted in technical triplicate (left panel); a representative blot is shown. Data are plotted
as the average of three biological experiments with the error bars representing the SEM
(right panel; ***, p<0.001). (B) BSC40 cells were infected with WT virus (MOI 5), and either
left unirradiated or UV irradiated (15, 30, 45 or 60 J/m2) at 4 hpi before being collected at
10 hpi and processed for PFGE analysis. A representative image of the EtBr staining is
shown (left) as well as the corresponding Southern blot (right); the arrow marks the
monomeric viral genome. Data are plotted as the average of six biological replicates with
the error bars representing the SEM (right panel; ***, p<0.001). (C and D) BSC40 cells
were infected with WT virus (MOI 5) for 4 h and left unirradiated or UV irradiated with 60
J/m2 before being fixed at 4.5 hpi and stained with DAPI (blue), anti-I3 (green), and either
anti-6,4-PP (C; red) or anti-CPD (D; red). Both 6,4-PPs and CPDs localize to the viral
cytoplasmic replication factories following UV irradiation at 4 hpi. Scale bar, 100 μm.
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might be partially digested by cellular cytoplasmic DNA nucleases such as DNase2 or
TREX1 [179, 180]. Using pulse-field gel electrophoresis (PFGE), we visualized the levels
of DNA and integrity of viral genomes at 10 hpi in control infections or infections exposed
to varying doses of UV irradiation at 4 hpi (Fig 4-1, B). Viral DNA was visualized both by
EtBr staining (left) and Southern hybridization (right); the 195 kb genome is shown by the
arrowhead. Consistent with our Southern dot blots, all concentrations of UV irradiation
reduced viral DNA levels by ~4-fold (Fig 4-1, B, quantified on the right). Irradiation did not
lead to the appearance of subgenomic fragments, suggesting that widespread DNA
degradation is unlikely to be occurring and supporting the hypothesis that
processive/productive viral DNA replication is blocked by UV-induced lesions.

Identification and assessment of UV lesions in viral genomes by performing
immunofluorescence

analysis

using

lesion-specific

antibodies.

We

performed

immunofluorescence analysis of infected cells that had been UV irradiated at 4hpi or left
untreated (Fig 4-1, C and D). In irradiated cells, clear signals corresponding to CPDs and
6,4-PPs localized to the viral cytoplasmic replication factories as marked by the replicative
single-stranded binding protein, I3. No lesions were detected in unirradiated cells,
validating the specificity of the antibodies. Although recognition of CPD and 6,4-PP lesions
in nuclear DNA by these antibodies requires a prior denaturation step [181], denaturation
was not required to detect UV-induced lesions in the vaccinia genome, and omission of
this step preserved the morphology of the cytoplasmic replication factories. These data
suggest that either the high AT content of the viral genome (68%) provides sufficient
access to the antibodies or that a significant portion of replicating DNA has single-stranded
character.
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Impact of UV irradiation on the profile of viral protein accumulation. The onset of viral DNA
replication is a prerequisite for the transition from early gene transcription to intermediate
and late gene transcription. Because we irradiated cultures at 4 hpi when replication was
ongoing, we would not expect this transition to have been prevented. However, transcript
levels might have been compromised by the decrease in the number of transcriptional
templates and/or the possibility that UV adducts might block transcription. Decreased viral
transcription could diminish the levels of intermediate and late proteins that accumulate.
We assessed the steady-state levels of the L4 and F17 late proteins at 18 hpi. As shown
in Figure 2A, exposure to 15-60 J/m2 UV led to a modest (~3-fold at 60 J/m2) dosedependent decrease in protein levels. In contrast, no reduction in the levels of the early
protein I3 were seen at any dose (Fig 4-2, A).

Impact of UV irradiation on the yield of infectious virus production. Having established that
UV irradiation at 4 hpi blocks further accumulation of viral genomes and has a modest
impact on the steady-state levels of late viral proteins, we next examined the impact on
the yield of infectious virus (MOI 5, 18hpi). Increasing doses of UV irradiation (15-60 J/m2)
decreased infectious yield in a dose-dependent manner (Fig 4-2, B), with 60 J/m2 leading
to a 35-fold decrease relative to the control. This same dose of UV had reduced DNA and
late protein accumulation (4- and 3-fold, respectively), suggesting that other processes
might be compromised.
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Does irradiation of cells prior to infection impact viral DNA replication and the
yield of infectious virus?
Irradiation of cells prior to infection (-1 hpi) reduces viral yield but has no impact on the
accumulation of the viral genome. UV irradiation activates numerous cellular stress
responses including the DDR pathway (Review in [182]) and the ER stress pathway [166,
183]. Therefore, we wanted to test the possibility that irradiation of cells impairs their
capacity to support viral infection, independent of the introduction of lesions into the viral
genome. BSC40 cells were therefore UV-irradiated 1 hr prior to infection, and infectious
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Figure 4-2: UV irradiation during infection reduces viral infectious yield and late
protein accumulation in a dose-dependent manner.
Late protein accumulation and viral infectious yield are reduced in a dose-dependent
manner following UV irradiation at 4 hpi. BSC40 cells were infected with WT virus (MOI
5). At 4 hpi, samples were either left unirradiated (blue) or irradiated with 15, 30, 45 or 60
J/m2 (pink to purple). All samples were harvested at 18 hpi and either processed for
immunoblot (A) or titrated via plaque assay to assess viral yield (B). Immunoblots were
probed for calnexin, p53, I3, L4, and F17 (n=3; a representative immunoblot is shown).
Viral yield is plotted as the average of three biological replicates with the error bars
representing the SEM (**, p<0.01; ***, p<0.001).
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yield and viral protein accumulation were assessed at 18 hpi. Pre-irradiation led to a dosedependent decrease in viral infectious yield (Fig 4-3, A), although less pronounced than
irradiation at 4 hpi: the impact of 30 and 60 J/m2 UV was 6- and 12-fold, respectively,
whereas decreases of 15- and 35-fold were seen after irradiation of 60 J/m2 UV at 4 hpi.
Notably, pre-irradiation of cells had no effect on the levels of viral DNA that accumulated
after infection (Fig 4-3, B), in contrast to the significant impact seen in cells irradiated at
4hpi. Clearly, exposure of cells to UV prior to infection could not have caused lesions
within the viral DNA. Furthermore, these data argue against the possibility that one or
more cellular factors needed for the replication of the viral genome might have been lost
or inactivated upon irradiation.

UV irradiation, both pre- and post-infection, diminishes protein synthesis. We also
compared the impact of pre-irradiation of cells (-1h) to irradiation during infection (+4h) on
the accumulation of late viral proteins (Fig 4-3, C). Interestingly, a modest and comparable
decrease in the levels of the L4 and F17 proteins was seen in both cases. These data
suggested that an impact of irradiation on protein synthesis might be involved. As shown
in Figure 4-3 D and E, we compared the profiles of nascent protein synthesis in
metabolically labeled cells. UV irradiation of uninfected cells reduced protein synthesis as
quickly as 1 hr past UV irradiation (Fig 4-3 D, compare lanes 1 and 2), as has been
reported previously. We also monitored protein synthesis at 3, 6, 9 and 12 h after infection
with vaccinia virus, comparing cells that had been left unirradiated (lanes 3-6) with those
irradiated at 1h prior to infection (lanes 7-10) or at 4h post-infection (lanes 11-4). Although
the overall profile of nascent proteins is consistent, irradiation decreased protein
synthesis, with the greatest impact being seen closest to the time of irradiation. In addition
to resolving the samples electrophoretically (Fig 4-3, D), we also quantified the TCAinsoluble [35S]-methionine from uninfected cultures either unirradiated or 1hr after UV
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Figure 4-3: UV irradiation prior to infection reduces viral infectious yield but not
DNA accumulation.
Although UV irradiation prior to infection reduces viral infectious yield, protein synthesis
and late protein accumulation, viral DNA accumulation is unaffected. (A) UV irradiation at
-1 hpi reduces viral yield. BSC40 cells were infected with WT virus (MOI 5) for 18 h and
were either left unirradiated or UV irradiated 1 h prior to infection (-1h) or at 4 hpi (4h) with
either 30 or 60 J/m2. Viral yield was assessed via plaque assay (n=3, average and SEM
plotted; **, p<0.01). (B) Viral infection at 4 hpi, but not at -1 hpi, reduces DNA
accumulation. Following the same experimental design as (A), samples were collected at
10 hpi and the levels of viral DNA assessed by Southern dot blot (n=3, average and SEM
plotted; ***, p<0.001). (C) UV irradiation at both -1 hpi and 4 hpi reduces late protein
accumulation. Samples described in (A) were also subjected to immunoblot analysis. Blots
were probed for calnexin, I3, L4, and F17 (n=3, a representative immunoblot is shown).
(D) UV irradiation at both -1 hpi or 4 hpi reduces protein synthesis. BSC40 cells were
either uninfected (lanes 1 and 2) or infected with WT virus (MOI 5) (lanes 3-14); cells were
also either left unirradiated (lanes 1 and 3-6) or irradiated at -1 hpi (lanes 2 and 7-10) or 4
hpi (lanes 11-14). At each time point (uninfected or 3, 6, 9 and 12 hpi), cells were labeled
with [35S]-methionine for 45 min; cell lysates were resolved by SDS-PAGE to visualize the
profile of nascent proteins (n=3; a representative image is shown). (E) UV irradiation of
BSC40 cells reduces protein synthesis ~3-fold. Samples resolved via SDS-PAGE were
also TCA precipitated and quantified via scintillation counting. Error bars represent the
standard error of the mean (***, p<0.001).
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irradiation (Fig 4-3, E). In samples prepared from uninfected BSC40 cells 1h after they
were UV-irradiated with 60 J/m2, there was a 3-fold reduction in the TCA-precipitable [35S]methionine-labeled proteins relative to control cells. The magnitude of effect is similar to
previously reported findings [166, 183]. To assess how UV-irradiation might lead to
decreased protein synthesis, we assessed the levels of various stress-related cellular
proteins (Fig 4-3 F). The levels of the ATR protein kinase, the DNA repair protein Ku70 or
the stress-related kinase Chk1 were unchanged by UV irradiation or infection. However,
the levels of pChk1 (the activated, phosphorylated form of Chk1) were significantly
upregulated after UV irradiation of either uninfected or infected cells. Most importantly for
the process of protein synthesis, the levels of the repressive, phosphorylated form of the
translation initiation factor eIF2α (pEIF2α) were significantly upregulated after irradiation
of uninfected or infected cells. The levels of total eIF2α were unchanged. Note that the
levels of pEIF2α are somewhat lower in irradiated, infected cells than in irradiated
uninfected cells, which may reflect the presence of the viral K3 protein, an eIF2α mimic.
Regardless, the increase in p-eIF2α seen after irradiation is likely the cause of the
decreased protein synthesis seen in Figure 3D.

UV irradiation prior to (-1 hpi) or during (4hpi) infection decreases production of
mature virions.
VV late proteins are crucial for morphogenesis and virion maturation. When cells are UV
irradiated prior to or post infection, steady state levels of late viral proteins are reduced.
To assess whether VV virion maturation was affected by UV irradiation, we took two
approaches. First, we performed transmission electron microscopy on samples harvested
at 18 hpi (Fig 4-4). Control, unirradiated cells contained numerous mature virions as well
as immature virions (IV) and immature virions with nucleoids (IVN) (Fig 4-4, A). In cells
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Figure 4-4: UV irradiation prior to or during infection causes defects in virion
maturation.
UV irradiation has a modest impact on the profile of virion assembly. BSC40 cells were
either left unirradiated (top) or irradiated prior to (-1 hpi, bottom) or post infection (4 hpi,
middle). Cells were infected with WT virus (MOI 5) for 18h before being processed for
electron microscopy. Representative images are shown. C, crescent membranes; IV,
immature virions; IVN, immature virions with nucleoids; MV, mature virions; * aberrant
virion. Scale bars, 200nm.
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that were irradiated at either -1 or 4 hpi, there was an evident reduction in the number of
mature virions as well as reduction in each of the morphogenesis intermediates
(crescents, IV, and IVN). Interestingly, there also appeared to be a small number of
electron dense virions in the cells that were irradiated at 4 hpi, reminiscent of aberrant
virions that lack encapsidated viral genomes (Fig 4-4, C) [17]. Our findings indicate that
UV irradiation, regardless of when it’s introduced, has a modest effect on virion maturation.

Analysis of the yield, composition and infectivity of mature virions produced
during control, pre- and post-irradiated infections.
Mature virions form light scattering bands after sucrose gradient sedimentation and both
the relative migration of these bands as well as the content and infectivity of the virions
within them can be assessed. We therefore resolved virions from our unirradiated, preirradiated, and post-irradiated infections using sucrose density gradients as previously
described [154]. Infections performed in pre- or post-irradiated cells produced 3- to 4-fold
fewer mature virions than control infections as assessed from the intensity of the light
scattering band (Fig 4-5, A). The position of the bands within the gradients was
comparable in all the samples. Therefore, we conclude that there is not an accumulation
of “empty” virions under any of these conditions, since virions lacking encapsidated
genomes are less dense than WT virions and sediment at a higher position in the gradient
[17].

The gradients were then fractionated and fractions surrounding the light scattering band
were analyzed for the levels of virion proteins, viral DNA and infectivity. Examination of
the protein content with the light scattering band showed that the levels of L4, a late viral
protein that is proteolytically cleaved during morphogenesis, and F17, a late viral protein,
were reduced in each fraction of the pre- and post- irradiated infections when compared
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to control infections (Fig 4-5, B). Assuming that the levels of the proteins are an indicator
of virion number, the values extrapolated from the immunoblots are consistent with those
extrapolated from the intensity of the light diffracting bands. Of note, the levels of residual,
unprocessed L4 are higher in the pre- and post-irradiated samples, indicating that virion
maturation may be partially compromised under these conditions.

We also assessed the content of viral DNA in each of our fractions using a Southern dot
blot protocol. We analyzed what we calculated to be the same number of virions for all
samples, based on the extrapolations of virion number described above. Analysis of the
data indicated that there was approximately a 33% decrease in the levels of viral DNA in
the pooled virion sample (fractions 11-14) in both our pre- and post-irradiated virions as
compared to the unirradiated virions (Fig 4-5, C). These data suggest that a portion of the
virions purified from irradiated infections lack the viral genome.

We next examined the specific infectivity of the virions collected from each condition by
pooling the peak fractions, 11–14, and performing a plaque assay. Compared to control
infections, the infectious yield was reduced ~15-fold in the pre-irradiated infections and
~40-fold in the post-irradiated infections (Fig 4-5, D). This reduction greatly exceeds the
~3- to 4-fold reduction in the relative intensities of the light diffracting bands and the levels
of L4 and F17. For the pre-irradiated samples, the reduction in virion production and the
modest decrease in encapsidated genomes might explain the majority of the decrease in
infectious yield.
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Figure 4-5: UV irradiation prior to or during infection reduces both virion number
and infectivity.
UV irradiation prior to or during infection reduces the yield of mature virions. BSC40 cells
were infected with WT virus (MOI 5) and either left unirradiated or UV irradiated prior to (1 hr) or post infection (4 hr). At 18 hpi, samples were collected and virions were purified
on sucrose gradients. Light scattering bands were photographed (A) before fractions were
dripped and collected for analysis by Southern dot blot (B), immunoblot (C), plaque assay
(D) and PFGE (E). (B) Virions produced from infections UV irradiated prior to or post
infection contain less DNA than WT virions. Volumes for Southern dot blot were adjusted
to load equal amounts of virions based on the intensity of the light scattering band and
spotted in technical duplicate (C) Encapsidated viral proteins are reduced in UV irradiated
infections. Peak fractions identified by BCA were immunoblotted for L4 and F17. (D) The
infectious yield produced following UV irradiation prior to or post infection is also reduced
compared to WT virions; virions produced from cells irradiated at 4 hpi contain CPD
lesions. Fractions 11 through 14 were combined and titrated on BSC40 cells (n=1; t=3,
average and SEM plotted; *, p<0.05). (E) UV irradiation during infection results in the
encapsidation of viral genomes containing UV lesions. The pooled fractions were also
resolved in duplicate by PFGE and assessed by EtBr staining and Southern blotting with
a [32P]-labeled viral DNA probe, or with the CPD recognizing antibody.
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Detection of UV-induced lesions in viral DNA within infected cells and purified
virions.
To further analyze the genomes present within the banded virions, we embedded the
virions in agarose plugs for analysis by PFGE. The DNA was resolved in duplicate: one
sample was visualized by EtBr staining and Southern blot analysis with a probe derived
from the viral genome, the other sample was probed for UV-induced lesions using an antiCPD antibody. Our EtBr and Southern blot analyses (Fig 4-5 E, left and middle) detected
encapsidated monomeric genomes (~194 kb), which were clearly present in decreased
levels in the samples prepared from pre- and post-irradiated infections relative to that
prepared from an unirradiated control infection. When probed with the CPD antibody (Fig
5E, right), it was evident that lesions were present in the monomeric genomes of virions
irradiated during infection (4 hpi) but not in those irradiated prior to infection (-1 hpi), as
would be expected. These data indicate that viral genomes containing UV-induced lesions
are indeed encapsidated; the significant reduction in the infectivity of these virion preps is
likely to reflect the inability of these damaged genomes to support gene expression in the
next round of infection.

There were also abundant CPD lesions present in a smear of DNA (~47kb) that must be
of cellular origin, because the smear is not recognized by the [32P]-viral DNA probe (middle
panel): this CPD-containing smear is present in the samples that were irradiated prior to
(-1 hpi) or after infection (4hpi), as would be expected. These fragments of cellular DNA
were carried along in the lysate loaded onto the sucrose gradients, and at least some of
the fragments must be present in the same fractions as the light-diffracting virion band.
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Assessment of the longevity and possible repair of CPD lesions within
intracellular viral genomes.
As shown in Figure 1, CPD and 6,4-PP lesions could be detected within viral replication
factories by immunofluorescence analysis. Furthermore, as shown in Figure 4-5, CPDcontaining genomes were encapsidated into mature virions. To gain a more quantitative
appreciation of the longevity of the lesions (introduced by irradiation at 4 hpi) throughout
the infectious cycle, uninfected cells or infected cells (control, pre- or post-irradiated) were
harvested and subjected to pulse-field gel electrophoresis. Duplicate sets of samples were
transferred to nitrocellulose membranes; one set was hybridized to a [32P]-labeled viral
DNA probe to visualize genomes (Fig 4-6 A, left) and the other set was probed with an
anti-CPD antibody (Fig 4-6 A, right) to visualize UV-induced lesions. As a control,
uninfected or infected (10 hpi) samples were used to identify viral monomeric genomes
(~194 kb). In parallel, we irradiated cells at 4 hpi and harvested them at 4.5, 7, 10 and 18
hpi. As expected from earlier analyses (Fig 4-1), the levels of the viral genome were
significantly lower in irradiated vs. unirradiated cells (Fig 4-6 A, left, compare lane 3 with
lanes 4-8). As seen in the anti-CPD blot, lesions were observed at all time points examined
within the monomeric genomes present in irradiated cells (Fig 4-6 A, right), indicating that
the lesions are long-lived. When we plotted the relative ratios of CPD:genome levels, we
observed a ~2-fold increase in viral monomeric genomes and ~2-fold decrease in CPDs
from 4.5 to 18 hpi following UV irradiation (Fig 4-6 B). However, it is important to note that
the level of viral genome present at 18hpi in irradiated cultures was <20% of that seen at
10 hpi in unirradiated cells (Fig 4-6 C).

CPDs make up ~75% of the UV lesions introduced by UV-C, but 6,4-PPs make up the
remainder and cause greater distortions between thymidine dimers. We next asked
whether 6,4-PPs decreased from viral genomes. We enriched the concentration of vDNA
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tested by extracting cytoplasmic DNA from infected, irradiated cultures at each of the
previous time points. Uninfected, irradiated cultures were used as a control to ensure our
extracted cytoplasmic DNA is of viral origin. 100ng of DNA was used to examine the levels
of CPDs and 400ng for detection of 6,4-PPs. Consistent with our previous results, CPD
levels remain relatively unchanged up to 10 hpi, but decrease ~2-fold from 10 to 18 hpi
(Fig 4-6, D). Levels of 6,4-PPs do not change up until 7 hpi, but there is a 3-fold decrease
from 7 to 18 hpi different than the profile seen for CPDs (Fig 4-6, E). The half-lives of these
lesions in the viral genomes differ by ~4 hr such that t ½ = 10 hr for CPDs and 6 hr for 6,4PPs. However, both forms of UV lesions are detectable at 18 hpi suggesting that any
degradation or repair of the genomes containing UV lesions is insufficient to remove all
lesions within one infectious cycle.
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Figure 4-6: UV lesions are long-lived in VV genomes.
When infected cells are irradiated at 4 hpi, a 2-fold increase in monomeric genomes and
a corresponding decrease in CPD lesions is observed at late times of infection (10-18 hpi).
BSC40 cells were left uninfected or infected with WT virus (MOI 5) and either left
unirradiated or irradiated with 60 J/m2 UV at 4 hpi. (A) Samples were collected at 4.5, 7,
10 and 18 hpi and processed for PFGE analysis; DNA transferred to nitrocellulose filters
was probed with either [32P]-labeled viral DNA (left) or anti-CPD antibody (right) (n=4, a
representative image is shown). (B) Data were quantified and plotted as the average of
four biological replicates. (C) BSC40 cells were infected with WT virus (MOI 5) and left
unirradiated or irradiated with 60 J/m2 UV at 4 hpi. Samples were collected at 4.5, 10 and
18 hpi and processed for PFGE analysis. Southern blots were performed with [32P]-labeled
viral DNA and the signal for monomeric viral genomes is plotted. Error bars represent the
standard error of the mean. 6,4-PPs levels decrease from the viral genomes at 10 hpi.
BSC40 cells were left uninfected or infected with WT virus (MOI 5) and either left
unirradiated or irradiated with 60 J/m2 UV at 4 hpi. (A) Samples were collected at 4.5, 7,
10 and 18 hpi, and cytoplasmic DNA was extracted and purified. Following
electrophoresis, DNA was transferred to nitrocellulose filters before being probed with the
anti-CPD antibody (D) or anti-6,4-PP antibody (E) (n=3, a representative image is shown).
Data were quantified and plotted as the average of three biological replicates (F).
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Does the cellular NER machinery modulate the impact of UV irradiation on
vaccinia virus infection?
As described above, lesions induced by UV irradiation of the infected cells at 4 hpi were
present within monomeric genomes harvested from 4.5 until 18 hpi. These lesions are
therefore long-lived. A small decrease in their levels was seen at late times post infection,
accompanied by a small increase in the levels of the viral genome. The cellular genome
encodes a suite of proteins that together comprise the nucleotide excision repair (NER)
pathway whose primary function is to respond to UV-induced DNA adducts. Although NER
proteins are usually nuclear in their localization, we nevertheless probed their importance
to the viral life cycle in UV-irradiated cells by generating stable cell lines depleted of key
NER proteins [184, 185] using lentivirus-mediated shRNA delivery. We depleted
Xeroderma pigmentosum complementation group A, F, and G (XPA, XPF, and XPG)
proteins from BSC40 cells; a control cell line expressing a scrambled shRNA (shSCRM)
was generated in parallel. Efficient depletion of the XP proteins was achieved, with
residual levels of these proteins being ~5-10% of the levels seen in control cells
expressing scrambled shRNAs (Fig 4-7 A). The resultant cell lines were infected and
irradiated at 4 hpi (Fig 4-7 B, lanes 1 and 2). No hypersensitivity to UV as measured by
DNA accumulation was seen upon depletion of any of the three XP proteins (column 2),
and the <2-fold changes observed for viral yields (column 1) were not biologically
significant. These data are consistent with the interpretation that the cellular NER proteins
do not participate in the repair of UV-induced lesions within the viral genome, as
suggested by earlier reports monitoring viral replication in cells derived from XP patients
[106].

Intriguingly, viral infectious yield is reduced in each of the XP depleted cell lines compared
to the shScramble control in the absence of UV irradiation (Fig 4-7, C).

139
Immunofluorescence analysis demonstrated that detectable amounts of XP-A and -G
localize to cytoplasmic replication factories regardless of UV irradiation (Fig 4-7, D). How
might depletion of XP proteins might decrease infectious viral yield? XP proteins are
known to metabolize DNA in that XPF and XPG act as opposite polarity endonucleases
(3’ and 5’, respectively) and XPA is a single stranded binding protein that interacts with
XPG to facilitate its enzymatic activity. We hypothesized that depletion of these proteins
might therefore impact vDNA replication. Indeed, depletion of each XP protein resulted in
a decrease in the levels of vDNA accumulated as detected by PFGE Southern (Fig 4-7,
E). XPG depletion resulted in the most severe impact (~10-fold decrease) and XPA the
least (~4-fold). These data suggest one of two things: either the XP proteins play a role in
viral DNA replication or depletion of these proteins perturb the cellular milieu such that the
depleted cells are less viable hosts for VV infection. Lack of identification of these proteins
on nascent viral DNA by isolation of proteins on nascent DNA (iPOND) supports the latter
hypothesis.
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Figure 4-7: Depletion of XP-A, -F or -G does not render infections hypersensitive to
UV irradiation.
(A) Generation of BSC40 cells with stable depletion of XP proteins. BSC40 cells were
stably depleted of either XP-A, -F or -G by lentiviral delivery of shRNA and selection with
Puro; immunoblot analysis confirmed knockdowns of 85-95% (n=3, a representative
image is shown). Multiple shRNA sequences were tested and the sequence that gave the
greatest depletion (underlined) was used for experimentation. (B) Depletion of XP-A, F,
and G do not lead to UV hypersensitivity of viral infections. Transduced BSC40 cells were
infected with WT virus (MOI 5) and left unirradiated or irradiated with 60 J/m2 UV at 4 hpi.
At 10 hpi, samples were collected and processed for Southern dot blot analysis (B, column
2). At 18 hpi, samples were collected and titrated on BSC40 cells to quantify viral infectious
yield (B, column 1) (n=3, *, p<0.05). Some XPA is present within viral replication factories
and depletion of XP proteins decreases infectious viral yield and DNA accumulation
absent of exogenous DNA damage. Immunofluorescence of WT infected BSC40 cells at
4.5 hpi (C). Transduced BSC40 cells were infected with WT virus (MOI 5). At 10 hpi,
samples were collected and processed for Southern dot blot analysis (C). At 18 hpi,
samples were collected and titrated on BSC40 cells to quantify viral infectious yield (D).
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Is the DNA ligase, A50, involved in viral DNA metabolism following UV irradiation?
Having found that cellular NER factors play no role in viral infections following UV
irradiation, we next asked whether VV might encode a mechanism to facilitate viral
genome metabolism following UV irradiation. Vaccinia infections performed with a viral
recombinant lacking the A50 gene, which encodes the viral DNA ligase, have been
reported to be hypersensitive to UV irradiation at 6 hpi [152, 186]. Using our system, we
found that vΔA50 infections were hypersensitive to UV irradiation at 4 hpi (Fig 4-8 A,
compare lanes 3 and 6), but not at -1 hpi (Fig 4-8 A, compare lanes 2 and 5) as assessed
by viral yield (18 hpi) (Fig 4-8 A, compare lanes 1-3 with 4-6). This hypersensitivity was
not correlated with any further reduction in late protein levels (Fig 4-8 B).

We also compared the levels of DNA that accumulated in WT and v∆A50 infections in the
absence or presence of UV by PFGE analysis (Fig 4-8 C). The levels of DNA seen during
v∆A50 infections were lower than that seen in WT infections, and the levels of DNA seen
during irradiated v∆A50 infections were barely detectable. We also quantified the levels of
DNA at 10, 14 and 18 hpi by dot blot analysis; the data are plotted as the % of DNA seen
in irradiated infections vs. those seen in unirradiated infections (Fig 4-8 D). For WT
infections irradiated at 4 hpi, the levels of DNA observed at these three timepoints were
18, 34 and 48% of those seen in the absence of irradiation. For v∆A50 infections, the
levels remained at 12% of that seen in unirradiated infections at all time points. These
data suggest that the loss of A50 has a negative impact on the metabolism of viral DNA
after infection, either by promoting degradation of the DNA or preventing new synthesis of
the DNA.
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Figure 4-8: Viruses lacking the A50 DNA ligase gene are hypersensitive to UV
irradiation.
(A) Viruses lacking the A50 gene are hypersensitive to UV irradiation at 4 hpi. BSC40 cells
were left unirradiated (lanes 1 and 4) or irradiated with 60 J/m2 UV at 1 hr prior to infection
(lanes 2 and 5) or 4 hpi (lanes 3 and 6). Infections were performed with either WT virus
(lanes 1-3) or a virus lacking A50 (vΔA50, lanes 4-6). Samples were collected at 18 hpi
and analyzed by plaque assay (A, n=3, average and SEM plotted; *, p<0.05). or
immunoblot (B, n=3, representative immunoblot shown). (C and D) Viral DNA
accumulation following UV irradiation is halted when viruses lack the A50 gene. BSC40
cells were left uninfected (lane 1), infected with WT virus (lanes 2, 3 and 5), or v∆A50
(lanes 4 and 6) virus. At 4 hpi, infected cultures were irradiated with 60 J/m2 UV (lanes 5
and 6). At 18 hpi, samples were collected, resolved by PFGE, stained with EtBr (8C, left)
and analyzed by Southern blot using a [32P]-labeled viral DNA probe (8C, right). (D)
Following the same conditions as in 8C, cultures were collected at 10, 14, and 18 hpi
before analyzing via Southern dot blot. Data were quantified and plotted as the average
of three biological replicates (error bars = SEM; *, p<0.05; **, p<0.01).

144

145
Does the viral DNA polymerase mediate de novo DNA synthesis after UV
irradiation?
Having seen a modest (2-fold) increase in the levels of viral DNA at late times after
irradiation (10-18hpi, UV irradiation at 4 hpi) (Fig 4-8), we examined whether this increase
required de novo DNA synthesis. Infected cells were UV-irradiated at 4 hpi, and then
infections were allowed to continue in the presence or absence of cytosine arabinoside
(araC), an inhibitor of the DNA polymerase. Samples were harvested from 4.5 to 18 hpi
and DNA was examined by PFGE. The inclusion of araC abrogated the 2-fold increase in
viral DNA seen at late times post-infection. In fact, a small decrease in the levels of
monomeric genomes was seen (not shown). These data do not allow us to say whether
this difference reflects increased DNA synthesis or decreased DNA degradation.

To assess whether the inhibition of the viral DNA polymerase after irradiation had an
impact on viral yield, cells were left unirradiated or irradiated at -1 (Fig 4-9 A) or 4 hpi (Fig
4-9 B), and araC was either omitted, added at the start of infection (following adsorption)
or added at 4 hpi. Cells were harvested at 18 hpi for analysis. Adding araC following
adsorption blocked DNA synthesis (not shown), the transition to late gene expression
(panels A and B, bottom, lanes and columns 2), and decreased viral yield by >2500-fold
(panels A and B, top). Adding araC at 4 hpi reduced viral yield 7-fold while late protein
levels were unchanged (Fig 4-9 A and B, lane 3). This finding further supports the
conclusion that the levels of viral DNA that have accumulated at 4 hpi are sufficient for
intermediate and late gene expression. Consistent with previous results, 60 J/m2 of UV
irradiation at -1 hpi reduced viral yield ~14-fold, and the addition of araC (at 4 hpi) to these
irradiated cells led to a further 2.6-fold difference in viral yield (Fig 4-9 A, top). Also
consistent with previous results, irradiation at 4 hpi reduced viral yield ~31-fold (Fig 4-9 B,
top). Unexpectedly, addition of araC immediately after irradiation (4 hpi) led to a further
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Figure 4-9: Inhibition of the viral DNA polymerase at the time of UV irradiation leads
to a significant further reduction in the production of infectious virus.
Inhibition of the E9 polymerase by araC greatly increases the sensitivity of VV infection
when UV irradiation is performed at 4 hpi, but not at -1 hpi. (A) Irradiation prior to infection:
BSC40 cells were left unirradiated (lanes 1, 2 and 3) or irradiated with 60 J/m2 UV at 1hpi (lanes 4 and 5). Cells were then infected with WT virus (MOI 5). AraC (20µM) was
added to infections 30 min (lane 2) or 4 h post-infection (lanes 3 and 5). At 18 h, samples
were collected and analyzed by plaque assay (top) or immunoblot (bottom). (B) Irradiation
during infection: The same experiment as described above was performed, but UV
irradiation was performed at 4 hpi (n=3, average and SEM plotted (A), *, p<0.05; **,
p<0.01; ***, p<0.001, or a representative immunoblot shown (B)).

147

148
10.6-fold decrease in the levels of DNA accumulated at 18 hpi (not shown) and a further
11-fold decrease in viral yield (Fig 4-9B, top). No impact was seen on the levels of late
proteins. Therefore, blocking the function of the viral polymerase at the time of irradiation
exacerbates the impact of UV-damage, strongly suggesting that the E9 protein is actively
metabolizing the viral genome following UV irradiation in a manner that has a major impact
on the levels of viral DNA and infectious virus.

Analysis of the yield, composition and infectivity of mature virions produced
during control, and post-irradiated infections with or without araC.
In Figure 4-9, we demonstrated that inhibition of the E9 DNA polymerase (with araC) at
the time of UV-irradiation exacerbated the impact on infectious viral yield by 10.6-fold. To
further understand why E9’s activity is important for viral infections following UV irradiation,
we purified virions produced during unirradiated, irradiated (4hpi), or irradiated and araC
treated (both at 4 hpi) infections. Consistent with our previous results, UV irradiated
infections produced ~3-fold fewer virions as compared to unirradiated infections (Fig 4-10
A, compare lanes 1 and 2). There was a further modest decrease in virions produced
when UV irradiated infections were treated with araC at 4 hpi (Fig 4-10 A, compare lanes
2 and 3). Again, the position of the light scattering band is comparable between each of
the samples, so there does not appear to be any major defect in genome encapsidation.

Fractions collected from the sucrose gradients were then assessed for viral protein levels,
infectivity, and DNA content. We expanded the repertoire of proteins analyzed to further
characterize the content of virions produced under each of the conditions. While still using
L4 and F17, we also used I6, A30, F10, H5 and I3. Again, the profile of protein content
from unirradiated and irradiated virions is consistent with our previous results and the fold
change seen in the light scattering band (Fig 4-10 B, compare lanes 1 and 2). However,
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the profile seen in the UV irradiated, araC treated virions is distinct in that there are further
reductions in the levels of I6, L4, F17, and A30 compared to the UV irradiated alone
condition (Fig 4-10 B).

Fractions 8 to 11 were pooled from each of the gradients and plaque assays were
performed to assess the yield of infectious virus from the sucrose-banded material (Fig 410 C). Irradiation reduced the yield of infectious virions by 35-fold, and irradiation + araC
treatment led to a 700-fold decrease in infectious yield. These data are within 2-fold of the
changes we saw in the infectious viral yield of one step infections under the same
conditions (Fig 4-9).

Detection of UV induced lesions in the encapsidated viral genomes of araC treated
UV irradiated infections.
As shown above, we were able to detect CPD lesions in monomeric viral genomes
following PFGE analysis of irradiated, infected cells (Fig 4-5 E). Using a similar approach,
we analyzed the virions that we had purified on sucrose gradients to determine whether
lesion-containing genomes were encapsidated. Mature virions from the peak fractions
(fractions 8-11) of our sucrose gradients were sedimented and the viral DNA encapsidated
therein was subjected to PFGE analysis (Fig 4-10 D). One replicate was stained with EtBr
and then probed with [32P]-labeled viral DNA, and the other was probed with the anti-CPD
antibody. The EtBr image indicates that we have an abundance of monomeric genomes
within the virions harvested from control infections (Fig 4-10 D left, lane 1) but fewer within
the virions purified from cells irradiated at 4 hpi or UV-irradiated and araC treated at 4hpi
(Fig 4-10 D left, lanes 2 and 3). The Southern blot analysis (Fig 4-10 D, middle lanes)
showed comparable results.
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We next assayed the presence and intensity of UV-induced CPD lesions with the
encapsidated genomes. As expected, no signal was seen in the virions purified from
unirradiated infections (Fig 4-10 D right, lane 1); however, CPDs were detected in the
virions purified from irradiated infections and, strikingly, even more were detected in the
virions purified with UV-irradiated infections that were treated with araC at the time of
irradiation (compare lanes 2 and 3). These data confirm that lesion-containing genomes
can and are encapsidated within mature virions, and are also consistent with the E9
polymerase playing a role in the removal or repair of CPD lesions in genomes subjected
to UV irradiation

Based on the data in Figure 4-5, we expected to see CPD-containing cellular DNA in the
pooled fractions retrieved from the gradients loaded with samples from irradiated
infections – indeed, a smear of ~48kb was observed (Fig 4-10 E, right, lanes 2 and 3).
The cellular origin of this material was confirmed by the absence of recognition by the viral
DNA probe (Fig 4-10 A, middle panel). The CPD signal was ~2.5-fold more intense in the
gradient representing the UV irradiation + araC (Fig 4-10 D, compare lanes 3 and 2); a
stronger smear of ~48 kb cellular DNA was also observed in the EtBr image (Fig 4-10 D,
left); this difference probably reflects the fact that a larger volume of sample was loaded
for lane 3 vs. 2.

Cumulatively, the data shown in Figure 4-8, 4-9 and 4-10 support the conclusion that the
A50 ligase and the E9 polymerase contribute to the metabolism or repair of the viral
genome following UV irradiation; future studies will be required to identify other important
viral factors.
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Figure 4-10: Inhibition of the E9 polymerase’s activity following UV irradiation leads
to the production of virions that have a lower infectivity and contain genomes with
a higher level of CPD lesions.
UV irradiation at 4 hpi (with or without the addition of araC) at the time of irradiation
reduces mature virion production. BSC40 cells were infected with WT virus (MOI 5) and
left unirradiated (sample 1) or irradiated at 4 hpi (samples 2 and 3); araC (20 µM) was
added to sample 3 immediately thereafter. Samples were collected at 18 hpi and virions
were purified; light scattering bands were photographed (A) before fractions were
collected for analysis by immunoblot (B), plaque assay (C) and PFGE (D). (B) Virions
purified from cells that were UV irradiated and immediately treated with araC contain lower
levels of some core proteins (L4, I6). Blots were probed for L4, F17, I6, and A30. (C) The
infectivity of virions produced following UV irradiation and araC treatment is greatly
reduced. Fractions 8-11 were pooled and titrated on BSC40 cells. (D) The genomes
encapsidated within virions produced following UV irradiation and araC treatment contain
an elevated level of CPD lesions. Fractions 8-11 were pooled, resolved by PFGE and
analyzed by EtBr staining and hybridization with a [32P]-labeled viral DNA fragment or by
probing with an anti-CPD antibody. (The upper portion of the blot in the anti-CPD panel
represents monomeric viral genomes and was exposed for a longer time than the lower
level of the blot, which corresponds to fragmented cellular DNA) (n=1, t=3), average and
SEM plotted, **, p<0.01; ***, p<0.001).
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Summary:
UV irradiation has long been used as a source for inactivation of vaccinia virus. Introducing
lesions into the viral genome that compromise the progression of the viral life cycle in the
subsequent rounds of infection [105, 106]. However, our studies examine the progression
of the viral lifecycle under various conditions following UV irradiation. When irradiating at
4 hpi, there is a dose-dependent decrease in viral infectious yield and late protein
accumulation (Fig 4-2 A and B), while DNA levels are reduced 3 to 4-fold at 10 hpi with
our lowest tested concentration of UV-C and are not dose dependent (Fig 4-1 A). This
data suggest VV DNA metabolism is quite sensitive to the introduction of UV lesions.

Eurkaryotes encode DNA polymerases (lambda and beta family) that conduct error prone
bypass synthesis across bulky adducts like those introduced by UV irradiation. Our
findings that no further DNA accumulation occurs from 4 to 10 hpi suggests that the viral
DNA polymerase cannot facilitate processive bypass synthesis. The minor 2-fold increase
in viral monomeric genomes aren’t seen until 18 hpi (Fig 4-6, B). The increase in DNA
levels could be due to recombinatorial activity resulting in either the formation of genomes
lacking UV lesions, or from the holoenzyme synthesizing DNA fragments lacking UV
lesions that are then recombined into full-length genomes. However, Shope fibroma virus
(SFV) mediated recombinatorial frequency between plasmids in infected SIRC cells
following UV irradiation at ~7 hpi is reduced in a dose-dependent manner [187]. Further
analysis is required to assess whether the vaccinia recombinatorial machinery is capable
of metabolizing UV lesion-containing DNA templates.

Interestingly, orthopoxviruses do not encode a CPD-photolyase gene that is present in
other chordopoxviruses like leporipoxvirus, avipoxviruses, and molluscipoxviruses [100,
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188]. CPD-photolyases cleave the covalent bonds formed between adjacent pyrimidine
bases directly upon photoreactivation thereby resolving the damaged DNA. In
Fowlpoxvirus, the CPD-lyase gene is not important for infection in the absence of UV
irradiation but is essential for infections in the presence of UV irradiation [100]. These data
suggest that the CPD-photolyase is the primary mechanism of UV repair in Fowlpoxvirus.
Based on the divergent evolution from chordopoxviruses to orthopoxviruses, we
hypothesized that vaccinia virus either encoded a redundant mechanism of UV lesion
repair or that the additional insults introduced by UV irradiation, besides damage to the
viral genomes, were hindering viral replication and therefore making the DNA repair
irrelevant for viral fitness.

The viral yield of HSV is unaffected by UV irradiation prior to infection while early protein
levels were only minutely reduced at 6 hpi [189]; however, vaccinia infectious yield is
reduced in a dose-dependent manner, where at 60 J/m2 UV-C 1hr prior to infection, viral
yield is reduced ~12-fold (Fig 4-3 A). Vaccinia DNA replication is unaffected, but late viral
protein levels essential for morphogenesis and virion maturation are reduced (Fig 4-3 B
and C). These reductions in late protein levels are sufficient to reduce the number of
mature virions as determined by virion purification and electron microscopy experiments
(Fig 4-4 and 4-5). UV irradiation induces the ER stress pathway and leads to the
phosphorylation of eIF2a reducing global levels of protein synthesis [166, 183]. Although
vaccinia encodes an eIF2a mimic, K3L, UV irradiation prior to or post infection reduces
global protein synthesis equally (Fig 4-3 D). These data posit that the activation of the
UPR via our concentration of UV irradiation (60 J/m2 UV-C) is sufficient to overcome the
suppression of eIF2a phosphorylation by K3L. Indeed, immunoblot analysis of infection
irradiated prior to or post infection had significant increases in the levels of phosphorylated

155
eIF2a (Fig 4-3 E). This could account for the reduction in protein synthesis seen in figure
4-3 D.

UV irradiation of BSC40 cells prior to or post infection result in both a reduction in virions
produced and infectivity of produced virions (Fig 4-5). While the reduction in virion number
is equivalent between the two conditions, infectivity of virions produced from UV irradiated
infections is 3-fold lower than when UV irradiating cells prior to infection (Fig 4-5 A and D).
Virions from both conditions contain ~2-fold less DNA even though UV irradiation prior to
infection does not affect viral DNA replication (Fig 4-5 B). The key distinction between
virions purified from cells irradiated prior to and during infection is that irradiated infections
produce virions that encapsidate genomes containing UV lesions (Fig 4-5 E). This finding
accounts for the 3-fold further reduction in the infectivity of our virions produced from
irradiated infections and further supports that UV lesions are long-lived in the viral
genomes.

The resulting insults to vaccinia replication following UV irradiation of the cell prior to
infection may shed some light on why vaccinia evolved to not encode the CPD-photolyase
gene (see paragraph 3 of discussion). If viral replication is significantly hindered due to
effects on the cellular metabolism and signaling caused by UV irradiation, then resolution
and repair of UV lesions from the viral genomes would not fully restore viral infectivity and
productivity within one round of infection. Further studies comparing the impact of UV
irradiation prior to infection on the viral lifecycles of poxviruses encoding the CPDphotolyase gene like fowlpoxvirus or myxoma virus and other orthopoxviruses like
cowpoxvirus or monkeypoxvirus could strengthen such a hypothesis.
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Repair of the UV lesions from the viral genome would need to occur early in the process
of DNA replication to restore processive DNA synthesis. However, levels of UV lesions do
not decrease from the viral genomes until late in infection (between 10 and 18 hpi) (Fig 46, A, B, D, and E). These reductions correspond to a slight increase in DNA levels at 18
hpi due to de novo synthesis, but DNA levels are still 5 to 10-fold lower than their
unirradiated counterparts (Fig 4-6 B and C). These data indicate that the decrease in UV
lesions seen from 10 – 18 hpi is incapable in restoring VV DNA levels to that of an
unirradiated infection. Using previously generated methods of calculating UV lesions per
kb per J/m2 UV-C, we are introducing anywhere from 77-97 CPDs and ~19 6,4-PPs into
each viral genome following UV irradiation with 60 J/m2 UV-C. At 18 hpi, there are ~30%
and ~20% of the 6,4-PPs and CPDs remaining in the viral genomes, respectively.
Therefore, there would only be ~16-20 CPDs and ~6 6,4-PPs remaining in each viral
genome given that removal was facilitated equally among all of the templates. We cannot
eliminate the possibility that at this magnitude of removal there could be genomes without
any UV lesions. These genomes could provide the templates for selective replication that
allow for DNA synthesis as detected between 10 and 18 hpi resulting in a 2-fold increase
in DNA levels.

As to the mechanism of UV lesion repair of the viral genomes, we hypothesized that there
were three possibilities: the NER is coopted to perform repair, vaccinia encodes and
utilizes a yet unknown mechanism of repair, or UV damaged viral genomes are degraded
over time. Our findings that depletion of essential NER proteins do not sensitize viral yield,
genomic integrity, or DNA levels to UV irradiation suggests that the NER is not important
for viral replication following UV irradiation. However, we did find that viral yield and DNA
levels were reduced (2 to 5-fold depending on the silenced gene) across each of NER
depleted BSC40 cells (Fig 4-7, C). Additional studies found that XPA, XPG, and ATR all
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localize to the cytoplasmic replication foci during vaccinia infection of BSC40 cells
independent of UV irradiation (Fig 4-7, D). Whether XPA, XPG, and XPF have specific
roles in vaccinia replication or if their removal creates a suboptimal cellular environment
for infection requires further investigation.

Previous studies identified that vaccinia infections lacking the A50 allele, the viral DNA
ligase, are more sensitive to UV irradiation when irradiated at 6 hpi [190]. Our findings
support and build on those data (Fig 4-8). When VV infections lack the A50 allele, there is
a 4-fold increase in sensitivity to UV irradiation during infection but no further sensitivity
when UV irradiation is introduced prior to infection (Fig 4-8 A). This pinpoints the increased
sensitivity to the introduction of UV lesions. There is no further decrease in protein levels,
but now there is no accumulation of vDNA from 10 to 18 hpi (Fig 4-8 B, C, and D). These
data suggest A50 is important for metabolism of the viral genome following introduction of
UV lesions.

We also found that E9 is important to UV irradiated infections, in that addition of AraC
following UV irradiation at 4 hpi further reduces viral infectious yield ~10-fold (Fig 4-9 and
4-10). Virions purified from these conditions found that there were similar amounts of
vDNA within the virions, but, most importantly, the levels of CPD lesions within the
encapsidated genomes were significantly higher in the virions purified from cells that were
not only irradiated at 4 hpi but treated with araC at the same time (Fig 4-10, D). These
data provide solid evidence that the E9 polymerase is performing a repair function that
removes a significant number of CPD lesions from irradiated genomes.

Therefore, viral genomes are actively metabolized following UV irradiation and these two
factors, A50 and E9, are important for this mechanism. These findings also support the
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hypothesis that any repair of the viral genomes following UV irradiation is facilitated by
viral machinery. Although the repertoire of viral genes does not include all the necessary
factors to facilitate canonical NER, there are several viral genes which could function in a
complementary manner. A few of these candidates include G5, A18, and A22. The
proposed model for UV lesion repair using viral machinery and the importance of G5 will
be discussed later (Discussion and Appendix, respectively).
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Chapter 5 - General Discussion and Future Directions
Discussion:
The studies herein expand our understanding of VV DNA metabolism beyond replication
and recombination and identify cellular factors important for viral replication. While cellular
factors are important for the production of an infectious virus, their role is clearly an
accessory to the viral replication machinery. These data are consistent in the field and fit
within the paradigm that VV encodes all the factors essential for genome replication.
Unexpectedly, VV encodes a mechanism capable of processing damaged genomes, a
possibly counterintuitive finding given the evolutionary advantage of viral mutagenesis.
This chapter will summarize our findings and provide insights into this work's implications
and future directions.

Importance of host factors in facilitating productive viral replication
Throughout these studies, we found that host factors were important, although not
essential, for replicating the viral genome (Chapters 3 and 4). Three groups of cellular
factors were extensively studied using shRNA-depletion, small molecule inhibitors, and/or
different cell lines. Each had distinct impacts on VV replication.

(i)

ATR

Ataxia-telangiectasia mutated and rad3-related (ATR) is a kinase essential for processing
stalled replication forks and damaged ssDNA templates (Reviewed in [141]). In nuclear
DNA viruses like human papillomavirus (HPV) and herpes simplex virus (HSV1), ATR is
essential for the replication of the viral genome [155, 171, 191]. The role of cellular DNA
metabolizing proteins in VV replication were relatively unstudied, most likely due to the
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autonomy from the host cell nucleus. Using small-molecule inhibitors targeting ATR, the
viral yield was reduced ~10-fold while little to no change was detected in the accumulation
of viral proteins (Fig 3-3). Only a minor defect in total vDNA levels was seen at 10 hpi, but
time course experiments identified a delay in accumulating viral genomes (Fig 3-4). The
quality of the viral genomes was also affected. PFGE Southern blots demonstrated an
accumulation of viral subgenomic fragments following inhibition of ATR’s kinase activity
(Fig 3-5). These were the only phenotypic effects on the viral lifecycle detected. Early gene
expression and uncoating were unaffected (Fig 3-8). Levels of phosphorylated SQ/TQ
sites were unchanged during viral infection until after 7 hpi, when the phenotypic impacts
of ATR inhibition were already apparent on viral replication (Fig 3-1 and 3-2). This finding
suggested that perhaps direct phosphorylation of a substrate by ATR was not involved.
So, how could ATR inhibition affect viral replication?

ATR is an essential gene resulting in embryonic lethality when mutated. Therefore, we
targeted an ATR accessory protein, hCLK2, for depletion using shRNA delivered via
lentiviral transduction [170]. hCLK2 is an accessory protein of ATR similar to TopBP1 and
ATRIP. hCLK2 interacts with ATR and mediates ATR’s kinase activity in that hCLK2 is
important, but not essential, for phosphorylation of downstream substrates. Depletion of
hCLK2 resulted in a similar impact on infectious viral yield but an even more significant
impact on vDNA accumulation at 10 hpi (Fig 3-6). hCLK2 only partially disrupts ATR’s
kinase activity, so could hCLK2 be the ATR substrate important for viral replication?

(ii)

RRM2

Ribonucleotide reductase small subunit (RRM2) is the rate-limiting component of the
ribonucleotide reductase complex (RR) and, therefore, nucleotide biosynthesis. Vaccinia
encodes homologs to the cellular RR (large and small subunit, I4 and F4, respectively)
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that are expressed early during infection [33, 39]. The viral components can interact with
the cellular components to form mixed RR complexes [40]. Intriguingly, only unpublished
studies have examined the importance of the cellular RR complex for viral replication,
where siRNA depletion of RRM2 reduced infectious viral yield about 10-fold (Evans et al.,
unpublished).

A recent discovery was that ATR’s kinase activity is indirectly responsible for stabilizing
the cellular RRM2 [192]. Using our small molecule inhibitors targeting ATR, RRM2 levels
decreased >10-fold by 2 h post-treatment (Fig 3-10). When infecting various cell lines,
there was a correlation between sensitivity to ATR inhibition and the impact on
endogenous RRM2 levels (Fig 3-12). Endogenous RRM2 levels in A549 cells were
approximately 5-fold lower than BSC40, HeLa, or CV1 cells, and infections of A549 cells
in the presence of ATR inhibitor resulted in little to no detectable accumulation of vDNA
(Fig 3-13).

Interestingly, the viral RRM2, F4, lacks the first ~80 AA of the cellular RRM2 [40]. The Nterminal region of RRM2 contains the CXL and Thr33 site responsible for cyclin-F
mediated degradation [192]. Therefore, we do not believe ATR inhibition would impact F4
steady-state levels. With these thoughts in mind, we developed cell lines expressing HAtagged derivatives of the cellular RRM2 protein, either full-length or deleted of amino acids
1-50, to examine whether expression of a cyclin F-resistant RRM2 might rescue the impact
of ATR inhibition on viral replication. Interestingly, whereas expression of the full-length
HA- -RRM2 did not rescue viral infections following ATR inhibition, expression of the
truncated RRM2 was able to increase the levels of virus production to WT levels (Fig 314). We hypothesized that rescue of the infectious yield would be due to a return to the
normal linear profile of viral DNA replication and no accumulation of subgenomic
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fragments (see Fig 5-1). In short, RR complexes form between both viral and cellular
subunits creating four potential combinations which support the WT rate of VV DNA
replication (A). When ATR’s kinase activity is inhibited, cyclin F levels would increase,
leading to proteasomal degradation of the cellular RRM2 (B). When VV infects cells with
low cellular RRM2 levels, the only small subunit available is the viral RRM2, F4. This not
only reduces the possible combinations of RRs, but also makes VV DNA replication
dependent on the steady-state levels of the viral subunit. Until sufficient levels of F4 are
expressed within infected cells, VV DNA accumulation would be delayed (B).

However, each infected cell line retained the delay in vDNA accumulation caused by ATR
inhibition (Fig 3-15). The resultant impact on the integrity of the viral genome as examined
by PFGE Southern is inconclusive. There are detectable viral subgenomic fragments that
accumulate in the cell lines expressing a cyclin-F resistant RRM2, albeit perhaps at a
somewhat lower level (Fig 3-15). Is the ∆N-RRM2 enzymatically active? If so, how is
expression of a cyclin-F resistant RRM2 rescuing the infectious viral yield of ATR inhibited
infections?

(iii)

XPA, XPF, and XPG

As an unexpected result, the depletion of three proteins of the XP family reduced infectious
viral yield and vDNA accumulation. These depleted cell lines were initially generated to
examine the importance of the XP proteins within the context of UV irradiation of infected
cells (Fig 4-7). However, it became apparent that there was no increased viral sensitivity
to UV irradiation when infecting each of these depleted cell lines. In comparing the relative
infectious yields to the scramble control cell line, we detected a small but significant impact
on infectious yield absent of UV irradiation (Fig 4-7, C – D). Examination of vDNA
accumulation and integrity by PFGE or dot blot Southern illustrated significant reductions
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Figure 6-1. Model of ATR-RRM2 importance for VV Replication
Depleting the cellular RRM2 reduces the available dNTPs for supplying viral DNA
replication early during infection. (A) Before infection, RRM2 and RRM1 are expressed
and maintained within the cytoplasm. The kinase activity of ATR is indirectly responsible
for stabilizing RRM2 by reducing the steady-state levels of Cyclin F. When these cells are
infected, VV encodes an RRM1 and RRM2 homolog, I4 and F4, respectively. The viral
and cellular components can interact to form the heterotetrameric RR complex. These
complexes produce the necessary dNTPs for maintaining the rate of viral DNA replication
early during infection. (B) When ATR’s kinase activity is inhibited, Cyclin F steady-state
levels increase, and RRM2 is phosphorylated on Thr33—resulting in RRM2 proteasomal
degradation. The loss of cellular RRM2 means that there will be fewer RR complexes
formed early during infection (only one RRM2 homolog, F4). Fewer dNTPs will be
available early during infection, so rates of viral DNA accumulation lag until sufficient RR
complexes are formed using the viral RRM2, F4.
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in the amount of vDNA accumulated. Could the XP family of proteins be important for viral
DNA replication?

Identification of factors bound to nascent vaccinia DNA via iPOND did not identify any of
the XP proteins [137]. The doubling time of XP depleted cells is also longer than the
scramble control, suggestive of some growth defects in the cells. Therefore, removal of
these proteins most likely disrupts the cellular milieu such that replication and metabolism
of the viral genome are more difficult. This is a common theme of our findings in studying
the importance of cellular proteins in viral replication. Further work will be required to
understand how depletion of the XP proteins causes a reduction in vDNA accumulation.

Depletion of RRM2 via ATR inhibition results in the accumulation of viral
subgenomic fragments. Is this indicative that ATR’s kinase activity is important
for viral recombination or that there exist no checkpoints for viral DNA
replication?
The accumulation of viral subgenomic fragments is a unique phenotype. To date, deletion
or mutation of G5’s enzymatic activity and deletion or mutation of I3’s DNA binding domain
are the only known conditions to cause accumulation of subgenomic viral fragments [18,
76]. A similar characteristic between these two proteins is that recombinatorial frequency
(rf) between plasmids during infection is reduced when either G5 is deleted or I3 is
silenced. One unexplored possibility is that the inhibition of ATR might reduce
recombinatorial frequency during VV infection. Using previously described assays, we
could examine the rf of infections in the absence or presence of an ATR inhibitor. We
could also return to our hCLK2 depleted cells and examine if there is any impact on rf, and
then compare such effects to those seen following ATR inhibition during VV infection.
However, this hypothesis seems unlikely as ATR does not appear to be phosphorylating
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any viral or cellular effectors until after the phenotypic effect on the VV infection is
displayed.

Another possibility is that viral DNA synthesis is unabated during endogenous replication
stress. Instead of halting viral DNA replication when holoenzymes encounter damaged
templates, synthesis may continue which could result in the accumulation of subgenomic
fragments or improper base pairing. While vaccinia encodes an RR complex, the rapid
rate of vDNA replication might require both the cellular and viral RR. In the absence of the
cellular RR early during viral DNA replication, nucleotides may be limiting when fewer viral
RR complexes are present. Eukaryotic DNA replication halts in the absence of
nucleotides, resulting in stalled replication forks that activate DDR signaling through ATR
(reviewed in [141]). Vaccinia DNA replication may not halt in the absence of nucleotides
(Fig 5-2). It is also possible that depletion of nucleotides increases the relative
concentrations of dUTP. While VV encodes numerous factors to control relative levels of
dUTP [34], increased relative concentrations may overwhelm or circumvent that control
and result in wrongful incorporation of uracil moieties (Fig 5-2, i). The viral polymerase,
E9, has similar affinities to dUTP as TTP, dATP, dGTP, and dCTP. The holoenzyme is
incapable of replicating across abasic sites, further implicating this as a possible
mechanism responsible for the formation of subgenomic fragments when cellular RRM2
is depleted [107].

However, it is important to note that viral DNA accumulates not only as subgenomic
fragments but also as monomeric genomes when ATR is inhibited during infection.
Furthermore, vDNA accumulates to levels seen in uninhibited infections after 10 hpi. We
hypothesize that, as infections proceed and greater levels of the viral RR are expressed,
the nucleotide pool is restored, allowing for proper vDNA replication.
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Figure 6-2. Are there checkpoints for VV DNA replication?
VV DNA replication might not encode checkpoint mechanisms like the cell to ensure
proper genome formation, resulting in an arrest in genome replication. The depletion of
dNTPs might shed light on how VV DNA replication does not utilize checkpoint
mechanisms (A). If dNTPs become the limiting factor for VV DNA replication, there are
many possible outcomes. Two possible outcomes might result in the accumulation of VV
subgenomic fragments (i vs. ii). The polymerase has a similar affinity for dUTP as TTP,
meaning that incorporation of uracil moieties might increase in frequency as the total levels
of dNTPs decrease. Following misincorporation of uracil, D4 or E9 (3’ – 5’ exonuclease
activity) could remove the dUMP. In this model, the viral holoenzyme is incapable of
replicating across an abasic site (only demonstrated in vitro), resulting in the formation of
a subgenomic DNA fragment. (ii) The second possibility is that the lack of any dNTPs
would halt VV DNA synthesis. If the holoenzyme either disassociated or was competed
off, the result would be the formation of a subgenomic DNA fragment.

168

169
Does the importance of RRM2 for viral DNA metabolism indicate a more
significant requirement for poxviruses to “prepare” cells to facilitate productive
viral replication?
RRM2 is expressed in a cell cycle-dependent manner with the greatest levels present
during S-phase and a rapid decrease in G2/M (Reviewed in [193]). In examining the larger
picture for the pathobiology of poxviruses, infection occurs within the epidermis where
many cells are quiescent. However, tissue culture cells actively replicate and progress
through the cell cycle. Earlier studies demonstrate that infection of quiescent cells versus
actively replicating cultures results in a ~10-fold reduction in infectious yield [29].
Furthermore, numerous viral factors like the DNA ligase, RR, uracil DNA glycosylase, and
thymidine kinase are essential in vivo but dispensable in tissue culture [29, 92, 152, 194196]. Could this be due to the cell cycle phase when infection occurs?

Recent studies have shown that the secreted vaccinia epidermal growth factor (VGF or
C11) pushes the cells surrounding an infected cell into S-phase; at the leading edge of
the plaque, ~8-fold more cells are actively incorporating nucleoside analogs compared to
uninfected cultures [197]. Many of the viral factors known to be dispensable during
infection of tissue culture cells, but essential in vivo, are important for nucleotide
biosynthesis or the regulation of the levels of dUTP (dUTPase and UDG). Could this
indicate that quiescent cells provide challenges to nucleoside biosynthesis, thereby
causing genomic issues for actively replicating poxviral genomes? If this is the case, the
phenotypic effects seen when inhibiting with ATR kinase inhibitors might shed some light
on the issues faced during infection of quiescent cells. Quiescent or non-dividing cells
have low levels of dNTPs similar to what we hypothesize is happening during infection of
ATR inhibited cells.

170

Perturbation of the cellular milieu via UV irradiation causes viral protein synthesis
and virion maturation defects. How might ER stress impact the viral lifecycle?
How do poxviruses subvert this cellular stress pathway?
In the process of examining the impact of exogenous DNA damage on the viral lifecycle,
we uncovered that UV irradiation of cells prior to infection causes a dose-dependent
decrease in infectious viral yield, reduces protein synthesis (~3-fold), but does not at all
impact vDNA accumulation (Fig 4-3). Virions produced from UV irradiated cells (-1hr) had
~2-fold less vDNA and an equivalent decrease in monomeric genomes, suggesting that
UV irradiation of the cell impairs viral genome encapsidation. These data were surprising
as HSV infection is unaffected by UV irradiation of cells prior to infection [171]. There were
two interesting points. The unfolded protein response (UPR) activated due to ER stress
caused by UV irradiation clearly impacts VV infection, leading to reduced levels of viral
proteins. VV derives membranes from the ER to form the virion membranes [198, 199], so
how does this process not elicit a detrimental ER stress response? Or, if it does, how do
poxviruses subvert the downstream activation of the UPR, thereby reducing rates of
protein synthesis? Certainly, poxviruses encode K3L, an eIF2a mimic, capable of blocking
eIF2a phosphorylation [200, 201], but that is but one effector activated by the UPR and
ER stress. A complete analysis of ER stress’s impact on VV replication may provide
insights into how poxviral infections circumvent and manipulate the UPR.

The second interesting finding was the modest disruption of viral genome encapsidation
following UV irradiation of the cell (Fig 4-5). Genome replication and processing are
unaffected by UV irradiation of the cell (Fig 4-3), so why is there an impact on viral genome
encapsidation? We hypothesize one of two possibilities: either UV irradiation translocates
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cellular factors accessory to the process of genome encapsidation to the nucleus, or
disruption of the cellular milieu hinders the process of genome encapsidation. Genome
encapsidation is only partially understood with three factors known to be essential: I6, a
telomere binding protein, A32, a hexameric AAA ATPase, and A13, a membrane-binding
protein [16, 17, 127-129]. Further studies are required to identify whether cellular proteins
might be important.

Poxviruses are capable of undergoing DNA repair following exogenous DNA
damage
DNA metabolism includes three elements: replication, recombination, and repair. VV
genome replication is a complex and intricate process unique in its autonomy from cellular
DNA replication machinery. Extensive characterization and study reveal that the virus
encodes DNA replication machinery similar to eukaryotic and prokaryotic DNA replication
systems. The detailed mechanism of poxviral genome replication remains elusive, as does
the mechanism of recombination. E9, G5, and I3 are important for the recombinatorial
frequency between plasmids in infected cells [18, 98, 99]. Again, the mechanism for this
process remains unknown. Relative to viral replication and recombination, DNA repair
remained unstudied. Rightfully so, viral DNA repair seemed counterintuitive for
evolutionary advantage. However, vaccinia is a large dsDNA virus encoding over 90
essential proteins for viral replication. The polymerase also encodes a proofreading 3’-5’
exonuclease activity, supporting that mismatched base pairing is detrimental to viral DNA
replication. An elegant study also found evidence that VV evolves using a genome
accordion model, implying that gene duplication events are more advantageous than
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error-prone DNA synthesis [202]. We hypothesized genome fidelity might be more critical
for viral replication than previously imagined.

Using an exogenous source of DNA damage physiologically relevant to VV (UV
irradiation), we examined the impact of DNA damage on the viral lifecycle. The
introduction of UV halts viral DNA accumulation and introduces UV lesions but does not
cause fragmentation of the viral genome (Fig 4-1). Their effect on infectious viral yield and
late protein levels is dose-dependent between 15 and 60 J/m2, but the impact on the
accumulation of vDNA is already maximal at 15 J/m2. (Fig 4-2). This finding can be
reconciled in that UV irradiation of the cell absent of infection causes a dose-dependent
decrease in infectious yield and late protein levels, albeit at a lesser magnitude (Fig 4-3).
The reduction in late protein levels can be accounted for by a reduction in protein
synthesis, which we believe is caused by phosphorylation of elongation initiation factor 2α
(eIF2α). Both irradiation of cells prior to and post-infection cause alterations in the
morphogenesis profile, resulting in the production of fewer mature virions with some
lacking viral genomes (Fig 4-4 and 4-5). The significant divergence between the virions
produced from irradiated cells and irradiated infections are that the latter encapsidate
genomes containing UV lesions, thereby accounting for the further decrease in infectivity
(Fig 4-5).

The UV lesions within the viral genome must be long-lived, as they are present within
encapsidated genomes at 18 hpi. However, is there any removal of these lesions from the
viral genomes? Indeed, both the CPDs and 6,4-PPs show a ~2-fold decrease by 18 and
10 hpi, respectively (Fig 4-6). These decreases are independent of the small but significant
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2-fold increase in levels of vDNA seen late (10 to 18 hpi) during infection, thereby
solidifying the interpretation that UV lesions are being removed. The question then
became how were the viral genomes were repaired. We proposed three possible
mechanisms: the cellular NER machinery was hijacked to facilitate repair, the viral
replication machinery, with similar activities to cellular NER proteins, performed a
minimalistic or patchwork repair, or the viral genomes were degraded.

BSC40 cells were depleted of XPA, XPF, or XPG using a lentiviral delivery system to
introduce shRNA (Fig 4-7). Irradiated infections in these cell lines were not hypersensitive
to UV irradiation when assessing the changes in viral DNA levels or infectious viral yield,
thereby eliminating the possibility the XP proteins were involved in the DNA repair of the
viral genomes. Surprisingly, vaccinia encodes proteins with similar activities to the six
necessary and sufficient proteins for cellular NER: A22, G5, D5, A18, I3, and H5 with the
viral DNA replication machinery then performing resynthesis and ligation (see Fig 6-3). In
short, XPC-Rad23b may be important for the recognition and initiation of UV lesion repair.
We tested the cellular proteins downstream of the recognition complex, but it may be that
XPC recruits the viral helicases A18 and D5 to unwind around the lesion. The newly
ssDNA permits binding of the undamaged DNA on the other strand by I3 or H5. These
DNA binding proteins could act like XPA and RPA in changing the conformation of the
DNA such that G5 and A22 are recruited to cleave either side of the UV lesion. Then, the
viral DNA replication machinery would resynthesize and ligate the excised viral DNA
template.
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We examined the importance of three factors in this process: A50, E9, and G5. A50 is
essential for accumulating viral DNA late (10-18 hpi) during infection, with deletion of A50
resulting in a 4-fold increase in sensitivity to UV irradiation (Fig 4-8). E9’s activity is even
more critical for viral replication following UV irradiation, as inhibition of its enzymatic
activity using cytosine arabinoside (araC) further reduces infectious yield 10-fold following
UV irradiation (Fig 4-9). Most importantly, virions produced from infections exposed to
both UV-irradiation and araC at 4 hpi have almost 3-fold more UV lesions than those
irradiated but not treated with araC (Fig 4-10). Finally, infections lacking G5 are almost
100-fold more sensitive to UV irradiation, and when a WT G5 allele is expressed in trans,
that sensitivity can be rescued (Fig App 1). However, G5 alleles lacking enzymatic activity
cannot rescue in sensitivity to UV irradiation, strongly suggesting that G5’s enzymatic
activity is essential for viral replication following UV irradiation (Fig App 1, B).
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Figure 6-3. A possible mechanism of UV lesion removal from VV genomes
Utilization of viral DNA metabolizing machinery to facilitate repair of thymidine dimers.
Following the introduction of a UV lesion (A), we have not eliminated the possibility that
the XPC-Rad23b recognition complex plays some role in recruiting the necessary repair
machinery (B). Without a recognition complex, A18 and D5 would unwind around the UV
lesion (C). This newly ssDNA would then be bound by I3 and/or H5. These proteins could
facilitate the nuclease activities and be important for the recruitment of G5 and A22 (D).
Following excision of the thymidine dimer, the 3’ overhang could recruit the viral
holoenzyme to synthesize across the 32nt gap. A ligase, viral or cellular, would then ligate
the newly synthesized DNA resulting in repair of the UV lesion.
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E9, A50, and G5 are important in facilitating viral replication following UV
irradiation. What other viral proteins might be important?
Based on our proposed model (Fig 6-3), D5, A18, A22, H5, and I3 are all possible
candidates for removal of UV lesions from the viral genomes. Following a similar
experimental design to that outlined in this work, we could examine the impact of
deficiencies in these on the sensitivity to UV irradiation administered prior to infection (to
account for the impact on the cell) and during infection (damage of the viral genomes).
Our interpretations would be complicated by the essentiality of these proteins in replicating
the viral genome, namely D5, H5, and I3 [24, 76, 203-208]. However, A22 and A18 are
prime targets as ts mutants mapping to the A18 allele have a defect in transcription (but
not DNA replication), and a virus expressing A22 under the tetracycline operator
accumulate similar amounts of viral DNA but only as concatemeric dimers or high order
species [27, 209-211]. Based on our model, we hypothesize that both A18 and A22 are
involved in the excision of the UV lesion from the viral genome, so performing Southern
blots examining the levels of UV lesions within the viral genomes when either is mutated
or absent would be of particular interest.

These studies in tissue culture cells provide insights into important factors but do not
elucidate the mechanism responsible for UV lesion repair. Purification of these proteins
could allow us to test the necessary and sufficient viral factors to repair a UV lesion in
vitro. By shifting our studies in vitro, we could examine whether the essential DNA
replication proteins H5, I3, or D5 are important in this process. Our studies herein provide
the foundation for such investigations.
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UV irradiation is but one form of DNA damage. How might poxviruses facilitate
DNA metabolism following other forms of DNA damage?
As mentioned, DNA repair is an understudied element of poxvirus DNA metabolism. Our
findings that the DNA replication machinery is important for removing UV lesions from the
viral genome suggest that these proteins might facilitate repair. UV irradiation causes a
bulky adduct by the introduction of an intrastrand thymidine dimer. However, there are
multiple forms of DNA damage poxviruses might encounter during DNA replication due to
endogenous stress. Here we briefly propose two forms of DNA damage and the
mechanisms possibly encoded by poxviruses to repair such damaged products (Fig 6-4).

(i)

Double-stranded breaks

Double-stranded breaks can occur from both exogenous (ionizing irradiation) and
endogenous (replication intermediates, degradation, stalled replication forks). VV is
known to undergo high rates of homologous recombination [97, 212]. I3, G5, and E9’s 3’5’ exonuclease activity are all important for recombinatorial frequency during infection.
We, therefore, propose that following the formation of a DSB, E9, or G5 chew back the
blunt dsDNA leaving an ssDNA overhang which I3 can bind. I3 was recently shown to
have single-strand annealing activity and could perform strand invasion of an undamaged
genome (Seahorn et al., unpublished). The overhang would recruit the viral holoenzyme
allowing for viral DNA synthesis and repair of the damaged viral genome. This mechanism
might be beneficial for viral DNA replication in being utilized as recombinatorial priming,
which will be discussed later.
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Figure 6-4. What other DNA repair mechanisms might the VV DNA metabolizing
machinery be capable of?
How might VV be capable of double-stranded break (DSB) repair and base excision repair
(BER)? (A) Double-stranded break repair occurs through exogenous (ionizing radiation)
or endogenous (collapsed replication forks) stress. The formation of a DSB could be
processed by the exonuclease activity of E9 (3’-5’) or G5 (5’-3’) (ii). I3 would load onto
ssDNA and facilitate strand invasion using strand annealing activity (iii and iv). The 3’
overhang would recruit the holoenzyme and begin synthesis (v). The result is the formation
of a full-length viral genome (vi). This mechanism could also be important for
recombination-dependent replication (see Fig 6-5). (B) Base excision repair (BER) is
responsible for fixing deaminated cytosines or misincorporated uracil moieties (B). We
have discussed that these abasic sites are detrimental to VV DNA replication (see Fig 62). D4 could process misincorporated uracil moieties to form an abasic site. A viral protein,
yet unknown, or the cellular apyrimidinic-lyase 1 (APE1) processes the abasic site. The
result is short or long patch repair dependent on whether a nuclease such as G5
processes the viral genome using its 5’-3’ exonuclease activity. Short or Long patch repair
would utilize the viral holoenzyme and a ligase, viral or cellular, to synthesize and ligate
the genome resulting in complete repair.
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(ii)

Base excision repair

Base excision repair (BER) is typically used to remove misincorporated uracil moieties or
deaminated cytosines, both of which can occur due to endogenous replication stress. VV
encodes a few factors known to be essential for BER. D4 is a uracil DNA glycosylase that
would remove the uracil moiety leaving an abasic site, G5 has flap endonuclease activity
similar to FEN1, and A50 is a DNA ligase [18, 107, 152]. We propose that the cellular
apyrimidinic/apurinic lyase 1 (APE1) could facilitate the removal of sugar-phosphate
backbone, allowing G5 to either extend the gap in what would become long patch BER.
The other option is that the polymerase would be recruited and add the single nucleotide
before A50 would ligate that newly added nucleotide to the template. If the cellular APE1
is not recruited, a yet unknown viral protein might be important.

The finding that VV is capable of DNA repair certainly expands our understanding of VV
DNA metabolism and sets the stage for an examination of other forms of DNA repair.

Insights into the structure-specific nuclease, G5, may provide insights into the
mode of vDNA replication.
Are subgenomic fragments accumulated during infections lacking the G5 protein
replication intermediates or degradation products?
The poxvirus nuclease, G5, is essential for forming full-length monomeric genomes [18].
Lack of G5 during VV DNA replication results in the accumulation of ~98% subgenomic
fragments and only about 2% full-length genomes. However, what these subgenomic
fragments are, degradation products or replication intermediates, remains unknown after
our experiments herein. Use of an inducible G5 virus (vIND G5-V5) did not provide any
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evidence as to whether these subgenomic fragments from a v∆G5 infection were
replication intermediates or degradation products. However, the experiments were marred
by a plethora of technical issues (Fig App 3 and 4). Intriguingly, vIND G5-V5 infection of
CV1-G5 cells appears as though rescue of infectious viral yield is dependent on the
addition of doxycycline. We could therefore use these reagents to examine whether
subgenomic fragments are “chased” into full-length viral genomes.

Do poxviruses utilize a mechanism of recombination-dependent replication to amplify the
viral genome?
As of yet, the mechanism of poxvirus DNA replication remains partially understood.
Previous studies identified that the essential factors responsible for vDNA replication are
of viral origin and that cellular proteins may play some accessory role [41, 139]. Whether
there is leading and lagging strand synthesis remains unknown, but the rate of vDNA
replication was assessed to be ~30 min per viral genome (in infected A549 cells) [137].
The processivity of the viral polymerase, E9, was found to be 30 nt/s in vitro [213, 214].
Extrapolation from these numbers would suggest that one holoenzyme could replicate one
viral genome in ~110 minutes or about 4-fold slower than the published rate of vDNA
replication. There could be a slew of reasons for this discrepancy. Processivity of the
polymerase in vitro might be slower than in vivo because the templates being used
(minichromosomes vs. viral genome). Another possibility for the reduced rates of
synthesis in vitro could be the necessity for essential DNA replication machinery such as
D5, the putative primase/helicase. These essential factors could facilitate a mechanism of
replication faster than just the holoenzyme on its own. One such mechanism is
recombinatorial priming.
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Figure 6-5. Model of recombinatorial priming using G5 and I3
Could poxviruses utilize recombination-dependent replication in synthesizing viral
genomes? VV DNA accumulates in multiple species: concatemerized intermediates,
processed monomeric genomes, and subgenomic fragments. The subgenomic fragments
may be intermediates of VV DNA replication. The blunt dsDNA intermediates would be
processed by G5’s 5’-3’ exonuclease activity (i and ii). I3 would load onto the ssDNA and
facilitate strand invasion of a complementing template (iii and iv). The 3’ overhang would
recruit the holoenzymes and begin synthesis. This might allow for multiple holoenzymes
replicating any one viral genome (v). The result is the formation of numerous genomes
from one template. Interestingly, this mechanism is also used in repairing DSBs.
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Recombinatorial priming is the process of utilizing multiple sites for DNA replication on
any one viral genome. Many DNA viruses such as HPV and HSV utilize this process in
what has now been coined ‘recombination-dependent replication’ or RDR (Review in
[215]). Many factors are essential for RDR, including a 5’-3’ exonuclease. At the time, no
poxviral gene had been identified with such activity. Dr. Czarnecki purified the poxviral
protein G5 and examined its enzymatic activity in vitro. He identified that G5 contained
both 5’ flap endonuclease activity (like Fen1) and 5’-3’ exonuclease activity (like Exo1)
(unpublished). Therefore, G5 could have been the missing puzzle piece in understanding
how poxviruses replicate their genome.

RDR viruses such as HPV, HSV, and T4 bacteriophage are characterized by inducing a
high rate of recombination during infection which is inseparable from the process of
replicating the viral genomes. Vaccinia encodes three factors known to be important for
recombination between plasmids in infected cells: I3, the replicative single-stranded
binding protein (with newly identified single-strand annealing activity), G5, the structurespecific nuclease, and E9, the DNA polymerase with 3’-5’ exonuclease activity. Therefore,
a proposed model of how vaccinia might utilize recombination to replicate its genome is
shown (Fig 6-5).

PFGE Southern blots of infected cells with WT virus detect three distinct viral DNA
species: subgenomic fragments (black brackets, only under some conditions), monomeric
genomes (red arrows), and concatemeric/branched templates (blue arrows) (See Fig 57). Whether the subgenomic fragments are replication intermediates or degradation
products, they may be utilized and processed using G5 or E9 exonuclease activity
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resulting in the formation of an ssDNA overhang. I3 could then readily bind such
overhangs and use its single-strand annealing activity to invade a full-length template
strand. When 3’ overhangs are generated, the holoenzyme would be recruited, and
synthesis would initiate. This process could occur at multiple different sites within one
genomic template depending on the complementarity of the ssDNA 3’ overhang.
Returning to the rates of vDNA accumulation mentioned, a 3-fold increase in the rates of
vDNA replication could be facilitated by recruiting 3 or more holoenzymes to replicate any
one viral genome. Extensive further analyses are required to identify the possible
involvement of recombinatorial priming in facilitating vDNA replication.

Summary:
To summarize, the work herein furthered our understanding of the involvement of
accessory cellular proteins for poxvirus DNA metabolism, expanded our understanding of
poxvirus DNA metabolism to include DNA repair following exogenous DNA damage, and
characterized the role G5 plays in DNA replication and repair. ATR, RRM2, and the XP
proteins all seem to play some accessory role in viral DNA metabolism, whether directly
or indirectly. ATR is important for vDNA replication, and conditions inhibiting ATR result in
decreases in vDNA levels early during infection and the formation of subgenomic
fragments. These studies have shed light on the cellular proteins that may be important in
supporting vDNA replication, in particular proteins important for nucleoside biosyntheis.
The replication defects between quiescent and actively replicating cells may provide a
context to identify such cellular proteins. Furthermore, there is some repair (~50%) of the
viral genomes following introduction of UV lesions. The viral replication machinery is
essential for this repair, while cellular NER proteins are unimportant. UV irradiation is but
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one form of exogenous DNA damage, and we have set the stage, not only for identification
of the mechanism responsible for the repair of UV lesions from the viral genome, but also
the characterization of how VV might cope with other forms of DNA damage both
endogenous and exogenous. Finally, these data have opened new areas and directions
of study in attempting to understand VV DNA metabolism.
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Appendix: Genetic and virological analysis of the role of G5 in
viral DNA metabolism
Rationale:
The mechanism of vaccinia virus DNA replication is only partially understood. Many
important factors for viral DNA replication have been identified via biochemical and
molecular analyses, but it’s clear that the process is more complex than previously
imagined. For example, discussions continue as to whether there is simultaneous leading
and lagging strand synthesis. Recombinatorial priming is hypothesized as one possibility
for how poxviruses replicate their genome at a rate much faster than DNA viruses like
HSV [137, 216]. More recently, multiple proteins involved in vDNA replication were found
to be important for the recombination between plasmids during infection [18, 98, 99]. The
essential nature of these proteins in the process of vDNA replication suggests an intimate
coupling between vDNA replication and recombination.

Recombination-dependent replication (RDR) is common among DNA viruses like HSV,
HPV, and T4 bacteriophage (Reviewed in [217]). Three n proteins encoded in common by
these RDR viruses are a 3’-5’ exonuclease, a single stranded binding protein, and a
structure-specific endonuclease. VV encodes proteins with each of these functions (E9,
I3, and G5) and each is essential for the process of vDNA replication. E9 is the viral DNA
polymerase with 3’-5’ “proofreading” exonuclease activity, I3 is the single-strand DNA
binding protein with strand annealing activity, and G5 is a structure-specific endonuclease
and exonuclease. Deletion of I3 or inhibition of E9 result in little to no accumulation of
vDNA; however, deletion of G5 results has minimal effects on bulk vDNA accumulation
[18, 76, 218]. However, G5 deletion causes a striking phenotype: the predominant
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accumulation of subgenomic fragments and a reduced frequencye of inter-plasmid
recombination ([18] and Czarnecki and Traktman, unpublished). Are the subgenomic
fragments produced from infections lacking G5 replication intermediates or
degradation products? We initiated the studies described below to provide insights into
the origin of these subgenomic fragments.

Careful biochemical analyses of purified G5 revealed that it posseses both 5’ flap
endonuclease and 5’ – 3’ exonuclease activity (Czarnecki and Traktman, unpublished).
The 5’ flap endonuclease activity of G5 is similar to that of XPG, which is a structure
specific endonuclease essential for the removal of UV lesions. Could G5 be important
for viral replication following the introduction of UV lesions into the viral genome?
Using the experimental design outlined in chapter 4 (Fig 4-8 and 4-9), we examined the
importance of G5 to the production of infectious virus following UV irradiation.

Results:
VV infections lacking the G5 allele accumulate vDNA as subgenomic fragments
G5, a predicted Exo1/Fen1 like nuclease, is expressed early during the VV infectious life
cycle. Mutating the predicted catalytic triad of G5 results in a phenotype identical to that
seen when with the G5 deletion virus (v∆G5), demonstrating that the enzymatic activity of
G5 is essential to its function. Most notably, vDNA accumulates almost exclusively as
subgenomic fragments during v∆G5 infections. Bulk vDNA levels are hardly changed, with
only a three-fold decrease between the WT and ∆G5 virus; however, viral infectious yield
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is reduced almost 50-fold. Previous reports suggest this is due to the inability of
subgenomic vDNA fragments to be encapsidated into virions [18].

What role might G5 play in VV DNA repair?
Dr. Maciej Czarnecki generated a knock-out vaccinia virus in which the endogenous G5R
allele was deleted and replaced with one encoding the RFP reporter protein. G5 is an
essential gene, so a cell line expressing the G5 allele was required before generation of
the deletion virus. The Flp-IN system was used to generate CV-1 cells that contain a single
copy of the gene encoding G5V5 expressed from a DOX-inducible promoter; the gene is
inserted into a common genomic locus using the FRT/FLP system. The Traktman lab has
used this system previously to generate cell lines expressing the F10 kinase, the I3 SSB
and the H5 scaffold protein [76, 108, 203]. As a control, a cell line expressing the
chloramphenicol acetyltransferase (CAT) protein were prepared in parallel. The v∆G5
virus was isolated after iterative rounds of plaque assays performed on the complementing
CV1-G5V5 cell line.

How does loss or mutation of G5 impact the ability of VV to replicate following exogenous
DNA damage?
VV is capable of partial DNA repair following damage of viral genomes via UV irradiation
(see chapter 4). E9 and A50 are important for this process, resulting in hypersensitivity to
UV irradiation when it is introduced during (but not prior to) infection (see Fig 4-8, 4-9, and
4-10). Based on our model (Fig 5-3), we examined whether G5 is important for viral
replication following UV irradiation.
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BSC40 cells were infected with WT or ∆G5 virus (MOI 5) for 4 h before either leaving the
samples unirradiated or irradiating with 60 J/m2 UV (blue vs pink, Fig App-3, A). Samples
were collected at 18 hpi and processed for assessment of infectious viral yield (Fig App1, A left) or viral protein accumulation (Fig App-1, A right). Consistent with previous results,
exposure to 60 J/m2 UV-C at 4 hpi reduced infectious viral yield from WT infections by
~35-fold. In contrast, the v∆G5 infectious yield was reduced almost 3700-fold when
irradiated infections were compared to control infections, evidence of an ~100-fold
increase in sensitivity to UV irradiation compared to the WT virus. Immunoblot analysis of
WT infections showed, as expected, that there was a decrease in the levels of late viral
proteins (L4 and F17) following UV irradiation at 4 hpi (lanes 3-4); a comparable, but not
greater, decrease was seen in the v∆G5 infections following irradiation (lanes 5-6).

We next asked whether G5’s enzymatic activity was important for viral replication following
damage of the viral genomes using UV irradiation. Using transgenic CV1 cells expressing
either CAT, WT G5, or G5 with mutations in the catalytic triad (D33A G5, A171V G5, or
D198A G5), infections were performed with the ∆G5 virus (MOI 5) in the absence of
irradiation (black bars) or irradiation at -1 hpi (light grey bars) or 4 hpi (dark gray bars) (Fig
App-1, B). In the presence of transgenic WT G5, there is a 10-fold decrease in yield when
cells were irradiated at -1 hpi and a 20-fold decrease when irradiated at 4 hpi. We know
from prior work (Czarnecki and Traktman, unpublished), that the G5 cells are somewhat
leaky, and so there is complementation of vΔG5 even in the absence of DOX. UV
irradiation prior to infection causes a minor defect (4-fold decrease) in v∆G5-infected CV1CAT cells, but UV irradiation during infection causes a severe defect (100-fold increase in
sensitivity to UV irradiation). These data suggest that the loss of G5 causes the greatest
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Appendix Figure 1. Infections performed in the absence of an active G5 enzyme are
hypersensitive to the impact of UV irradiation.
Infections lacking G5 are hypersensitive to the effects of UV irradiation at 4 hpi, exhibiting
an ~100-fold further decrease in viral yield (A). BSC40 cells were infected with either WT
or ∆G5 virus (MOI 5). At 4 hpi, a subset of samples were UV irradiated with 60 J/m2 UVC. Samples were harvested at 18 hpi and processed for immunoblot analysis (right) or
titrated via plaque assay to assess viral yield (left). Viral yield is plotted as the average of
three biological replicates with the error bars representing the SEM. Immunoblots were
probed for XPG, calnexin, A20, I3, L4, and F17 (n=3; a representative immunoblot is
shown). Only enzymatically active G5 can rescue the hypersensitivity observed when
vΔG5-infected cells are exposed to UV irradiation at 4 hpi. (B). CV1-CAT, -G5, -D33A, A171V, and -D198A cells were induced 24 hr prior to infection. Cells were either left
unirradiated, irradiated prior to infection (-1 h), or irradiated during infection (4 hpi). These
cells were then infected with v∆G5 virus (MOI 5). At 18 hpi, samples were harvested and
titrated via plaque assay to assess viral yield. Viral yield is plotted as the average of three
biological replicates with the error bars representing the SEM.
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increase in sensitivity of VV to UV irradiation yet seen (Loss of A50 = 4-fold increase in
sensitivity and inhibition of E9 = 10-fold increase in sensitivity).

In cell lines expressing G5 mutants lacking enzymatic activity and infected with the ∆G5
virus, there is no rescue of infectious viral yield as there is a ~10-fold decrease compared
infected WT G5 cells. There is little to no further decrease when each of these cell lines
are irradiated prior to infection, but ~100-fold further decrease when these cells are
irradiated during infection. These data demonstrate that G5’s enzymatic activity is
essential for viral replication following damage of the viral genomes via UV irradiation.

Generation of an inducible G5-V5 virus

Beyond G5’s role in DNA repair, we were immensely curious as to why infections lacking
the G5 protein produce >98% of the vDNA as subgenomic fragments. Two hypotheses
were generated: these subgenomic fragments were either degradation products
accumulating in the absence of G5 or replication intermediates requiring recombination
and processing by G5 to form full-length monomeric genomes. The stability and
accumulation of these vDNA fragments supported the latter hypothesis, but careful
analysis was required to identify whether these fragments could be utilized to form fulllength viral genomes. Using tools generated by Dr. Maciej Czarnecki, we set about
generating a recombinant vaccinia virus in which G5’s expression was inducible.

pJS4 vIND 3xTetOp G5-V5 was designed by Dr. Paula Traktman and the G5 cassette
was generated by GeneArt (Fig App-2). The key features of the plasmid are described in
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Appendix Figure 2. Plasmid map of inducible G5-V5 pJS4 NeoR TetR
This plasmid encodes a G418-resistance cassette (Neo), necessary for selection of our
recombinant viruses, and the tetracycline repressor gene (TetR) under the regulation of a
bidirectional early/late viral promoter (Green). The G5-V5 allele was placed under the viral
I2 promoter (Green) and 3x tetracycline operators (Orange). Furthermore, the left (TKL)
and right (TKR) portions of the viral TK gene flanked the genes of interest, allowing
integration of the cassette into the non-essential TK locus.
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the legend; briefly, the inducible G5V5 allele lies downstream of 3 TET operators and the
plasmid also encodes the TET repressor. With this plasmid (pIND G5-V5), we performed
infection transfections with the ∆G5 virus on BSC40 cells. Sequential iterative plaque
purifications and selection using G418 resulted in the generation of our desired vIND G5V5. Stocks of these viruses were generated using sucrose sedimentation as previously
described.

First, we wanted to test whether expression of G5-V5 was inducibly controlled in our vIND
G5-V5 viruses. BSC40 cells were infected with the vIND G5-V5 for 10 h either in the
presence or absence of doxycycline. Samples were collected and processed for
immunoblot (Fig App-3, A). Each of the independent parental vIND G5-V5 viruses
expressed G5-V5 in the presence of DOX; no G5V5 was observed in the absence of DOX.
The same samples were also analyzed by plaque assay to quantify the yield of infectious
virus. In addition to comparing the yield + and – DOX, we also compared these
recombinants to WT virus (green bar) and v∆G5 (red bar) (Fig App-3, B). Gratifyingly, in
the absence of DOX, the levels of virus produced by the inducible recombinants was
nearly as low as that seen from infections performed with v∆G5. Surprisingly, however,
we observed very little rescue of viral yield in the presence of DPX.

Two explanations seemed possible: either the inducible G5-V5 allele was mutated and the
protein therefore inactive, or expression of G5-V5 from the inducible virus was insufficient.
Sequencing of the G5-V5 allele, the homology arms of the TK locus, and the Tetracycline
locus confirmed that there were no mutations or abnormalities. Therefore, we performed
a time course of infection in BSC40 cells (1, 2.5, 4, and 7 hpi) in the presence or absence
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Appendix Figure 3. vIND G5-V5 expression and infectious yield in the absence or
presence of inducer (DOX).
Expression of V5-tagged G5 under the TetOn system (A). BSC40 cells were infected with
WT virus, v∆G5 or vindG5-V5 (MOI 5) in the presence or absence of DOX. All samples
were harvested at 18 hpi and either processed for immunoblot (A) or titrated via plaque
assay to assess viral yield (B). Immunoblots were probed for calnexin, V5 (G5), and TetR
(n=3; a representative immunoblot is shown). Viral yield is plotted as the average of three
biological replicates (for WT and ∆G5 infections) with the error bars representing the SEM.
The levels of G5V5 produced from the inducible virus + DOX are less than those seen
from a virus that produces G5V5 constitutively from the same promoter. BSC40 cells were
infected with vG5-V5 or vindG5-V5 virus (MOI 5). Samples were harvested at 1, 2.5, 4,
and 7 hpi and processed for immunoblot analysis. Immunoblots were probed for calnexin,
V5 (G5) with a long exposure shown, I3, and L4 (n=3; a representative immunoblot is
shown).
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of DOX and examined the samples by immunoblot. There are no antibodies available to
detect endogenous G5, so we compared the levels of G5 over time to a recombinant virus
that expresses V5-tagged G5 (vG5-V5). It is important to note that the vG5-V5 has G5
controlled by the I2 promoter and still has the endogenous G5 allele. Levels of V5-tagged
G5 were highest in the vG5-V5, and detectable levels were seen as early as 2.5 hpi, when
viral uncoating has begun but prior to or coincident with the initiation of genome replication
(Fig App 3-C). In contrast, the vIND G5-V5 accumulates G5-V5 to detectable levels at 1
hpi, but never reaches the level of accumulation seen in the vG5-V5.

Why else might the vIND G5-V5 be deficient for rescue in the presence of DOX? The CV1
-CAT and CV1-G5 cell lines were infected with the vIND G5-V5 isolates (+/- DOX) and
quantified viral yield was quantified at 18 hpi (App-4, A). As previously seen (Czarnecki,
unpublished), the CV1-G5 cells rescue viral yield during v∆G5 infections in both the
absence and presence of DOX, consistent with the cell line being somewhat leaky for G5
expression. However, this same cell line gave us the desired result upon infection with
vindG5-V5, with low levels of infectious virus being produced in the absence of DOX and
good rescue seen upon the addition of DOX.
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Appendix Figure 4. The replication defect of vindG5 can be rescued during DOXinduced infections of CV1-G5V5 cells.
Infection of CV1-G5V5 cells with vindG5V5 results in a rescue of virus production in a
DOX-dependent manner (A). CV1-CAT or -G5 cells were left uninduced or induced 24 hr
prior to infection with DOX (light grey). Cells were then infected with WT virus, ∆G5, or
vindG5-V5 (MOI 5). At 18 hpi, samples were harvested and titrated via plaque assay to
assess viral yield. Viral yield is plotted as the average of three biological replicates with
the error bars representing the SEM.
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Discussion:
G5’s enzymatic activity is essential for viral replication following UV irradiation, as
infections lacking G5 or complemented with a mutant lacking G5’s enzymatic activity result
in ~100-fold increase in viral sensitivity to UV irradiation at 4 hpi (Fig App-1). This finding
builds on the model presented in figure 5-3 and sets the stage for further analysis to
understand whether G5’s enzymatic activity is essential for UV lesion repair of VV
genomes.

The answer as to whether the subgenomic fragments accumulated during VV infections
without G5 are replication intermediates or degradation products remains elusive. Could
expression of the tetracycline repressor from the vIND G5-V5 (3 op) supplement those
produced from the CV1-G5 cell line? If so, then infection with the vIND G5-V5 (3 op) would
suppress the genetic leakiness seen in the CV1-G5 cell line. These conditions would allow
us to use the CV1-G5 cell line and vIND G5-V5 to address the original question of whether
subgenomic DNA fragments are replication intermediates or degradation products. We
are now poised to conduct such experiments. We could infect CV1-G5 cells with the vIND
G5-V5 virus in the absence of DOX. At 7 hpi, when subgenomic fragments have
accumulated, we will add in DOX to allow for expression of G5. We expect that full-length
genomes would accumulate after expression of G5, but would this be due to de novo
synthesis or recombination of replication intermediates? To further refine these
experiments, we will add cytosine arabinoside (see Fig 4-9) to block de novo synthesis at
7 hpi after adding DOX. Therefore, if we see full-length genomes accumulate, they will
have formed via processing of subgenomic fragments into monomeric genomes.
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